Systems and methods for dissecting tissue - Patents.com

Abstract

An elongated electrode is supported between the two arms and configured to flex, generate plasma, and incise tissue. Each of the arms is configured to penetrate tissue with the electrode supported between them and form a pocket with the incision. Each arm may include a distal tip shaped to penetrate tissue, and an internal curved structure, such as a track, is shaped to allow the electrode to slide over the curved structure while the electrode is tensioned. The internal curved structure may include an electrically insulating material that provides electrical insulation to the tensioned sliding electrode. An opening formed in the lumen allows the electrode to extend between the curved structure and an exposed portion of the electrode suspended between the two arms. The separation distance between the two arms can be adjusted to vary the exposed length of the electrode and create a pocket incision of variable width.

Description

[Technical field]

[0001] (CROSS REFERENCE TO RELATED APPLICATIONS) This PCT application claims the benefit under 35 U.S.C. §119(e) of U.S. Provisional Patent Application No. 63 / 284,587, filed November 30, 2021, entitled "Systems and methods for incising tissue," the entire disclosure of which is incorporated herein by reference.

[0002] The subject matter of this application is related to PCT / US2020 / 070757, filed November 6, 2020, entitled "Systems and methods for incising tissue," and published May 14, 2021 as WO2021092628, and PCT / US2022 / 072626, filed May 27, 2022, entitled "Systems and methods for incising tissue," the entire disclosures of which are incorporated herein by reference. [Background technology]

[0003] Tissue ablation and dissection can be used in many ways to perform procedures, such as surgical procedures. For example, lasers can be used to correct refractive errors, such as myopia, remove cataracts, and treat glaucoma and retinal diseases. Tissue ablation and dissection can also be used in orthopedics and cardiology, for example, to perform surgical procedures.

[0004] Research related to the present disclosure suggests that the effectiveness and availability of surgical procedures may, at least in some cases, be related to the limitations of the devices used to incise and ablate tissue. For example, lasers such as femtosecond lasers may be complex and treatments may take longer than would be ideal. Also, the tissue removal profile along the laser-induced incision may not be as smooth as would be ideal, at least in some cases. Also, in laser treatments, tissue remnants and debris, such as plumes associated with laser irradiation, may affect the accuracy and effectiveness of ablation and incision.

[0005] Mechanical cutting with a blade, such as a microkeratome blade, may be used for some surgical procedures, but research related to the present disclosure suggests that mechanical cutting with a blade may, at least in some cases, be less precise than would be ideal and produce a rougher surface. Mechanical keratomes have been used to generate corneal flaps for surgical procedures such as LASIK, but research related to the present disclosure suggests that mechanical keratomes may take somewhat longer than would be ideal, and the resulting flap may, at least in some cases, be somewhat irregular and rougher than would be ideal. A scalpel or diamond knife may be used to manually cut two separate flaps into tissues such as sclera and / or corneal tissue in conventional tubeplasty, but this is technique-dependent and may be somewhat difficult for at least some practitioners, which may result in associated postoperative complications. It would be useful to reduce technique-dependence and postoperative complications.

[0006] Femtosecond lasers have been used to generate corneal flaps and pockets, but research related to this disclosure suggests that, at least in some cases, the time to form the flap may take longer than would be ideal, and the ablation process may not be as complete as would be ideal. The Small Incision Corneal Leaf Extraction (SMILE) procedure is an approach to reshaping the cornea that utilizes a femtosecond laser system to ablate tissue along the border of a three-dimensional corneal leaflet within a pocket inside the corneal stroma. The leaflet may be removed through a corneal opening, resulting in refractive correction related to the shape of the removed leaflet. However, research related to this disclosure suggests that, at least in some cases, the three-dimensional corneal leaflet formed and removed using this procedure may be shaped sub-ideally, and the ablation process may not ablate the tissue properly. For example, a "tissue bridge" may remain after laser treatment, which may be related to incomplete ablation along the border. To remove the corneal leaflet, the tissue bridge may be mechanically severed from the corneal leaflet before the corneal leaflet is extracted, i.e., "dissecting" the corneal leaflet. This additional dissection step may, at least in some cases, be somewhat more cumbersome than would be ideal and potentially pose some risk to the patient. Because the mechanical dissection may not precisely follow the intended profile of the corneal leaflet to be removed, the refractive correction may, at least in some cases, be sub-ideal and potentially introduce aberrations. Also, the amount of time and energy to ablate the tissue that defines the leaflet and the opening may be somewhat greater than would be ideal.

[0007] Electrodes have been proposed to treat tissue, but previous approaches may potentially result in more tissue damage and less precise incisions than would be ideal. Electrodes that generate plasma have been proposed, but these previous approaches may not be very suitable for cutting large amounts of tissue, and the accuracy may be sub-ideal, at least in some cases. Also, at least some of the previous approaches may be sub-ideal for forming pockets in tissue. Research related to the present disclosure also suggests that infiltration of tissue and conductive materials, such as conductive liquids, into the device may result in sub-ideal performance, at least in some cases. For example, with some surgical procedures, such as eye surgery, it may be useful to hydrate the tissue with a fluid, such as saline, but the presence of saline may reduce the accuracy of the incision, in part, due to the electrical conductivity of the saline.

[0008] In light of the above, there exists a need for an improved approach for treating tissue using incisions that ameliorates at least some of the aforementioned limitations. Ideally, such an approach would reduce complications and treatment times and provide more precise incisions with improved outcomes. Summary of the Invention [Means for solving the problem]

[0009] The embodiments of the present disclosure provide improved methods and systems for dissecting tissue, such as dissecting tissue and forming pockets in tissue. In some embodiments, an elongated electrode is supported between two arms and configured to flex, generate plasma, and dissect tissue. In some embodiments, the arms are each configured to penetrate tissue with the electrode supported between them, which can allow the electrode to be more precisely positioned to form a pocket, such as a corneal pocket, with the dissection. In some embodiments, the arms each include a distal tip that is shaped to penetrate tissue, and an internal curved structure, such as a track, is shaped to allow the electrode to slide over the curved structure while the electrode is tensioned. The internal curved structure may include an electrically insulating material that provides electrical insulation to the tensioned sliding electrode. In some embodiments, an opening is formed in the lumen to allow the electrode to extend between the curved structure and the portion of the electrode suspended between the two arms. In some embodiments, the opening is configured to reduce infiltration of materials, such as tissue and fluids, that could potentially reduce the performance of the electrode.

[0010] In some embodiments, the separation distance between the two arms can be adjusted to vary the exposed length of the electrode and create a pocket incision of variable width. In some embodiments, the arms are adjustable relative to one another to reduce the size of the opening to the incision, such as a pocket, that is formed in the tissue. While the arms can be adjusted in many ways, in some embodiments, the arms are configured to overlap and reduce the size of the opening to the incision. In some embodiments, the location of the overlap is adjusted while the electrode is advanced and retracted in the tissue to correspond with the location of the opening while the width of the incision is varied from side to side.

[0011] The arms can be configured to penetrate tissue in many ways and may include a sharp distal tip to penetrate tissue. In some embodiments, the arms each include a blade that extends to a tip and allows an incision to be made with mechanical movement in the tissue. Alternatively, or in combination, the arms can be configured to incise tissue using plasma.

[0012] An electrical energy source can be operably coupled to the electrode and configured to provide electrical energy to the electrode and generate plasma. In some embodiments, a tensioning element is operably coupled to the elongated electrode. The tensioning element can be configured to provide tension to the elongated electrode and enable the elongated electrode to flex in response to the elongated electrode engaging tissue and generating plasma. In some embodiments, the tensioning element operably coupled to the flexible elongated electrode allows for the use of small diameter electrodes, such as 5 μm to 20 μm diameter electrodes, which can enable thin incisions to be made with reduced tissue damage. In some embodiments, tensioning the electrode allows the electrode to more precisely incise tissue by reducing variability in the position of the electrode along the incision path.

[0013] In some embodiments, the elongated electrode is operably coupled to one or more components to enable tissue ablation along the path. The elongated electrode can be coupled to a support structure that moves with the electrode and provides the incision along the path. The support structure can be configured to support one or more arms, such as a plurality of arms, that support an electrode suspended between the arms. The support structure, the one or more arms, and the elongated electrode may comprise components of an electrode assembly. The electrode assembly can be operably coupled to a translation element to provide translational movement to the electrode to incise the tissue. In some embodiments, a contact plate is configured to engage the tissue and shape the tissue prior to incision with the elongated electrode, which can provide improved accuracy of incision and shaping of the tissue to be removed.

[0014] In some embodiments, a gap extends between the support structure and the electrodes suspended between the arms, which can provide bidirectional tissue dissection and reduce treatment time. In some embodiments, the gap is sized to receive tissue and dissect the tissue extending into the gap as the support structure and electrodes are retracted proximally. In some embodiments, the support structure and electrodes are advanced into the tissue with a first configuration of one or more contact plates on a first pass, dissecting the tissue with the first dissection, and the support structure and electrodes are retracted proximally with a second configuration of one or more contact plates, dissecting the tissue. In some embodiments, the second configuration is different from the first configuration, and the tissue dissected with the first pass extends into the gap and dissected with the second pass to provide an excised volume of tissue for subsequent removal. In some embodiments, the ablated volume of tissue comprises a thickness profile corresponding to the difference between a first profile of the first configuration and a second profile of the second configuration of the one or more contact plates. In some embodiments, a corneal strip corresponding to a refractive correction of the eye is incised with the first and second passes, and the corneal strip can be subsequently removed to provide the refractive correction.

[0015] In some embodiments, the elongated electrode is configured to dissect tissue, such as corneal tissue. A source of electrical energy is operably coupled to the elongated electrode and configured to provide electrical energy to the electrode. A contact plate is configured to engage a portion of tissue, such as the cornea, and shape the tissue prior to dissecting the cornea with the electrode. A support structure can be operably coupled to the elongated electrode and the plate, the support structure configured to move the electrode relative to the plate and dissect the corneal tissue with the electrode.

[0016] In some embodiments, the corneal contact plate is configured to provide complementary interlocking features on the upper and lower surfaces of the incision in tissue, such as corneal tissue.

[0017] In some embodiments, the suction elements are configured to provide complementary interlocking features on the upper and lower surfaces of an incision in tissue, such as corneal tissue, which may be part of a flap or pocket.

[0018] In some embodiments, the elongated electrode is configured to incise a pocket in the tissue.

[0019] In some embodiments, the elongated electrodes are configured to cut variable widths into tissue, such as corneal tissue, which may be part of a flap or pocket. (Incorporated by reference)

[0020] All patents, applications, and publications referenced and identified in this specification are incorporated herein by reference in their entirety and shall be considered to be incorporated by reference in their entirety even if referenced elsewhere in this application. [Brief description of the drawings]

[0021] A better understanding of the features, advantages, and principles of the present disclosure will be obtained by reference to the following detailed description that sets forth illustrative embodiments and the accompanying drawings listed below.

[0022] [Figure 1A] FIG. 1A is directed to a schematic image of an eye shown in cross-section and indicating anatomical locations therein, according to an embodiment of the present disclosure.

[0023] [Figure 1B] FIG. 1B is directed to a plot showing the relationship between measured threshold discharge voltage and pulse duration for negative and positive voltages for a single long, thin electrode, in accordance with an embodiment of the present disclosure.

[0024] [Figure 2A] 2A-2F depict examples of different conditions encountered with varying electrode / tissue spacing and / or electrode voltage, according to embodiments of the present disclosure. [Figure 2B] 2A-2F depict examples of different conditions encountered with varying electrode / tissue spacing and / or electrode voltage, according to embodiments of the present disclosure. [Figure 2C] 2A-2F depict examples of different conditions encountered with varying electrode / tissue spacing and / or electrode voltage, according to embodiments of the present disclosure. [Figure 2D] 2A-2F depict examples of different conditions encountered with varying electrode / tissue spacing and / or electrode voltage, according to embodiments of the present disclosure. [Figure 2E] 2A-2F depict examples of different conditions encountered with varying electrode / tissue spacing and / or electrode voltage, according to embodiments of the present disclosure. [Figure 2F] 2A-2F depict examples of different conditions encountered with varying electrode / tissue spacing and / or electrode voltage, according to embodiments of the present disclosure.

[0025] [Diagram 3]FIG. 3 is directed to plots showing the relationship between measured negative threshold voltage and electrode diameter for fixed pulses of varying duration, in accordance with an embodiment of the present disclosure.

[0026] [Figure 4] 4 and 5 are directed to an electrode subsystem of a system for dissecting a target tissue structure, according to an embodiment of the present disclosure. [Diagram 5] 4 and 5 are directed to an electrode subsystem of a system for dissecting a target tissue structure, according to an embodiment of the present disclosure.

[0027] [Figure 6] FIG. 6 is directed to a system for dissecting a target tissue structure, according to an embodiment of the present disclosure.

[0028] [Figure 7] FIG. 7 depicts a flowchart illustrating steps for practicing a method according to an embodiment of the present disclosure.

[0029] [Figure 8A] 8A-8D are directed to a system for dissecting a target tissue structure, according to an embodiment of the present disclosure. [Figure 8B] 8A-8D are directed to a system for dissecting a target tissue structure, according to an embodiment of the present disclosure. [Figure 8C] 8A-8D are directed to a system for dissecting a target tissue structure, according to an embodiment of the present disclosure. [Figure 8D] 8A-8D are directed to a system for dissecting a target tissue structure, according to an embodiment of the present disclosure.

[0030] [Figure 9] FIG. 9 depicts a flowchart illustrating steps of a method according to an embodiment of the present disclosure.

[0031] [Figure 10A]10A-10F are directed to a system for dissecting a target tissue structure, according to an embodiment of the present disclosure. [Figure 10B] 10A-10F are directed to a system for dissecting a target tissue structure, according to an embodiment of the present disclosure. [Figure 10C] 10A-10F are directed to a system for dissecting a target tissue structure, according to an embodiment of the present disclosure. [Figure 10D] 10A-10F are directed to a system for dissecting a target tissue structure, according to an embodiment of the present disclosure. [Figure 10E] 10A-10F are directed to a system for dissecting a target tissue structure, according to an embodiment of the present disclosure. [Figure 10F] 10A-10F are directed to a system for dissecting a target tissue structure, according to an embodiment of the present disclosure.

[0032] [Figure 11A] 11A and 11B are directed to a segmentally adjustable contact element according to an embodiment of the present disclosure. [Figure 11B] 11A and 11B are directed to a segmentally adjustable contact element according to an embodiment of the present disclosure.

[0033] [Figure 12A] 12A and 12B are directed to a disc-shaped corneal strip, according to an embodiment of the present disclosure. [Figure 12B] 12A and 12B are directed to a disc-shaped corneal strip, according to an embodiment of the present disclosure.

[0034] [Figure 13] 13-15 are directed to different corneal strip configurations according to embodiments of the present disclosure. [Figure 14] 13-15 are directed to different corneal strip configurations according to embodiments of the present disclosure. [Figure 15] 13-15 are directed to different corneal strip configurations according to embodiments of the present disclosure.

[0035] [Figure 16A] 16A and 16B are directed to histological images of a porcine cornea containing an incision made according to an embodiment of the present disclosure. [Figure 16B] 16A and 16B are directed to histological images of a porcine cornea containing an incision made according to an embodiment of the present disclosure.

[0036] [Figure 17] FIG. 17 is directed to a plot showing an exemplary electrode voltage versus time, according to an embodiment of the present disclosure.

[0037] [Figure 18] FIG. 18 is directed to a high speed video image of a porcine cornea being dissected, according to an embodiment of the present disclosure.

[0038] [Figure 19A] 19A-19D depict a side view of a tissue "flap" and a side view of a tissue "pocket" according to an embodiment of the present disclosure. [Figure 19B] 19A-19D depict a side view of a tissue "flap" and a side view of a tissue "pocket" according to an embodiment of the present disclosure. [Figure 19C] 19A-19D depict a side view of a tissue "flap" and a side view of a tissue "pocket" according to an embodiment of the present disclosure. [Figure 19D] 19A-19D depict a side view of a tissue "flap" and a side view of a tissue "pocket" according to an embodiment of the present disclosure.

[0039] [Figure 20] FIG. 20 depicts a side of a system configured to create a tissue flap or tissue pocket according to an embodiment of the present disclosure.

[0040] [Figure 21] FIG. 21 depicts aspects of a system according to an embodiment of the present disclosure.

[0041] [Figure 22A] 22A-22C depict aspects of a system according to an embodiment of the present disclosure. [Figure 22B] 22A-22C depict aspects of a system according to an embodiment of the present disclosure. [Figure 22C] 22A-22C depict aspects of a system according to an embodiment of the present disclosure.

[0042] [Figure 23] FIG. 23 depicts aspects of a system according to an embodiment of the present disclosure.

[0043] [Figure 24A] 24A and 24B depict an embodiment constructed in accordance with the present disclosure. [Figure 24B] 24A and 24B depict an embodiment constructed in accordance with the present disclosure.

[0044] [Diagram 25] FIG. 25 depicts an embodiment constructed in accordance with the present disclosure.

[0045] [Figure 26] FIG. 26 depicts aspects of a system configured in accordance with an embodiment of the present disclosure.

[0046] [Figure 27A] 27A-27C depict aspects of a system configured in accordance with an embodiment of the present disclosure. [Figure 27B] 27A-27C depict aspects of a system configured in accordance with an embodiment of the present disclosure. [Figure 27C] 27A-27C depict aspects of a system configured in accordance with an embodiment of the present disclosure.

[0047] [Figure 28A] 28A and 28B depict aspects of a system configured in accordance with an embodiment of the present disclosure. [Figure 28B] 28A and 28B depict aspects of a system configured in accordance with an embodiment of the present disclosure.

[0048] [Figure 29] FIG. 29 depicts aspects of a system configured in accordance with an embodiment of the present disclosure.

[0049] [Diagram 30] FIG. 30 depicts aspects of a system configured in accordance with an embodiment of the present disclosure.

[0050] [Figure 31A] 31A-31C depict aspects of a system configured in accordance with an embodiment of the present disclosure. [Figure 31B] 31A-31C depict aspects of a system configured in accordance with an embodiment of the present disclosure. [Figure 31C] 31A-31C depict aspects of a system configured in accordance with an embodiment of the present disclosure.

[0051] [Diagram 32] FIG. 32 depicts a side of a system configured to create a pocket incision according to an embodiment of the present disclosure.

[0052] [Figure 33A] 33A-33K depict sides of a system configured to create a pocket incision according to an embodiment of the present disclosure. [Figure 33B] 33A-33K depict sides of a system configured to create a pocket incision according to an embodiment of the present disclosure. [Figure 33C] 33A-33K depict sides of a system configured to create a pocket incision according to an embodiment of the present disclosure. [Figure 33D] 33A-33K depict sides of a system configured to create a pocket incision according to an embodiment of the present disclosure. [Figure 33E] 33A-33K depict sides of a system configured to create a pocket incision according to an embodiment of the present disclosure. [Figure 33F] 33A-33K depict sides of a system configured to create a pocket incision according to an embodiment of the present disclosure. [Figure 33G] 33A-33K depict sides of a system configured to create a pocket incision according to an embodiment of the present disclosure. [Fig. 33H] 33A-33K depict sides of a system configured to create a pocket incision according to an embodiment of the present disclosure. [Figure 33I] 33A-33K depict sides of a system configured to create a pocket incision according to an embodiment of the present disclosure. [Figure 33J] 33A-33K depict sides of a system configured to create a pocket incision according to an embodiment of the present disclosure. [Figure 33K] 33A-33K depict sides of a system configured to create a pocket incision according to an embodiment of the present disclosure.

[0053] [Figure 34A] 34A-34E depict aspects of the pocket incisions and their creation according to an embodiment of the present disclosure. [Figure 34B] 34A-34E depict aspects of the pocket incisions and their creation according to an embodiment of the present disclosure. [Figure 34C] 34A-34E depict aspects of the pocket incisions and their creation according to an embodiment of the present disclosure. [Fig. 34D] 34A-34E depict aspects of the pocket incisions and their creation according to an embodiment of the present disclosure. [Figure 34E] 34A-34E depict aspects of the pocket incisions and their creation according to an embodiment of the present disclosure.

[0054] [Diagram 35] FIG. 35 depicts aspects of the pocket incisions and their creation according to an embodiment of the present disclosure.

[0055] [Diagram 36] FIG. 36 depicts a side of a system configured to create a pocket incision, according to an embodiment of the present disclosure.

[0056] [Figure 37] FIG. 37 depicts aspects of the pocket incisions and their creation, according to an embodiment of the present disclosure.

[0057] [Figure 38] FIG. 38 depicts aspects of the pocket incisions and their creation according to an embodiment of the present disclosure.

[0058] [Figure 39] FIG. 39 depicts a side of a system configured to create a pocket incision according to an embodiment of the present disclosure.

[0059] [Figure 40A] 40A-40E depict aspects of pocket incisions and their creation according to an embodiment of the present disclosure. [Figure 40B] 40A-40E depict aspects of pocket incisions and their creation according to an embodiment of the present disclosure. [Figure 40C] 40A-40E depict aspects of pocket incisions and their creation according to an embodiment of the present disclosure. [Figure 40D] 40A-40E depict aspects of pocket incisions and their creation according to an embodiment of the present disclosure. [Figure 40E] 40A-40E depict aspects of pocket incisions and their creation according to an embodiment of the present disclosure.

[0060] [Figure 41A]41A-41C depict aspects of pocket incisions and their creation according to an embodiment of the present disclosure. [Figure 41B] 41A-41C depict aspects of pocket incisions and their creation according to an embodiment of the present disclosure. [Figure 41C] 41A-41C depict aspects of pocket incisions and their creation according to an embodiment of the present disclosure.

[0061] [Diagram 42] FIG. 42 depicts a side of a system configured to create a pocket incision according to an embodiment of the present disclosure.

[0062] [Figure 43A] 43A-43F depict aspects of pocket incisions and their creation according to an embodiment of the present disclosure. [Figure 43B] 43A-43F depict aspects of pocket incisions and their creation according to an embodiment of the present disclosure. [Figure 43C] 43A-43F depict aspects of pocket incisions and their creation according to an embodiment of the present disclosure. [Fig. 43D] 43A-43F depict aspects of pocket incisions and their creation according to an embodiment of the present disclosure. [Figure 43E] 43A-43F depict aspects of pocket incisions and their creation according to an embodiment of the present disclosure. [Figure 43F] 43A-43F depict aspects of pocket incisions and their creation according to an embodiment of the present disclosure.

[0063] [Diagram 44] FIG. 44 depicts a side of a system configured to create a pocket incision according to an embodiment of the present disclosure.

[0064] [Figure 45A]45A-45F depict aspects of pocket incisions and their creation according to an embodiment of the present disclosure. [Figure 45B] 45A-45F depict aspects of pocket incisions and their creation according to an embodiment of the present disclosure. [Figure 45C] 45A-45F depict aspects of pocket incisions and their creation according to an embodiment of the present disclosure. [Figure 45D] 45A-45F depict aspects of pocket incisions and their creation according to an embodiment of the present disclosure. [Figure 45E] 45A-45F depict aspects of pocket incisions and their creation according to an embodiment of the present disclosure. [Fig.45F] 45A-45F depict aspects of pocket incisions and their creation according to an embodiment of the present disclosure.

[0065] [Figure 46A] 46A-46E depict aspects of the pocket incisions and their creation according to an embodiment of the present disclosure. [Figure 46B] 46A-46E depict aspects of the pocket incisions and their creation according to an embodiment of the present disclosure. [Figure 46C] 46A-46E depict aspects of the pocket incisions and their creation according to an embodiment of the present disclosure. [Figure 46D] 46A-46E depict aspects of the pocket incisions and their creation according to an embodiment of the present disclosure. [Figure 46E] 46A-46E depict aspects of the pocket incisions and their creation according to an embodiment of the present disclosure. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0066] Detailed Description The following detailed description provides a deeper understanding of the features and advantages of the invention described in this disclosure through the embodiments disclosed herein. Although the detailed description includes many specific embodiments, these are provided only as examples and should not be construed as limiting the scope of the invention disclosed herein.

[0067] The disclosed systems and methods are highly suitable for incorporation into previous devices and surgical procedures, such as microkeratomes, e.g., SMILE, that incise tissue and create one or more of a flap, pocket, or corneal strip for removal from the tissue. The disclosed methods and systems are highly suitable for refractive correction and prosthetics, such as removal of corneal stroma to modify the anterior corneal surface and to create a pocket incision for placement of an intracorneal prosthesis. The disclosed methods and systems are highly suitable for lens removal and combination with prosthetics, such as removal of lens nucleus and cortex for placement of an intraocular lens. As a non-limiting example, plasma-induced incisions may be created in the capsule to produce a capsular incision. Incisions may be created to produce lens fragments or to simplify lens fragmentation and / or lens removal. Incisions may be created in the retina to produce a pocket or flap. In some embodiments, incisions are made in the trabecular meshwork TM to improve drainage and / or reduce intraocular pressure ("IOP"), for example, for the treatment of glaucoma, or in the iris to create an iridotomy.

[0068] Although reference is made to incisions in ocular tissue, the systems and methods of the present disclosure are also well suited for making incisions in non-ophthalmic surgical procedures such as orthopedic surgery, cardiovascular surgery, neurosurgery, robotic surgery, pulmonary surgery, urological surgery, and soft tissue surgery. Although reference is made to cutting ocular tissue, the methods and systems of the present disclosure are also well suited for making incisions in one or more of collagen tissue, cartilage, stromal tissue, nervous tissue, vascular tissue, muscle, and soft tissue.

[0069] As a non-limiting example, FIG. 1A illustrates various anatomical locations within the eye that may be suitable for practicing the present disclosure. The eye includes the cornea, sclerocorneal limbus, sclera, capsular bag, lens, retina, iris, and TM. Although not shown, for purposes of clarity, Schlemm's canal may be located adjacent to the TM. The systems of the present disclosure can be used to treat any of these locations. In some embodiments, the cornea is shaped to provide refractive treatment of the eye. In some embodiments, the sclera is incised, e.g., to provide a filtering bleb and treat glaucoma. In some embodiments, at least a portion of the capsule is incised, e.g., to access the cortex and nucleus of the lens. In some embodiments, at least a portion of the lens is incised and removed. In some embodiments, the retina is treated, e.g., with electrodes. In some embodiments, the iris is incised, e.g., with electrodes. In some embodiments, tissue associated with the TM and Schlemm's canal is incised, for example with reference to glaucoma surgery.

[0070] In some embodiments, application of sufficient voltage, including cyclic or pulsatile voltage, to electrodes in or around biological tissue (i.e., "target tissue structure") may result in the formation of vapor derived from an initial current and / or electric field established by heating at least certain components of the tissue (e.g., water in the tissue) in proximity to the electrodes to about the vaporization temperature (or "critical temperature", e.g., 100°C for pure water at standard pressure). The contents of such vapor cavity may then be ionized by the electric field, disrupting (or equivalently "ablating" or "removing") at least a portion of the target tissue structure, and thermal containment may be achieved, thereby reducing the amount of residual damaged tissue produced, particularly if the pulse duration of the pulsatile voltage waveform is sufficiently short compared to the thermal relaxation time of the target tissue structure. The generation of the vapor may be due to a phase change process, and thus the associated temperature increase may cease via a latent heat process once the vaporization temperature is reached. The volume of the vapor cavity (or equivalently, "bubble") may increase as the amount of vapor increases, and may be directly proportional to the electrode voltage and / or current supplied to the tissue by the electrode as a larger volume of tissue is heated. Similarly, the pressure within the bubble may increase as the amount of vapor increases, and may be directly proportional to the electrode voltage and / or current supplied to the tissue by the electrode as a larger volume of tissue is heated. A plasma may then be formed within the vapor cavity, at least in part, by ionizing the vapor if the electrode is operated at a sufficiently large voltage such that the resulting electric field strength within the vapor cavity exceeds the discharge threshold and generates plasma-induced ablation (the combination of which, when generated along the electrode, may generate plasma-induced cutting). As a non-limiting example, the discharge threshold may be selected from the group consisting of an ionization threshold, a dielectric breakdown threshold, a dielectric breakdown threshold, a glow discharge threshold, a plasma threshold, an ablation threshold, a disruption threshold, and combinations thereof. If the electrode voltage is large enough, the resulting electric field strength can enable secondary discharges and produce arcs. Avoiding such arcing can be advantageous, as will be explained elsewhere herein.The plasma can again allow current to flow through the electrode, vapor, and tissue, thus causing further temperature increase. Bulk electrode temperature can be directly proportional to the amount of current flowing through the electrode, and / or surface collisions of ions and charged particles, chemical reactions, and radiation, which itself can be a function of the amount of plasma generated. Energy can be efficiently delivered to the target tissue structure to achieve thermal confinement within at least a portion of the target tissue structure in the vicinity of the electrode and / or vapor cavity, and to generate and / or sustain the vapor cavity. Thermal confinement can be achieved when the energy is deposited in the target at an energy deposition rate that exceeds the energy dissipation rate, such as when the current flows nominally only through the tissue in a time that is less than or equal to about the thermal time constant of the tissue, as can be achieved using a cyclic or pulsatile voltage. The thermal time constant can be the thermal relaxation time, as defined by the size or shape or geometry of the electrode, the size or shape or geometry of the vapor cavity, and combinations thereof. The time constant may alternatively be defined as the mechanical response time, such as the displacement relaxation, due to the transient deformation of tissue adjacent to the collapsing vapor cavity. For a semi-infinite slab of material, the thermal relaxation time τ is: [ka] where d is the distance in the tissue and α is the thermal diffusivity of the tissue. For the sclera and cornea, α is ∼0.14 mm 2 ·s -1 For example, such a thermal relaxation time for a d=~2 μm damage range is τ=~28 μs. Damage is defined herein as at least partially denatured tissue or at least partially denatured tissue components resulting from a mechanism for generating an incision, such as plasma, heating, etc. Such mechanical response times may be dictated by the compressibility and density of the material, which in turn may be related to tissue hydration. For most species, including humans, water may contribute approximately 76% of the weight of the corneal stroma.

[0071] In some embodiments, for example, with respect to examples relating to soft tissue, the following relationship may be satisfied: [ka] can be used to approximate the mechanical properties of the tissue, where K and G are the bulk and shear moduli, respectively; [ka] where β is the tissue compressibility and the average elastic modulus of corneal tissue can range between ∼1 and ∼3 MPa. Thus, a sufficiently concentrated and rapid increase in temperature of a material (i.e., tissue or tissue components or constituents) can vaporize a quantity of that material. The vaporization can be explosive, causing tissue "disruption", also known as "fracture", "rupture", and "ablation". The extent of the vapor cavity can decrease as the electric field strength squares the distance from the electrode (e.g., ∝r -2 ) may essentially mediate a plasma discharge process when operated as described within a compressible material, at least in part due to the transient mechanical deformation and displacement of the material, such as tissue, and the discharge may cease when the bubble grows to an extent where the distance from the electrode surface to the bubble surface is too large to continue to support the discharge throughout the vapor cavity at the operating voltage, as the electric field strength may be proportionally reduced. Maintaining a glow-type discharge, or disabling an arc-type discharge, may be beneficial for producing precision incisions with minimal collateral damage. Flashing light may accompany the plasma. The rate of the flashing of light may depend on the speed. The intensity of the flashing of light may depend on the energy per pulse or power to the electrode.

[0072] In some embodiments, the required voltage and associated energy deposition can be reduced by decreasing the width of the electrode, as shown in FIG. 1B, which contains a plot 600 of the relationship between the negative voltage threshold for tissue vaporization versus the diameter of an elongated cylindrical electrode for .about.50 μs pulses using electrode lengths of .about.1 mm, .about.2 mm, .about.5 mm, and .about.10 mm, corresponding to curves 602, 604, 606, and 608, respectively. Such electrodes can be considered "extended electrodes" due to the aspect ratio between the width and length of the electrode. That is, an extended electrode has a cross-sectional distance that is significantly smaller than its incision length. This voltage can be made as low as possible, and cutting with this voltage can be possible when the voltage exceeds the breakdown threshold without allowing significant thermionic emission, where "significant" refers to an amount that significantly contributes to tissue thermal damage beyond that which would otherwise be present. The electric field around the electrode is as follows: [ka] is proportional to the distance r, such that: e is the electric field at the surface of the electrode, and r e is the radius of the electrode. Thus, the difference between the electrical potential on the surface of the electrode and that at a distance R from the nominally cylindrical elongated electrode is [ka] Thus, it may be said that the electric field is nominally spherical at distances greater than the length L of the electrode, and at distances comparable to L, the potential drops to zero, [ka] The power density of Joule heat generated by a current density j in a conductive material with resistivity γ can be assumed to yield: [ka] The minimum energy density A required to evaporate the surface layer of water in tissue can be calculated as: [ka] where ΔT is the temperature rise of the liquid layer during a pulse of duration τ and ρ=~1 g / cm 3 is the density of water, C=~4.2 J g -1 ·K -1 is its heat capacity. Therefore, the voltage U required for evaporation is [ka] This voltage and associated energy deposition can be reduced by decreasing the thickness of the electrode, i.e., the radius of the aforementioned wire. The pulse duration τ can be calculated based on the thermal relaxation time τ of the target tissue structure for a given electrode geometry. r For example, the 1 / e relaxation time for an oblong cylinder can be kept shorter than [ka] where: [ka] is the thermal diffusivity of the material, k is the thermal conductivity, which is given by α for a pure tungsten wire electrode of ∼20 μm diameter. tungsten =~0.66mm 2 ·s -1 and α tissue =~0.14mm 2 ·s -1 , τ of ~65μs r, i.e., ∼1 / 5 of that of an equivalent cylinder of water or tissue. From these curves it can be noted that for a wire electrode of ∼10 mm length and diameter less than ∼30 μm, utilizing a negative voltage of ∼−200 V may be adequate to dissect the target tissue structure while maintaining a ∼200 V margin to the positive breakdown threshold, as will be described elsewhere herein.

[0073] In some embodiments, the discharge may begin with the vaporization of tissue surrounding the electrode and continue when the voltage is high enough to bridge the ionized gas-filled vapor gap between the electrode and the tissue. If the voltage is not sufficient to maintain such a vapor cavity along the entire length of the electrode, the liquid may contact the electrode and allow current to pass through that interface. The depth of heating may be proportional to the length of the liquid-electrode interface. Thus, the extent of the damage zone may increase with decreasing voltage for an otherwise fixed system. Higher voltages may correct this, but if the voltage exceeds both the negative and positive plasma thresholds, the electrode may become too hot and the plasma discharge may become self-sustaining, as will be explained elsewhere with respect to FIG. 3. Thermionic emission may be avoided, limiting the concomitant damage to the tissue. Turbulence may destroy the vapor cavity and both the electrode and the tissue may be damaged. The electrode may be thin so that a low voltage may support the vapor cavity and the voltage may be slightly above the plasma threshold. A thin thickness of the vapor cavity may be maintained around at least a portion of the electrode at voltages below any plasma threshold. Translating the electrode may allow contact of a small area of ​​tissue, which may be conceptualized as a single contact point or punctate contact. Such punctate contact may produce a sudden vaporization and ignite a plasma discharge in a proportionally confined volume, thereby disrupting the tissue. After one section of tissue has been disrupted in this way, a different section of tissue may already be touching somewhere on the advancing electrode, leading to subsequent vaporization, discharge, and subsequent disruption in this area. The fusion of such disruptions may be considered an incision. The heat distribution around the punctate discharge may be nominally spherical. The extent of the heat deposition may be small, r -4The tissue damage zone may be scaled as r = r ≈ 1 / 2 , where r is the radius of the discharge, and the tissue damage zone may now depend more on the radius of the electrical discharge and less on the length of the electrode. If the radius of the point discharge is in the range of 10 μm, a sequence of such discharges may cut the tissue in a "perforated" or "staccato" manner by repeatedly destroying different regions of the tissue along the electrode length (i.e., in non-contiguous locations, or equivalently, in non-overlapping regions), leaving a damage zone only about a few μm thick. These discontinuous decomposition regions may be considered to constitute non-uniform decomposition. Such discontinuous decomposition may be achieved if the electrode is allowed to flex (or equivalently, "deform" or "vibrate" or "bend" or "stretch") as described elsewhere herein. Constant arcing may be avoided and the plasma may be allowed to remain in the glow regime by repeatedly destroying regions of the tissue, thereby modulating the electrode voltage and reducing damage from thermal ions and resulting thermal effects. The different regions of tissue within the target tissue structure that may be repeatedly destroyed may, but need not, be adjacent to one another.

[0074] 2A illustrates electrode 702 approaching tissue 2 along direction 12 with a gap 622 existing between electrode 702 and tissue region 620, the region of tissue closest to the elongated electrode. In this exemplary embodiment, both ends of electrode 702 are connected in parallel to driver 18 via connection 20, with the return path to driver 18 being via connection 22 from return electrode 24. Driver 18 may be considered to be an electrical energy source that provides electrical energy to the electrode to produce plasma in the target tissue structure.

[0075] FIG. 2B illustrates an initial instantaneous connection of the electrode 702 with the tissue 2 at the contact area 620, with the gap 622 decreasing to .about.0.

[0076] 2C illustrates a condition where the magnitude of the voltage on the electrode 702 exceeds at least a negative voltage plasma threshold in region 620 (not shown), which may cause vaporization of at least components of tissue 2 in tissue region 626, creating a vapor cavity 635, and allowing current 624 to flow to the return electrode 24, creating a damage zone 628. Such damage zone 628 may then be limited in extent to a volume of tissue immediately adjacent to tissue region 620, and any such tissue regions 625 and 627 may become the next portion of tissue 2 to initiate vaporization in the same manner as region 620 previously did, as described elsewhere herein, creating a staccato process, where a non-contiguous portion of the electrode may contact an associated non-contiguous portion of the target tissue during dissection. The discharge may begin with vaporization of tissue surrounding the electrode and continue while the voltage is high enough to bridge the gap vapor between the electrode and the tissue and ionize the vapor in the gap. If a portion of such an electrode does not have contact with tissue, as may be the case when, for example, a vapor bubble is formed centered in that region of the electrode, the electrode temperature may rise and increase resistivity. For example, as may occur when a portion of a wire draws more current than another portion of the wire when connected in series to a power source in a "power limited mode," the average power may remain constant, but localized overheating in the region of increased resistivity may cause a portion of the wire to vaporize and break down. However, this may be reduced (or avoided) if the electrodes are placed at a common voltage, as may occur when both ends of a wire are connected to the same location in a circuit (or "node"). In this exemplary configuration, when one portion of the electrode becomes more resistive due to overheating and current may pass through another portion of the electrode, the current through the heated region may decrease, as described above with respect to the series connection configuration, keeping the wire from breaking. The speed of the moving electrode may be selected to satisfy the condition of constant tension below the burst tension of the wire. Too little tension can reduce the rate. If the electrode is not in contact with the tissue, there can be no heat transfer from the electrode to the tissue and the electrode temperature can increase.The arc current may then increase due to the electrode temperature increase, initiating a positive feedback loop that may cause overheating of the tissue and / or electrode when the electrode is under relaxed and / or low tension conditions, which in turn reduces the likelihood that a small area of ​​tissue will contact the electrode and produce the aforementioned staccato discharge. Since the plasma threshold is polarity dependent, the discharge may act as a rectifier, and the rectified current may be used as feedback to cut at about the minimum negative voltage threshold for plasma discharge, including, as a non-limiting example, operation in the glow discharge regime. In this configuration, the damage zone may now depend on the radius of the electrical discharge instead of the electrode length. A perforation sequence of discharges, the range of which is in the ∼10 μm range, may result in a damage zone between ∼1 μm and ∼3 μm thick. The duty cycle of the power supply (e.g., driver 18 or “electrical energy source”) may be kept at ∼100% in this configuration due to the perforation discharge process.

[0077] 2D illustrates a condition in which the voltage on the electrode 702 falls below the plasma threshold and may fail to maintain a vapor cavity 635 such as region 626 in the previous figure, expanding the contact area 620 along the electrode 702 and producing an extended contact area 630 that is larger than the contact area 620, allowing more current 624 to flow from the electrode 702 through the tissue 2 to the return electrode 24, producing a damage zone 628 larger than that of FIG. 2C that may extend to a portion of the tissue 2 behind in the direction 12 via thermal conduction. If the electrode voltage fails to maintain the vapor cavity 635 along the electrode, tissue and / or liquid may contact the electrode, allowing large currents to pass through the interface. The extent of the damage may be proportional to the length of the electrode-tissue interface, i.e., the extended area 630. Thus, the damage zone extent may increase with decreasing voltage. Similarly, a large damage zone may also occur if no voltage is supplied to the electrode prior to its contact with the tissue, since a relatively large portion of the electrode may simultaneously contact the tissue before the discharge process is initiated. To avoid such damage, a threshold voltage may be applied to the electrode before it contacts the tissue and an incision is produced, as described with respect to FIG. 2C. Another way to protect the tissue from overheating may be by using a non-conductive liquid such as ElectroLubeSurgical or a viscoelastic substance (e.g., Healon). Such a non-conductive liquid may serve as both a coolant and a protection against current-related tissue damage, such as electroporation. For example, a non-conductive liquid may be injected into the cutting area to protect tissue near the target tissue that may be in the current return path. The non-conductive liquid may also be cooled before use.

[0078] FIG. 2E illustrates a condition in which the magnitude of the voltage on the electrode 702 may exceed both the negative and positive plasma thresholds, producing a contact area 620 extending along the electrode 702 and producing a vaporization area 626 that may exceed that of the vaporization area 626 in FIG. 2C. Similarly, more current 624 may flow from the electrode 702 through the tissue 2 to the return electrode 24 in this configuration than in FIG. 2C, producing a larger injury zone 628 than in FIG. 2C. An electrode voltage that exceeds both the negative and positive plasma thresholds may cause the electrode to become hot enough to provide self-sustaining thermionic emission. Turbulence may block the vapor cavity 635, damaging the electrode and / or tissue.

[0079] The elongated electrode may comprise a nominally circular cross-section (or "rounded") wire, and a reduction in electrode width may be comparable to a reduction in the diameter (or equivalently, its "cross-sectional distance") of the wire. The voltage may be kept as low as possible while still rupturing the tissue to avoid overheating the target tissue. The electric field from a nominally cylindrical electrode may tend to zero at a distance on the order of the electrode length, which may in turn cause an unnecessarily extended damage zone in the tissue when using such an electrode with an aspect ratio ≫ 1 (e.g., when the electrode comprises a long, thin wire). The staccato process of tissue destruction as described herein may provide a reduced damage zone due to the inherent interruption of the current flowing through the tissue that may accompany the approach, since in the absence of tissue disruption, the current may nominally flow substantially only through the tissue when the tissue contacts the electrode.

[0080] Although typically circular in cross section, wires may be made in square, hexagonal, flattened rectangular, or other cross sections. Thus, electrodes may alternatively be constructed using conductors of nominally non-circular cross section, such as those of rectangular cross section. Such nominally non-circular cross section wires may be available from Eagle Alloys (Talbott, TN). Rectangular cross section electrodes may be produced by stamping foil sheets, such as those also available from Eagle Alloys (Talbott, TN). Non-circular cross section electrodes may further be configured such that their thinnest dimension is nominally parallel to the translation direction to provide electrode deformation capability along the translation direction and increased stiffness in the orthogonal direction. Conductive wires or threads with high melting points that form part of an electrical circuit may be referred to as filaments, as would be understood by one skilled in the art.

[0081] FIG. 2F illustrates a condition where the electrode 702 can be comprised of electrode regions 650, 652, and 654 that do not necessarily represent the entire incision length. The electrode as shown is deforming during the incision, and electrode regions 652 and 654 are displaced in the direction of motion 12 while electrode region 650 is not displaced, which can occur when at least one of electrode regions 650-654 is flexible. As a non-limiting example, configuring electrode 702 to be flexible, such as by using a thin wire for at least a single region of electrode regions 650-654, can provide such deformation capability. In an exemplary embodiment, the new region of tissue closest to the electrode, the most proximal tissue region 620, is now approached by electrode region 652, which was tissue region 625 in FIG. 2C, and can become the next portion of tissue 2 to cause vaporization in the same manner as region 620 was previously performed, creating a piece-wise incision. The shape of tissue 2 is altered by ablation of at least a single tissue region, thus causing a portion of tissue 2 to undergo vaporization in the same manner as previously performed region 620, creating a segmental incision, and the non-contiguous portions of the electrodes may contact the associated non-contiguous portions of the target tissue during the incision.

[0082] Figure 3 shows a ~8 mm long fish immersed in a bath of physiologically balanced salt solution. [ka] A plot 610 is shown measuring the relationship between polarity dependent voltage thresholds for vaporization versus pulse duration for negative voltage discharge (curve 614) and positive voltage discharge (curve 612) using a pulsatile voltage delivered with a tungsten wire electrode, and observing such discharges using a camera. The lower threshold voltage for the negative discharge regime may help to create incisions with less damage than those of the positive discharge regime due to the associated lower current. Thus, the driver 18 may be configured to utilize a negative voltage bias.

[0083] A pulsating voltage waveform can be used to generate the plasma as described. In water, for example, the vapor cavity operates with a nominally sinusoidal waveform having a peak voltage of .about.300V. [ka] Away from the thick electrode, ~0.5 m s averaged over a bubble lifetime of ~500 μs -1The plasma expands at an average rate of 100 Hz and may cease to discharge due to collapse of the vapor bubbles (and possible subsequent cavitation), which may transfer momentum between the material and the electrode. In this configuration, the time required to reignite the plasma may be on the order of a few milliseconds, which is long compared to the pulse period of energized waves in the MHz regime, which may require significantly larger voltages to sustain the discharge. However, if the distance between the tissue and the electrode surface is reduced, such as by moving the electrode, the destruction may be reinitiated more quickly. The velocity of the resulting cut produced by the plasma may be referred to herein as the "tissue velocity." The frequency of the pulsating electrode voltage may be configured in the MHz range, allowing multiple cycles during tissue destruction and / or bubble life. As a non-limiting example, the nominal type of the waveform may be selected from the group consisting of a sinusoidal waveform, a square waveform, a triangular waveform, a ramp waveform, a periodic waveform, an aperiodic waveform, and combinations thereof. The amount of time it takes for the electrode to move into contact with the tissue and for evaporation to occur may be longer than the amount of time it takes to complete the discharge process. When the electrode is not disrupting the tissue, it may be in a cool state, and the time when the electrode is in contact with the tissue and not disrupting it may cause tissue damage due to heat diffusion from the electrode into the tissue, which in turn may require more energy to overcome the reduced electrode temperature. Thus, a lower cutting duty cycle may produce more collateral thermal damage to the tissue than a higher cutting duty cycle.

[0084] In some embodiments, the inability to achieve thermal containment may result in collateral tissue damage. For example, this may be true for rigid electrodes, since while the velocity at all locations along the electrode is constant, the velocity of the tissue along the electrode may not be constant, i.e., there may be a distribution of tissue velocities in both time and space along the cutting edge of the electrode. A rigid electrode may only move as fast as the slowest cutting speed it achieves. That is, a rigid electrode may cut a complete path along its cutting edge in order to advance and further cut, and therefore may need to limit the instantaneous cutting speed by compacting areas of tissue onto the electrode prior to cutting, allowing only an average cutting speed. Hot spots along the cutting edge of a rigid electrode may provide point-like evaporation, but those same locations may then linger in the tissue, even with a rigid extending electrode, awaiting similar destruction elsewhere. The time spent lingering may be longer than the thermal or mechanical response time of the tissue, resulting in collateral damage due to heat dissipation into the tissue, especially in the presence of excess liquid. A more efficient use of energy may be the desiccation of the next area of ​​tissue to be incised. Activating a rigid electrode at too fast a translation rate may not allow complete incision and may cause "traction forces." Collateral damage may therefore be reduced if the activation rate of the electrode is nominally matched to the discharge rate within the vapor cavity 635.

[0085] In some embodiments, the deformable electrode may move with a piece-by-piece velocity profile through the material it cuts. That is, unlike a conventional rigid electrode, a portion of the deformable electrode may advance into the cavity (or "bubble") created by the vaporization event, then vaporize a new region of tissue before other regions along the electrode advance in a similar manner, thus allowing a velocity distribution of instantaneous cutting speed along the electrode. Such a deformable electrode may be kept under tension along its length, which in turn may advance the deformable electrode through tissue at a rate determined, at least in part, by the average cutting rate, and at least in part, by the local cutting rate, which itself may be determined, at least in part, by the tension on the electrode. The mass (or mass density) and / or stiffness of the deformable electrode may at least in part dictate its ability to advance into the cavity created by the vaporization event. The average cutting rate can be influenced by moving the electrode or electrode assembly (e.g., along the x-axis, where +x may be defined as the intended direction of incision) using a translation element (or "translation device") and actuator. As non-limiting examples, the translation element may be selected from the group consisting of a translation stage, a linear stage, a rotary stage, a rail, a rod, a cylindrical sleeve, a screw, a roller screw, a traveling nut, a rack, a pinion, a belt, a chain, a linear motion bearing, a rotary motion bearing, a cam, a flexure, a dovetail, and combinations thereof. As used herein, the terms "stage" and "slide" are considered equivalent when used to describe a translation element, device, or system. As non-limiting examples, such actuators may be selected from the group consisting of a motor, a rotary motor, a squiggle motor, a linear motor, a solenoid, a rotary solenoid, a linear solenoid, a voice coil, a spring, a moving coil, a piezoelectric actuator, a pneumatic actuator, a hydraulic actuator, a fluid actuator, and combinations thereof. Alternatively, the electrode assembly may be manually actuated.

[0086] In some embodiments, the tension may be selected to accommodate the stiffness of the material being used to form the electrode, as may be represented by its elastic modulus. By way of non-limiting example, the elastic modulus may be selected from the group consisting of flexural modulus, Young's modulus, bulk modulus, section modulus, and shear modulus. For a deformable electrode that is supported by a support structure at least at a single end, the elastic modulus E of the electrode material may be determined by the allowable deflection distance. [ka] where L is the unsupported length of the electrode, and I is the second moment of area for the cross-sectional shape of the electrode, which can be used to determine the tension F for the electrode, as explained previously herein, ∼2r e For a rectangular electrode, [ka] where w is the thickness of the electrode in the direction perpendicular to the deflection and h is the thickness of the electrode in the direction of deflection. Similarly, the second moment of a cylindrical electrode, such as a wire, can be given by: [ka] where r represents the radius of the cylinder.

[0087] In some embodiments, there may be a trade-off, particularly in systems with a moving elongate electrode, between the characteristic range of the electrode (i.e., “dimension” or “thickness” or “size”) (e.g., diameter in the case of a wire or other such elongate electrode) and its corresponding mechanical stability, and thus the strength and durability of the instrument constructed thereby. Thus, a thin wire electrode that is tensioned and stretched may relax and provide increased mechanical stability over a thin wire electrode. The increased mechanical stability may represent increased incision accuracy (e.g., such an electrode may be less likely to drift laterally with respect to the incision direction). Alternative embodiments may further comprise a tensioning element mechanically coupled to the electrode to provide a more constant tension nominally on the electrode. The thin deformable elongate electrodes as described herein have a fundamental frequency (or equivalently, a mechanical resonance frequency)

Chemical formula

Chemical formula

Chemical formula

Chemical formula

[0088] In this configuration, such an electrode can be translated in the x-direction, displaced ("repelled") by x=~20 μm, [ka] A system of such deformable electrodes may produce a local peak velocity of ∼1 m s 2 , which is constrained to motion primarily along the x-axis, the cutting direction (i.e., parallel to the direction of electrode translation, or equivalently, transverse to the direction of elongation), thereby minimizing lateral errors to the intended cutting direction. Such a configuration may provide reduced thermal damage and / or reduced traction forces compared to that of a system consisting of rigid electrodes, since primary heat deposition and / or heat spread may be relatively reduced by utilizing such deformable electrodes to better match tissue velocities. Such deformable (or "flexible") electrodes may have a local velocity of ∼1 m s 2 , which may be inversely proportional to the deflection on the electrode, and which may tend to follow the plasma and relieve increased tension thereon. -1 , and thus may move faster than its associated plasma cuts tissue. In doing so, the electrode may be said to "flex" or "deform" or "vibrate" or "stretch" or "bend". Thus, an elongated electrode as described herein may vibrate transversely to the axis of elongation of the electrode. As a non-limiting example, the following table lists various configurations of electrode materials, sizes, and their corresponding mechanical resonant frequencies. [Table 1]

[0089] In some embodiments, thermal containment can be achieved if the discharge is produced within a single cycle of the pulsating voltage waveform, such as within a nanosecond time frame. From the laser-tissue interaction field, it can be seen that explosive vaporization with a nanosecond pulse can produce peak temperatures of 200° C., and the resulting volume of the void (or “crater” or “cavity”) can exceed the volume substantially heated by 50%. For example, photodisruption is known to produce such damage volumes. The ejection of steam and / or moisture and / or debris from the incised area can inhibit the formation of an arc discharge between the electrode and its environment, even at high temperatures, which a thin deformable electrode can inherently provide, especially if the deformable electrode contacts tissue along an area that is less than its circumference and produces a void that is larger than the interaction volume as described for certain effects of photodisruptive nanosecond laser pulses. This extended damage volume can aid in the ejection of debris and / or moisture and / or steam. For example, the ejection of moisture. [ka] The energy E required to heat the sphere from ~20°C to ~200°C is [ka] However, a bubble smaller than the extent of the electrode may nevertheless provide a resulting cavity of sufficient extent to allow passage of the entire electrode, as may be the case with tissue contact along only ≈1 / 2 to ≈2 / 3 of the electrode circumference (or equivalently, only ≈1 / 2 to ≈2 / 3 of the electrode diameter as geometrically projected onto the tissue), due to the resulting increase in crater volume. In this case, the corresponding reduction in energy required to induce a plasma is [ka] and the extent of the resulting crater may be, as may be particularly true for mechanically compliant tissues, [ka] As a non-limiting example, a power of ∼15 W may be sufficient to accommodate an entire electrode of ∼10 mm incision width, with a pulse repetition frequency ("PRF") of ∼1 MHz (or equivalently, ∼1.5 W mm -1 (average linear average power density) delivered to the electrode, and τ pulse For example, for PRF = 1 MHz and E = 1 μs, it can provide an energy per cycle (or "pulse") of 15 μJ. pulse = ~15μJ, works as described, ~10mm long [ka] For a wire electrode, the effective ablation length per pulse is given by the following relationship: [ka] can be observed, and L a can be 1.32 mm. Furthermore, L a does not have to comprise a single continuous length, but rather the individual lengths of the discontinuous zones (or equivalently, non-overlapping regions) may be approximately L per pulse. a The electrode may also be comprised, at least in part, of separate instances of discrete ablations or discrete ablation regions distributed along the entire electrode length, such that they may sum to a value of [ka] L etc. a The effective translational velocity (or "rate"), v, is determined by a Continuing with the previous exemplary configuration, a 10 mm long catheter may be inserted into the catheter and translated through the tissue. [ka] The total effective length along the electrodes is ~1.32 mm, which is ~660 mm s -1 The effective translation velocity v a , while the electrode may deform as it cuts, and the actual local peak velocity of at least a single portion of the electrode may be greater than the velocity of underlying translation via the actuator, v, as described elsewhere herein. t and due to the elasticity of the electrode and the tension applied to it, v a That is, v t v a does not have to be equal to v t is ~1mm s -1 and ~5,000 mm s -1 Optionally, v t is ~10mm s -1 and ~1,000 mm s -1 Optionally, v t is ~50mm·s -1 and ~500mm·s -1 As a non-limiting example, PRF=~1 MHz and E pulse = ~10mm long under ~300mN tension operating with ~15μJ [ka] The tungsten wire is ~300mm·s -1 Peak V t , can be translated with a plasma to incise the corneal tissue with minimal concomitant damage. In view of the foregoing, the system can be configured to allow the electrode velocity to nominally match the tissue velocity with the moving front of the plasma-induced bubble along the length of the deformable electrode being translated through the tissue to be incised. Variable velocities can be used as discussed elsewhere herein.

[0090] FIG. 4 shows that tensioned electrode assembly 5 may include tension element 700, which in turn may be operatively coupled to electrode 702 and affixed to electrode assembly 4 via attachments 704 and 706, such that tension element 700 allows electrode subassembly 702 to flex while in contact with tissue 2 (not shown in this figure). The incision portion of electrode 702 may comprise only a portion of the conductive portion of electrode 702. Radial structures 708 located on arms 710 and 712 may provide a smooth surface for electrode 702 during extension to avoid excessive strain that may be imparted at more abrupt transitions. Arms 710 and 712 may be considered at least part of a support structure intended to provide mechanical stability to at least a portion of electrode 702. A gap may exist between arms 710, 712 and may serve to receive tissue before and / or during and / or after creating an incision, as shown in this embodiment. In some embodiments, the tensioned electrode assembly 5 comprises a support structure, as described herein.

[0091] In some embodiments, a processor, e.g., a controller, is operably coupled to the elongated electrode and provides movement to the elongated electrode. For example, the processor can be configured with instructions provided to control an actuator to move one or a component of the electrode assembly. In some embodiments, the processor is configured with instructions, for example, to advance the electrode distally and retract the electrode proximally.

[0092] In some embodiments, the elongated electrode is sized for insertion into the tissue, and the processor is configured with instructions to dissect the tissue with the electrode to define a volume of dissected tissue within the pocket. While the volume can be configured in many ways, in some embodiments, the volume comprises a shape profile, for example, a shape profile of a corneal strip. In some embodiments, the processor is configured with instructions to move the electrode with a first movement to define a first dissected surface on a first side of the tissue volume, and with a second movement to define a second dissected surface on a second side of the tissue volume. In some embodiments, the processor is configured with instructions to advance the electrode distally to define a first surface on the first side of the tissue volume, and retract the electrode proximally to define a second surface on the second side of the tissue volume. In some embodiments, a gap extends between the elongate electrode and the support structure, the gap being sized to receive tissue such that the tissue extending into the gap is incised as the electrode is retracted proximally.

[0093] In some embodiments, the movement of the electrodes is coordinated with the shape of one or more contact plates to define the incised tissue volume. In some embodiments, the contact plate comprises a first configuration to define a first surface on a first side of the tissue volume and a second configuration to define a second surface on a second side of the tissue volume. In some embodiments, the first contact plate comprises a first shape profile to define a first surface on a first side of the tissue volume and a second shape profile to define a second surface on a second side of the tissue volume, for example, the first and second surfaces of a corneal strip comprise the tissue volume. In some embodiments, the contact plate comprises a plurality of actuators operably coupled to a processor, the processor configured with instructions to shape the contact plate with a first surface profile for the first incision and to shape the contact plate with a second profile for the second incision. In some embodiments, the processor is configured with instructions to shape the contact plate with a first profile, cut a first side with a first shape profile, shape the contact plate with a second profile, and cut a second side with a second profile, wherein the total time is, for example, about 10 seconds or less, e.g., 5 seconds or less, or 2 seconds or less.

[0094] The support structure may be fabricated at least in part from a material selected from the group consisting of tungsten, nitinol, steel, copper, brass, titanium, stainless steel, beryllium-copper alloy, cupronickel alloy, palladium, platinum, platinum-iridium, silver, aluminum, polyimide, PTFE, polyethylene, polypropylene, polycarbonate, poly(methyl methacrylate), acrylonitrile butadiene styrene, polyamide, polylactic acid, polyoxymethylene, polyether ether ketone, polyvinyl chloride, polylactic acid, glass, ceramic, and combinations thereof. The tension element 700 may be connected directly to at least a portion of the electrode subassembly 4 as shown, or alternatively to at least a portion of a subsequent element to which the electrode subassembly 4 is attached, such as the coupler 52 or the electrode assembly mount 17. As non-limiting examples, the tension element 700 may be a spring, a coil spring, a leaf spring, a torsion spring, an elastic mesh, a hinge, a living hinge, and combinations thereof. The deformable electrode may be supported by a support structure and allowed to deform while generating plasma-induced incision in the target tissue or target tissue structure. The electrode (e.g., electrode 702 or a portion thereof) may be at least partially composed of a material selected from the group consisting of tungsten, nitinol, steel, copper, brass, titanium, stainless steel, beryllium-copper alloy, cupro-nickel alloy, palladium, platinum, platinum-iridium, silver, aluminum, and combinations thereof. Alternatively, the electrode may comprise a wire composed of the same materials listed immediately above. Alternatively, the electrode may be coated in an area to inhibit conduction and / or incision in that area. Alternatively, tubing may be used in place of a coating to insulate an area of ​​the electrode. Such coatings or tubing may be selected from the group consisting of polyimide, PTFE, polyethylene, polypropylene, polycarbonate, poly(methyl methacrylate), acrylonitrile butadiene styrene, polyamide, polylactic acid, polyoxymethylene, polyether ether ketone, polyvinyl chloride, polylactic acid, glass, ceramic, and combinations thereof.The electrodes (e.g., electrode 702) may be wires having a diameter between 3 μm and 300 μm. Alternatively, the wires may have a diameter between 10 μm and 50 μm. Alternatively, the wires may have a diameter between 12 μm and 17 μm. Tension element 700 was tensioned to 295 mN, which may also correspond to an elongation of 0.5%. [ka] As may be the case for tungsten wire in, the electrode may be configured to provide a tension such that the resulting force on the electrode is .about.80% of the rated or measured yield strength of the electrode or its material. Optionally, the tension may be between .about.50% and .about.95% of the yield strength. Optionally, the tension may be between .about.70% and .about.85% of the yield strength. Other configurations may also be proportioned using relationships related to moment of area second as described herein above with respect to allowable deflection distance (e.g., [ka] 4.7 N or 3.8 N rated yield tension for a nominally pure tungsten wire with a diameter of 4.7 N. The coupler 52 may be operatively coupled to the cutting electrode mechanism 502 via the coupler 74. As a non-limiting example, the coupler 74 may be a receptacle configured to receive a disposable module consisting of the element electrodes 4, the coupler 52, and the electrode mounting portion 17, the electrode mounting portion 17 comprising mating features compatible with those of the coupler 74, such as threads, clasps, snap fittings, and combinations thereof. The cutting electrode mechanism 502 may further comprise mating features compatible with those of the couplers 71 and 72, which may themselves be mechanically coupled to the actuators 50 and 504, respectively, to provide an axis of motion to move at least a portion of the electrode subassembly 4 and tensioned electrode assembly 5 to create an incision in tissue 2 (not shown). Alternatively, by way of non-limiting example, the element electrode subassembly 4, coupler 52, electrode mount 17, cutting electrode mechanism 502, and coupler 74 may be packaged within the probe body 26 as a disposable module configured to engage a more complete dissection system and actuate the electrode or electrode assembly or probe assembly along the axis of motion 12. Although not shown for reasons of clarity, at least a portion of the probe body 26, including the tensioned electrode assembly 5, may be adapted to move using a translation element to ensure mechanical stability and accuracy along at least a single direction of motion.

[0095] FIG. 5 shows a tensioned electrode assembly 5 similar to that of FIG. 4, where the radial structure 708 may further include a channel 720 within which the electrode 702 may be placed, which may reduce positional errors due to unintentional electrode movement, particularly transverse to the intended incision direction. The tension element 700 may be configured as a living hinge (or hinge, as shown) within or along the arms 710 and 712. The arms 710 and 712 may be made of a notched rigid material, as shown, to provide a living hinge 722. As non-limiting examples, materials suitable for creating a living hinge may be selected from the group consisting of polyethylene, polypropylene, polycarbonate, poly(methyl methacrylate), acrylonitrile butadiene styrene, polyamide, polylactic acid, polyoxymethylene, polyether ether ketone, polyvinyl chloride, beryllium copper, and combinations thereof. In cases where the living hinge 722 is integral to the arm 710 or 712 and an electrically conductive material may be selected, such cutting electrode may be soldered, brazed, adhered with a conductive adhesive, and / or welded to the arm. In cases where the living hinge is integral to the arm 710 or 712 and an electrically insulating material is selected, the electrode 702 may be otherwise adhered to the arm or soldered, brazed, and / or welded to an adjacent conductive material.

[0096] FIG. 6 illustrates system 800, a system for dissecting tissue such as ocular tissue, including cornea, limbus, and stromal tissue. System 800 may include a tensioned electrode assembly 5 similar to that of FIGS. 4 and 5. Electrode subassembly 4 may be coupled to electrode mounting portion 17 via coupler 52. As a non-limiting example, coupler 52 may be made to be at least partially electrically insulated. Electrode subassembly 4 may include arms 710 and 712, electrode 702, and tension element 700 operably coupled to electrode 702 and affixed via attachments 704 and 706 to create tensioned electrode assembly 5 such that tension element 700 may allow electrode 702 to stretch while in contact with tissue 2. Attachments 704 and / or 706 may be achieved via soldering, brazing, adhesives, compression fittings, crimping, and combinations thereof. Radial structures 708 located on arms 710 and 712 may provide a smooth surface for electrode 702 during extension to avoid excessive strain that may be incurred at sharper corners. Tension element 700 may be connected directly to a conductive portion of electrode 4 or alternatively to a subsequent element to which electrode 702 is configured, such as coupler 52 or electrode mount 17. An incision may be made by moving along axis of motion 12. In this exemplary configuration, tensioned electrode assembly 5 may consist of elements 700, 702, 704, 706, 708, 710, and 712, all of which may be constructed at least in part from conductive materials and thus held at approximately the same voltage by driver 18 (not shown), all of which may be considered to comprise tensioned electrode assembly 5. Alternatively, electrode subassembly 4 and tensioned electrode assembly 5 may be identical.Alternatively, some of the aforementioned elements may be at least partially composed of electrically insulating material and therefore may not be at the same electrical potential as other elements composed at least partially of conductive material, and the electrode subassembly 4 may be considered to be a subsystem of the tensioned electrode assembly 5, as shown, with only those elements comprising at least partially conductive material. As non-limiting examples, the tension element 700 may be a spring, a coil spring, a leaf spring, a torsion spring, a resilient mesh or web, a hinge, a living hinge, and combinations thereof. The torsion spring may be such as that found in a stapler. As non-limiting examples, the conductive electrode material may be selected, at least in part, from the group consisting of tungsten, nitinol, steel, copper, brass, titanium, stainless steel, beryllium-copper alloy, cupro-nickel alloy, palladium, platinum, platinum-iridium, silver, aluminum, and combinations thereof. Alternatively, the electrode 702 may be at least in part composed of a wire composed of the same material. Alternatively, the electrode subassembly 4 may be comprised of elements, at least in part, of an electrically insulating material. Alternatively, the electrode subassembly 4 may be coated in certain areas to inhibit conduction and / or dissection in those areas. Similarly, tubing may be used in place of a coating to insulate areas of the electrode assembly. By way of non-limiting example, such coatings or tubing may be selected from the group consisting of polyimide, PTFE (e.g., Teflon), polyethylene, polypropylene, polycarbonate, poly(methyl methacrylate), acrylonitrile butadiene styrene, polyamide, polylactic acid, polyoxymethylene, polyether ether ketone, polyvinyl chloride, polylactic acid, glass, ceramic, and combinations thereof. A return electrode (not shown) may be placed on or near the patient's eye and connected to the driver 18. A series load of between .about.150 .OMEGA. and .about.500 .OMEGA. may be placed in line with the electrode to provide a current limit. The coupler 52 may be operably coupled to the cutting electrode mechanism 502 via the coupler 74.Alternatively, as non-limiting examples, the element electrodes 4, coupler 52, electrode mount 17, cutting electrode mechanism 502, coupler 74, or a subset thereof may be packaged as a disposable module configured to engage within probe body 26 and thus system 800 via couplers 71 and 72, which may comprise mating features compatible with those of actuators 50 and 504, respectively, such as threads, clasps, snap fittings, and combinations thereof. Actuator 504 provides an axis of motion (or equivalently, e.g., "translation" along the direction of motion of axis of motion 14) and may be coupled to position encoder 51 via connection 53, and both position encoder 51 and actuator 50 may be connected to a translation device and / or actuator driver 57 via connections 55 and 59, respectively. As non-limiting examples, connections 55 and 507 may comprise at least one of the following: mechanical couplers, electrical couplers, magnetic couplers, and optical couplers. Actuator 504 also provides an axis of motion (e.g., axis of motion 12) and may be coupled to position encoder 506 via connection 505, and both position encoder 506 and actuator 504 may be connected to actuator driver 508 via connections 509 and 511, respectively. Note that only a single axis of motion may be relied upon in practicing certain embodiments of the present disclosure, such as in the generation of a corneal flap utilizing a single incision. Motion axes 14 and 12, which are the axes of motion for actuators 50 and 504, respectively, may be configured to be orthogonal, or at least non-colinear. Actuators 504 and 50 may be configured to actuate tensioned electrode assembly 5 or a portion thereof along motion axes 12 and 14. Position encoders 51 and 506 may be mechanically coupled to the module onto which electrode subassembly 4 is mechanically coupled via connections 55 and 507, respectively, to provide more reliable position information than non-co-located sensors may provide.Alternatively, the actuator 50 may be configured to correspond to (or "move along") the axis of motion 14 and made to actuate (or "translate") the contact plate 804, and the connection 55 may be made with the contact plate 804 or a structure supporting the contact plate 804. The driver 18 may be configured to provide a controlled voltage and / or a controlled current to the electrodes 4. The driver 18 may provide an alternating voltage and / or current waveform to the electrodes 702. The type of such waveform may be selected from the group consisting of, by way of non-limiting examples, pulsating, sinusoidal, square, sawtooth, triangular, fixed frequency, variable frequency, and combinations thereof. The driver 18 may be configured to provide a waveform with a peak-to-peak full range voltage between 50V and 1,000V. Alternatively, the driver 18 may be configured to provide a waveform with a peak-to-peak full range voltage between 200V and 500V. The driver 18 may be configured to supply a waveform with a carrier (or "base") frequency between 10 kHz and 10 MHz. Alternatively, the driver 18 may be configured to supply a waveform frequency between 500 kHz and 2 MHz. Alternatively, the driver 18 may be configured to supply a waveform frequency between 800 kHz and 1.2 MHz. The burst duration may also be used, as well as the electrode velocity v. tThe driver 18 may further be modulated to generate a duty cycle comprising bursts of pulses at a modulation frequency between 100 Hz and 3 MHz. The duty cycle may be between 0.01% and 100%. Alternatively, the duty cycle may be between 50% and 100%. Alternatively, the duty cycle may be between 95% and 100%. The driver 18 may be configured to provide an average power between 1 W and 25 W. Alternatively, the driver 18 may be configured to provide an average power between 12 W and 18 W. The driver 18 may be configured to provide an energy per cycle (or equivalently, "energy per pulse") between 1 μJ and 100 μJ. Alternatively, the driver 18 may be configured to provide an energy per cycle between 5 μJ and 50 μJ. Alternatively, the driver 18 may be configured to provide between .about.10 .mu.J and .about.20 .mu.J of energy per cycle.

[0097] In some embodiments, a flap may be described as an incision that results in a "flap" of tissue that can be elevated and pivoted on a "hinge" to provide access to the tissue beneath. As a non-limiting example, cutting a section of tissue to a depth of 130 μm and cutting a plane at that depth just below the tissue surface may result in a flap with the uncut edge as its hinge. The flap may be separated by completing the uncut edge of the exemplary incision. In some embodiments, a pocket may be described as an incision that separates a first depth (or layer) of tissue from a second depth (or layer) of tissue or tissue section without necessarily creating a flap. As a further non-limiting example, cutting one side of tissue to a depth and cutting a plane at that depth just below the tissue surface may result in a pocket.

[0098] In some embodiments, due to the plasma discharge at the electrode 702, a significant drop in the input impedance of the driver 18 may cause a local current spike, which in turn may destroy the electrode and / or cause damage to tissue. The power delivered to the electrode (or equivalently, the "delivered power", or equivalently, the "maximum power output") may instead be limited to avoid such a situation. Average power suitable for practicing embodiments of the present disclosure is ∼1 W mm−1, particularly during glow discharge. -1 and ~10W mm -1 The power delivered may be between v and t during the initial exposure to more reliably initiate dielectric breakdown. Alternatively, the voltage and / or current waveform (or alternatively, the power control signal) used to power the electrode 702 may further be adjusted to account for the instantaneous or expected length of tissue engagement and / or the electrode translation velocity v t may be modulated or adjusted to be proportional to

[0099] As a non-limiting example, when dissecting the cornea, the voltage may be increased from an initial value corresponding to when the electrode 702 is about to, or is expected to, initially engage tissue and is nominally oriented toward a more central corneal region to a higher voltage corresponding to when the electrode 702 is, or is expected to, traverse the central cornea and thus has a relatively longer tissue engagement length than initially, the electrode voltage may then be decreased as the electrode 702 continues to traverse the cornea 2 and dissect tissue, with an essentially shorter engagement length, the decrease may, but need not, be configured to be the opposite of the initial increase. The position of the electrode 702 within the cornea 2 may be inferred using an encoder in the translation subsystem, as described elsewhere herein. In one embodiment, the voltage provided by driver 18 is such that the tensioned electrode assembly 5 is tensioned by tensioning element 700 to ∼300 mN and travels ∼2,000 mm s along direction 12 with the initial electrode location being about 4 mm to about 7 mm from the side closest to the target tissue to be incised. -2With a constant acceleration of ~300mm s -1 The maximum rate of (i.e., v t, max ) for the incision of the electrode 702, which is translated by [ka] The electrode may be configured to deliver a maximum peak-to-peak bipolar nominally sinusoidal voltage of ∼500V (with amplitudes of both ∼+250V and ∼−250V relative to a nominal neutral voltage, which need not be ground voltage), with a PRF (or “carrier frequency”) of ∼1 MHz, which may ramp up from ∼0V to a maximum amplitude during the initial ∼50 μs of translation, and then ramp down back to ∼0V during the final ∼100 μs of translation. Note that such constant acceleration may result in a linear velocity profile in which the electrode may be forced to rest inside the target tissue, as may be required to create a flap or corneal strip, as opposed to a complete incision, as will be described elsewhere herein.

[0100] In some embodiments, the monitor 514 may be configured to monitor the voltage and / or current supplied to the electrode 702 via connection 516 and provide data regarding the voltage and / or current to the driver 18 via connection 518. The data regarding the voltage and / or current of the electrode 702 may be in the form of a signal from the comparator. The system controller 60 may be operatively coupled to the driver 18 via connection 62, which is at least a unidirectional connection. Alternatively, the connection 62 may also be a bidirectional connection in which the controller 60 is at least capable of sensing and / or responding to signals from the driver 18. The signal from the monitor 514 may also be provided to the system controller 60 and acted upon therein, thereby controlling the incision made by the electrode 702. The monitor 514 may reside within the system controller 60 and / or communicate with the system controller 60 via the driver 18. Such a signal may be a safety signal regarding the sensed voltage or current, such as when the voltage or current is outside of a defined boundary. In further alternative embodiments, the driver 18 and / or the monitor 514 may provide feedback to the controller 60 or use such feedback internally. Such feedback may be, by way of non-limiting example, EMF or current feedback and may be useful in determining when the electrode 702 contacts tissue and / or the status of the plasma. Such a status may be, for example, whether the plasma is in a glow discharge regime. The connection 65 connects the controller 60 and the actuator 50 and is at least a unidirectional connection. The actuator 50 may consist of at least one electric motor and may further comprise a position encoder. The connection 65 may alternatively be a bidirectional connection and signals such as position, velocity, acceleration, out of bounds error, etc. are shared between the controller 60 and the actuator 50. In further alternative embodiments, the actuator 50 may provide feedback to the controller 60 or use such feedback internally or may share such feedback as a signal with the controller 60.Such feedback may be, by way of non-limiting example, force feedback and may be useful in determining when the electrode 702 contacts tissue or when it exerts excessive force on the tissue to be incised. Similarly, connection 67 connects the controller 60 and the power source 70 and is at least a unidirectional connection. In further alternative embodiments, the power source 70 may provide feedback to the controller 60 or use such feedback internally and may share such feedback as a signal with the controller 60. Such feedback may be, by way of non-limiting example, an error signal. Such an error signal may be a temperature error, an input voltage error, an output voltage error, an input current error, an output current error, etc. Similarly, connection 68 connects the controller 60 and the user interface 80 and is at least a unidirectional connection from the user interface 80 to the controller 80. In further alternative embodiments, the user interface 80 may provide feedback to the controller 60 or use such feedback internally and may share such feedback as a signal with the controller 60. For example, user interface 80 may be a graphical user interface or a button or foot pedal used to signal actuator 50 to move electrode subassembly 4 and / or tensioned electrode assembly 5 to incise tissue. Actuator drivers 57 and 508 may be connected to system controller 60 via connections 65 and 510, respectively. User interface 80 is connected to system controller 60 via connection 68, through which user commands may be transmitted.

[0101] In some embodiments, the system controller 60 comprises a processor configured with instructions to determine a profile of tissue to be removed from the eye and provide refractive correction. The processor can be configured to determine a geometric profile of one or more plates used to provide refractive correction for the patient. Also, although reference is made to the controller 60, the controller 60 may constitute a component of a distributed computing system and may be operatively connected to one or more processors as described herein, such as a distributed processing system.

[0102] In some embodiments, the system 800 may further comprise a contact plate 804, a support element 802, a suction element 810, and an associated vacuum device that may be used to secure the contacted tissue 2. An incision 42 may be made in the tissue 2 (the cornea and / or corneal stroma in this exemplary embodiment) by moving at least a portion of the tensioned electrode assembly 5 along the axis of motion 12 and using the actuator 504 to generate a scaffold 43. The contact plate 804 may be incorporated to flatten the cornea by moving it along the axis of motion 14 over the anterior surface of the cornea using the actuator 50. The contact plate 804 may further comprise a contact surface 806 (not shown). The contact plate 804 may be used to flatten the cornea, particularly when the contact surface 806 is nominally approximately planar. As a non-limiting example, the contact plate 804 may be configured to be a flat glass window to allow visibility therethrough. By way of non-limiting example, the contact plate 804 may be made of a material selected from the group consisting of glass, crystalline, ceramic, metal, polymer, and combinations thereof. A contact element 808 (not shown) may be disposed on the distal surface of the contact plate 804 and provide a clean and / or sterile surface for contact with the tissue 2 and may be configured as a thin, conformal, peel-and-stick sterile barrier, which may also be disposable. By way of non-limiting example, the contact element 808 may be made of a material selected from the group consisting of polyethylene (PE), polyvinyl chloride (PVC), polypropylene (PP), oriented PP (OPP), biaxially oriented PP (BOPP), polyethylene terephthalate (PET), and combinations thereof. The contact plate 804 may be supported, at least in part, by the support 802. Support 802 may further be, at least in part, a support element for tensioned electrode assembly 5, such as arms 710 and 712, which also support electrode 702 and tension element 700 and form at least a portion of electrode subassembly 4 and / or tensioned electrode assembly 5. Arms 710 and 712 may thus be considered to be a support structure for electrode 702.Alternatively, the support 802 may be operably coupled to the probe body 26 and / or the sheath 6. Alternatively, the contact plate 804 may be moved relative to the tissue 2 along with the support 802. The suction element 810 may be used to stabilize the eye containing the tissue 2 relative to the contact plate 804 and / or the electrode 4. The suction element 810 may be configured as a nominally open annular ring as shown, or alternatively by any other applicable structure for achieving fixation to the eye, such as a single open pocket or multiple open pockets. The suction element 810 may be operably coupled to a vacuum pump 850 via a vacuum line 870 to provide negative pressure within the suction element 810. For patient safety and system reliability, a vacuum switch 852 and / or a vacuum sensor 854 may be installed between the suction element 810 and the vacuum pump 850 and connected via connections 860 and 862, respectively. System controller 60 may be connected to vacuum pump 850, vacuum switch 852, and vacuum sensor 854 via electrical connections 864, 866, and 868, respectively. In this configuration, actuator 50 may correspond to axis of motion 14 and be configured to actuate (or "translate") contact plate 804, and connection 55 may be made with contact plate 804 or such structure supporting contact plate 804. Contact plate 804 has a linear motion of 0.1 mm·s. -1 and ~1,000 mm s -1 and in alternative embodiments, the translation may be performed at a rate or speed between 10 mm s -1 and ~100mm·s -1 The motion corresponding to actuator 50 may be configured to be at least partially simultaneous with actuator 504 or its velocity profile.

[0103] In some embodiments, system 800 may be further configured such that tensioned electrode assembly 5 comprises, at least in part, electrode 702. Electrode 702 may comprise a tungsten wire of ∼12.5 μm diameter and at least ∼99% purity extending across arms 710 and 712 to form a bridging distance of ∼12 mm, for example, using a mechanical coil spring to apply a tension of ∼300 mN on electrode 702.

[0104] In some embodiments, the incision may form a flap or pocket or a combination thereof based on whether the electrode cut width is approximately greater than or approximately equal to the lateral extent of the target tissue structure to be incised and whether the electrode is penetrated laterally outward from the tissue. That is, a flap may be created in the anterior aspect of the cornea by using the contact plate 804 to flatten or otherwise compress the anterior corneal surface, resulting in a lateral dimension for the incision 42 between .about.3 mm and .about.11 mm, or alternatively, between .about.8 mm and .about.10 mm (all of which may be less than the aforementioned bridging distance to provide a flap incision). The flap incision may be configured to provide a D-shaped incision 42 as shown, with the straight sections of the D-shaped incision being the hinge portions. Similarly, a pocket incision may be created when the electrode bridging distance is less than the lateral extent of the compressed cornea presented to the electrode. Alternatively, a combination flap / pocket incision may be created using a pocket incision configuration, allowing the electrodes to traverse the entire distance through the cornea, resulting in an incision that is shaped as a fully rounded rectangle or a partially rounded rectangle (e.g., when configured with no straight cut portions). In an alternative embodiment, the driver 18 supplies a sinusoidal waveform that may have a peak-to-peak full range voltage of ∼250 V, at a frequency of ∼1 MHz and a power limit of ∼15 W, and provides a ∼200 mm s along the direction of motion 12, utilizing steps 102-122 of flowcharts 100 and 200, as shown in Figures 7 and 9. -1 and ~0mm·s -1The electrode translation rate between (i.e., while the electrode is stopped at the edge of the incision, v t =~0mm s -1 ) to incise corneal tissue. Step 202 of flowchart 200 may be utilized for interruption of power to the electrodes in coordination with the movement of the electrodes and contact plate 804 such that the electrodes are provided with a voltage of nominally .about.0V for an intermediate period while the electrodes move in a first direction and then in a second direction, as may be the case when contact plate 804 is moved along the direction of movement 14 to remove a portion of tissue (e.g., a "chip" of intrastromal tissue). Alternatively, electrode voltage and / or power may be a function of electrode speed and / or position and / or cutting range, as described elsewhere herein.

[0105] Alternatively, variable acceleration may be utilized to generate a motion profile for the electrode that results in a non-linear velocity profile. Such a motion profile requires a higher order control model and incorporates “jerk” and / or “acceleration” and / or “acceleration-acceleration” factors, as a non-limiting example, v within the first ∼50 μs. t Asymmetric acceleration / deceleration may be provided such that the range of is similar for the final ~10 μs.

[0106] The speed and / or speed profile and / or effective incision width may be taken into consideration when controlling (eg, "modulating") the power to the electrodes.

[0107] As non-limiting examples, the power to the electrode 702 may be adjusted by selecting a maximum value of a parameter selected from the group consisting of voltage, current, carrier frequency, modulation frequency, duty cycle, power set point, power limit, energy per pulse set point, energy per pulse limit, and combinations thereof.

[0108] As a non-limiting example, the modulation relationship describing the controlled power output of the electrodes 702 driven by the driver 18 may be selected from the list consisting of the following: fixed relationship, constant relationship, linear relationship, non-linear relationship, logarithmic relationship, sinusoidal relationship, exponential relationship, polynomial relationship, and combinations thereof. The relationship may be directly proportional or inversely proportional depending on the system configuration and determinable using the descriptions and equations contained herein. The controlled power output may be considered as instantaneous power and / or average power and / or peak power. The modulation may be achieved, as a non-limiting example, through the control of the driver 18. The term "modulation" is used herein to indicate the alteration of an otherwise consistent output, waveform, or signal. As used herein, "modulating" a waveform is comparable to "enveloping" a waveform, and "modulation envelope" is comparable to "envelope." Alternatively, no modulation may be used to essentially envelope a waveform, including a pulsatile waveform.

[0109] As a non-limiting example, when creating a corneal flap incision, the duty cycle D c is the effective incision width y a This can be modulated by utilizing a composite relationship that represents the velocity profile v t Multiplied by target tissue x c is modeled as a circular chord length of radius R that varies as a function of distance into the cavity (i.e., the height of the circular cap), [ka] This can result in R and v t, max , may be normalized using a nominal value for , to provide a generic envelope function.

[0110] Alternatively, the voltage required for evaporation, U, is [ka] and at least a component of the modulation relationship for the electrode voltage V provided by the driver 18 to the electrode 702 is [ka] It should be noted that the preceding example involves an exponential relationship, at least in part, because the radical root is the inverse function of the power.

[0111] Alternatively, the energy per cycle provided by the driver 18 to the electrodes 702 may be determined, at least in part, by v t and / or at least in part, depends on the value of the effective incision width y a The energy per cycle may be configured to deliver an energy per cycle that may depend on the value of

[0112] Alternatively, the duty cycle provided by the driver 18 to the electrodes 702 may be determined, at least in part, by v t and / or at least in part, depends on the value of the effective incision width y a The pulse width may be configured to deliver a duty cycle that may depend on the value of

[0113] Alternatively, the voltage provided to the electrode 702 by the driver 18 may be determined, at least in part, by v t and / or at least in part, depends on the value of the effective incision width y a The input may be configured to deliver a voltage that may depend on the value of

[0114] Alternatively, the current limit provided by the driver 18 to the electrode 702 may be determined, at least in part, by v t and / or at least in part, depends on the value of the effective incision width y a The current limit may be configured to deliver a current that may depend on the value of

[0115] Alternatively, the power limit or set point provided by the driver 18 to the electrode 702 may be determined, at least in part, by v tand / or at least in part, depends on the value of the effective incision width y a The power limit or set point may be configured to deliver a power limit or set point that may depend on the value of

[0116] Alternatively, the PRF provided by the driver 18 to the electrode 702 may be, at least in part, t and / or at least in part, depends on the value of the effective incision width y a The PRF may be configured to deliver a PRF that may depend on the value of

[0117] Alternatively, v t is determined, at least in part, by the effective incision width y a and / or x c may depend on [ka] It is.

[0118] Alternatively, the tensioned electrode assembly 5 is tensioned by tension element 700 to about 300 mN and moves along direction 12 at a speed of ∼1,000 mm s with the initial electrode location being between ∼2 mm and ∼4 mm from the side closest to the target tissue to be incised (i.e., the electrode's nearest point along its axis of motion). -2 With a constant acceleration of ~200 mm s -1 For the cutout portion of the electrode 702, which is translated at a maximum rate of [ka] As may be useful when made of ∼99.99% pure tungsten wire, the voltage provided by driver 18 may be configured to deliver a maximum peak-to-peak bipolar nominally sinusoidal voltage of ∼600V (with amplitudes of both ∼+300V and ∼−300V relative to nominal neutral) with a PRF (or “carrier frequency”) of ∼1 MHz that ramps linearly from ∼0V to maximum amplitude for the initial ∼50 μs of translation and ramps back to ∼0V for the final ∼50 μs of translation.

[0119] In a further alternative embodiment, the duty cycle provided by the driver 18 may be configured to deliver a duty cycle that ramps up from 0% to a maximum amplitude between 70% and 100% for the initial 50 μs of translation and ramps down back to 0% for the final 10 μs of translation. The duty cycle may be generated utilizing a modulation frequency such as a square wave gating function. The square wave gating function may be configured to have variable "on" and / or "off" times. The relationship of the variable "on" and / or "off" times may be as may be described elsewhere herein with respect to relationships for describing controlled power output of the electrodes.

[0120] In a further alternative embodiment, the duty cycle provided by driver 18 is determined, at least in part, by v t The electrode speed may be configured to deliver a duty cycle that may depend on the value of v t =0mm s -1 ) to its maximum value, the duty cycle may be gradually increased from ∼0% to a maximum amplitude between ∼70% and ∼100%, and the duty cycle is then reduced to ∼0% as the electrode speed is reduced back to stationary.

[0121] In a further alternative embodiment, the maximum power output provided by driver 18 is determined, at least in part, by v tThe pulse width may be configured to deliver a maximum power output that may depend on the value of , which may ramp up from ∼0% to a maximum amplitude between ∼70% and ∼100% while the electrode speed is increased from stationary to its maximum value, and the maximum power output is then reduced to ∼0% as the electrode speed is reduced back to stationary.

[0122] In a further alternative embodiment, the voltage provided by driver 18 is determined, at least in part, by v t The duty cycle may be configured to deliver a voltage that may depend on the value of , which may increase gradually from ∼0% to a maximum amplitude between ∼70% and ∼100% while the electrode speed is increased from stationary to its maximum value, and the duty cycle is then reduced to ∼0% as the electrode speed is reduced back to stationary.

[0123] FIG. 7 illustrates a method of dissecting tissue. Flowchart 100 includes steps 102-122, which may be completed sequentially or in any suitable order. In step 102, an eye is selected for treatment. Step 104 involves activating the system, and step 106 involves positioning the probe on the tissue to be treated. Step 108 involves activating the vacuum system and securing the tissue relative to the probe (such as via the vacuum system described above). Step 110 involves positioning the contact plate at a first location on the tissue. Step 112 involves power being applied to the electrodes. Step 114 involves translating (or "moving" or "actuating") the electrodes in a first direction (along axis of motion 12, the "+x-direction", etc.). Step 116 involves discontinuing power to the electrodes. Step 118 involves removing the vacuum fixation, freeing the tissue and detaching the eye being treated. Step 120 involves disengaging the electrode from the just incised tissue. Step 122 involves deactivating the system and disengaging it from the eye. The thin electrode may be allowed to break as the system is disengaged from the patient. Alternatively, the electrode may be translated in a second direction nominally opposite to the first direction. Alternatively, steps 108 and 110 may be swapped and power may be applied to the electrode once in contact with tissue 2. Alternatively, steps 116-120 may be eliminated to produce an ablation. Alternatively, steps 116 and 118 may be eliminated only if there is a low risk of collateral damage due to tissue heating while the actuator is changing direction. Alternatively, step 116 may involve a tapered reduction in power to the electrode and step 112 may involve a tapered increase in power to the electrode as described elsewhere herein.

[0124] 7 illustrates a method of dissecting tissue according to some embodiments, but one of ordinary skill in the art will recognize that many adaptations and variations may be made in accordance with this disclosure, for example, steps may be performed in any suitable order, some of the steps may be repeated, some of the steps may be omitted, combinations thereof.

[0125] In some embodiments, a processor as described herein is configured with instructions to perform one or more of the steps of the method of FIG.

[0126] 8A-8D are directed to details according to an embodiment of the present disclosure, where the tensioned electrode assembly 5 is shown in an orthogonal view to that of FIGS. 4-6, such that the axis of motion 12 may be in or out of the plane of the view, while the axis of motion 14 may be vertical, and the steps of FIG. 7 may be followed. FIG. 8A shows that the contact plate 804 may be configured to be in a central portion of the support 802 and move relative to the support 802 along the axis of motion 14. The contact surface 806 of the contact plate 804 may be generally planar and generally parallel to the cut portion of the electrode 702. The electrode 702 is initially shown in this view as being behind the cornea. The contact element 808 may be placed on the contact surface 806 to create a sterile disposable for use only during a single procedure. The contact element 808 may nominally conform to at least a portion of the contact surface 806. The portion of the contact surface 806 to which the contact element 808 conforms may be the central portion. The suction element 810 may be configured to contact the eye containing the tissue 2 in the area near the outer cornea and / or corneoscleral limbus 838 as shown, to immobilize and stabilize the cornea 843 (not shown in this figure). Alternatively, the suction element 810 may be contacted at least to the side of the cornea 843 to better stabilize the tissue 2 against the incision of the electrode 702. The cornea 843 may comprise an anterior corneal surface 842 and a posterior corneal surface 844. In this case, the target tissue 2 is considered to be stromal tissue within the cornea 843 and may be contained between the anterior corneal surface 842 and the posterior corneal surface 844. An intraocular lens 840 is shown for orientation purposes and may be a natural lens or an artificial prosthetic lens. In this embodiment, the contact element contacts the apex of the anterior corneal surface 842 of the cornea 843. Tensioned electrode assembly 5, as shown, may include arms 710 and 712 and electrode 702. The configuration of this figure may represent steps 102, 104, and 106 of FIG.

[0127] 8B shows the system of FIG. 8A where contact plate 804, and therefore contact element 808, may be said to be moved farther along axis of motion 14 to flatten cornea 843 and tissue 2 therein. Electrode 702 may be caused to incise tissue 2 by traversing a path along axis of motion 12, as described elsewhere herein, creating incision 45 and thereby scaffold 43 (not shown in this figure). The configuration of this figure may represent steps 108, 110, 112, and 114 of FIG. 7.

[0128] Figure 8C shows the system of Figure 8B in a different orientation, as supported by axes of motion 12 and 14, such that incision 45 is seen to progress through tissue 2 as electrode 702 is translated along axis of motion 12 (shown proceeding from left to right in this view). Actuation of electrode 702 may be performed in its final position, as may be the case when creating a flap incision.

[0129] FIG. 8D shows the system of FIGS. 8A-8C, where the contact plate 804, and therefore the contact element 808, may be said to have been moved along the axis of motion 14 to come to rest just on the apex of the corneal surface 842, as in FIG. 8A. The figure now shows the incision 45, which may form the surface for the scaffold 43 (not shown). The surface shape of the scaffold 43 so generated may be nominally characterized as approximately that of the anterior corneal surface 842. Alternatively, the surface shape of the central region of the scaffold 43 (not shown) so generated may be characterized as an average value of at least a portion of the surface shapes of the anterior corneal surface 842 and the contact surface 806 (or the contact element 808). The average may nominally be an arithmetic mean, a geometric mean, a harmonic mean, a weighted mean, or a combination thereof. The configuration of this figure may represent steps 116, 118, 120, and 122 of FIG. 7.

[0130] FIG. 9 describes a method similar to that of FIG. 7 with additional steps 202-212, where step 116 may be performed optionally to allow the electrodes to cut during step 202. That is, alternatively, steps 116 and 118 may be eliminated only if there is a low risk of collateral damage due to tissue heating while the actuator is changing direction and / or strain on the unpowered electrodes may cause failure of the electrodes due to the change in position of the contact plates. Step 202 involves positioning the contact plates in a second position, which may be a translation of the entire element or a translation of at least a portion of the element. The translation of at least a portion of the element may be utilized to generate a non-planar contact plate surface and provide the desired corneal deformation, as will be described with respect to FIGS. 11A and 11B. Alternatively, certain contact plates may be swapped in step 202 to provide the desired corneal deformation. The corneal reshaping may be intended to generate a surface that defines at least a portion of the corneal fragment, such as the base 43, to achieve at least a portion of the desired three-dimensional tissue ablation profile. The corneal fragment may then be removed to cause a refractive change in the cornea 843 of the patient's eye. Step 204 may be optionally performed if step 202 is removed, but may otherwise be similar to step 112. Step 206 involves translating the electrode in a second direction, which may nominally be opposite to the first direction. Step 208 involves disengaging the electrode from the tissue, as may occur if the translation of step 206 brings the electrode outside the tissue 2. Step 210 involves removing power to the electrode and may be similar to step 116 of FIG. 7. Step 212 involves removing the vacuum fixation, freeing the tissue, and disengaging the eye being treated, which may be similar to step 118 of FIG. 7. Step 122, similar to step 122 of FIG. 7, involves deactivating the system and detaching it from the eye.

[0131] 9 illustrates a method of dissecting tissue according to some embodiments, but one of ordinary skill in the art will recognize that many adaptations and variations may be made in accordance with this disclosure. For example, steps may be performed in any suitable order, some of the steps may be repeated, some of the steps may be omitted, combinations thereof.

[0132] In some embodiments, a processor as described herein is configured with instructions to perform one or more of the steps of the method of FIG.

[0133] 10A-10F are directed to a system similar to that of FIGS. 8A-8D in which the shape of contact surface 806 may be configured as other than planar, and is shown as convex, and additionally configured such that a corneal strip (e.g., corneal strip 820) may be incised into the (stromal) tissue 2 of the cornea 843. The difference between the first incision profile and the second incision profile may correspond to the shape of the corneal strip of tissue to be removed from the cornea to treat a refractive error of the eye.

[0134] Figure 10A shows a system configured similarly to that of Figure 8A with the addition of a curved surface 806 on the contact plate 804. Similarly, a contact element 806 is placed on the curved contact surface 806 and nominally matches the curvature. The configuration of this figure may represent steps 102-108 of Figures 7 and 9.

[0135] Figure 10B shows the system of Figure 10A where contact plate 804, and therefore contact element 808, has been moved farther along axis of motion 14 and may be said to be in contact with cornea 843 and tissue 2 therein. Unlike the configuration of Figures 8A-8C, in this configuration the cornea is not necessarily flattened, but is compressed differently to at least partially conform to the curvature (or "shape", in cases where curvature alone may not be sufficient to adequately describe contact surface 806) of contact surface 806 to produce incision 46. The configuration of this figure may represent steps 110-112 of Figures 7 and 9.

[0136] Figure 10C shows the system of the previous Figure 10X in a different orientation, as supported by axes of motion 12 and 14, such that incision 45 is seen to progress through tissue 2 (shown in this view proceeding from left to right) as electrode 702 is translated along axis of motion 12. Actuation of electrode 702 may be performed in its final position, as may be the case when creating a flap incision.

[0137] 10D shows the system of FIG. 10X above, with the contact plate 804 translated forward, and the incisions 46 now shown. Such incisions 46 may form the surface of the foundation 44 (not shown). The surface shape of the foundation 44 so produced may be characterized as the average value of the surface shapes of the anterior corneal surface 842 and the contact surface 806 (or contact element 808). The average may nominally be an arithmetic mean, a geometric mean, a harmonic mean, a weighted mean, or a combination thereof.

[0138] FIG 10E shows the system of the previous FIG 10X where a second incision, incision 45, may now be made. The configuration of this figure may represent steps 202-206 of FIG 9. Alternatively, incision 45 may be made by swapping contact plate 804 or a portion thereof to provide a different surface shape for incision 45. A flat contact surface may be used for at least one of the incisions.

[0139] FIG 10F shows an eye treated with the system of the previous FIG 10X, where a corneal strip 820 has been incised into the (stromal) tissue 2 of the cornea 843 and is bounded by a surface created by incisions 45, 46. Incisions 45, 46 may also form incisions 47 when electrodes are cut across the entire cornea rather than to create a pocket in the cornea. This configuration may represent the result of completing the remaining steps of FIG 9. The shape of the surface created via incisions 45, 46 may be selected to affect the refractive correction to the cornea 843 of the patient's eye. The refractive correction may be defined, at least in part, by diagnostic measurements such as keratometry, ocular aberrometry, wavefront aberrometry, corneal topography, and combinations thereof, and the nominal shape of the corneal strip may be defined to optically balance (or correct) the measured aberrations, as described in Sekundo W. Small Incision Lenticule Extraction (SMILE) Principles, Techniques, Complication Management, and Future Concepts. 2015. Springer Cham Heidelberg and associated citations therein.

[0140] In some embodiments, for the cornea, the approximate tissue profile for the tissue to be removed may be expressed as follows:

[0141] T(x,y)~=W(x,y) / (n-1), where T is the thickness in microns, W is the wavefront error in microns, n is the refractive index of the cornea, and x and y are coordinate bases corresponding to a plane such as the pupil or a plane near the apex of the cornea. The wavefront error can be expressed in a number of ways, for example, using elevation angle in microns or individual Zernike coefficients.

[0142] Other approaches may also be used to determine the thickness profile of the tissue to be removed, for example, with reference to the SMILE procedure, as would be known to one of skill in the art.

[0143] 11A and 11B are directed to a piecewise adjustable contact plate 804 for reshaping the cornea to generate corneal grafts or other therapeutic incisions. The adjustable contact plate 804 can be operably coupled to a controller and configured to shape the cornea and provide refractive correction for embodiments referring to small incision corneal graft extraction as described herein. FIG. 11A depicts the piecewise adjustable contact plate 804, comprised of a sub-plate (or equivalently, "element") 8061, which may constitute a contact surface 806, both housed within a housing 8042 and mounted to a base 8044. FIG. 11B depicts the same contact plate 804 in a cross-sectional view to expose an actuator 8100, which is operably coupled to the sub-plate 8061 within the housing 8042. In this embodiment, each of the subplates 8061 may be affixed to an actuator 8100, as shown and described with respect to the system of FIG. 6, allowing each subplate 8061 to be individually actuated using additional actuators and associated monitoring and control subsystems (the connections are not shown in this figure). As a non-limiting example, the subplates 8061 may be glued or soldered to the actuator 8100 using epoxy. The actuator 8100 may be selected from the group consisting of a piezoelectric actuator, a motor, a pneumatic actuator, a fluid actuator, and combinations thereof. As shown in the exemplary embodiment, the subelements 8062 may be constructed using a material selected from the group consisting of glass, ceramic, quartz, silicon, metal, polymer, and combinations thereof. Such subplates 8061 may be actuated along an axis of motion (e.g., axis of motion 14).Such sub-plates 8061 may be translated (or "displaced") to form piecewise contact surfaces 806 with freeform profiles (or "shapes" or "surface profiles") to address optical aberrations, including higher order aberrations such as defocus, radial distortion, sphere, spherical aberration, cylinder, cylindrical aberration, astigmatism, coma, and trefoil, in prescribing surface shape precision for a corneal fragment to be removed from tissue 2 within cornea 843, generating contact surfaces 806 with discrete, but arbitrarily, addressable profiles for use in generating incisions 45 and / or incisions 46. Such sub-plates 8061 are configured to be nominally rectangular as shown, but need not be, and other geometries are considered within the scope of the present disclosure. Contact elements 808 (not shown) are located on the distal surface of the contact plate 804 and may provide a clean and / or sterile surface for contact with tissue 2 and may be configured as a thin, conformal peel-adhesive sterile barrier, which may also be disposable, as described elsewhere herein. Rather than utilizing step 202 of FIG. 9 to reposition the contact plate 804, the present embodiment may allow step 202 to be modified to reconfigure the contact plate to a second configuration prior to creating another incision. The number of actuators 8100 may be determined by the spatial resolution requirements and / or surface form accuracy tolerances of a given prescription. As a non-limiting example, there may be an array 10 of square cross-sectionally shaped actuators 8100, or there may be an array 14 of such actuators 8100, or there may be an array 28 of such actuators 8100, which when configured to be squarely packed within a nominally 12 mm diameter disc-shaped contact surface, respectively, of ∼2.0 mm per actuator 8100. 2 , ~1.44mm 2 , and ~0.80 mm 2Alternatively, a more regular array, such as a 4×4 square array, may be used, resulting in 16 actuators 8100. When such a regular array of 16 square cross-sectional shaped actuators 8100 is positioned concentrically with a nominally 12 mm disc-shaped contact surface, the area per actuator is ∼9 mm 2 , but the corners of the array may be outside the 12 mm disk boundary. Similarly, a 10x10 square array may be ∼1.44 mm 2 This can result in an area per actuator of

[0144] Alternatively, the customized contact plate 804 and / or contact surface 806 may be machined with a surface profile for use in creating the incision 45 and / or the incision 46 to address higher order aberrations in prescribing surface shape accuracy for the corneal piece to be removed from the tissue 2 within the cornea 843. Alternatively, such customized contact plate 804 and / or contact surface 806 may be used individually in creating the incision 45 and / or the incision 46. Alternatively, a first customized contact plate 804 and / or contact surface 806 may be used in creating the incision 45 and a second customized contact plate 804 and / or contact surface 806 may be used in creating the incision 46, and the first and second customized contact plates 804 and / or contact surfaces 806 may be configured with different surface profiles. 9 to reposition the contact plate 804, the present embodiment may allow that step 202 to be modified to be replaced (or "swapped") with a second contact plate prior to creating another incision. The means of fabricating such customized contact plate 804 and / or contact surface 806 may be selected from the group consisting of additive manufacturing, injection molding, machining, and combinations thereof.

[0145] In some embodiments, the optical prescription may comprise one or more of the following: surface curvature, power in diopters, material properties, refractive index, ocular wavefront measurements, or thickness. In some embodiments, the surface form accuracy of the optical system may be defined as the perturbation of the optical surface from the optical prescription. Low frequency errors are typically defined as irregularities, deviation fringes, or flatness, and may tend to transfer light from the center of the Airy disk pattern into the first few diffractive rings. This effect may reduce the magnitude of the point spread function without broadening it, and thus reduce the Strehl ratio. Mid-frequency errors (or small angle scatter), defined using a slope or (PSD) requirement, tend to broaden or smear the point spread function (PSF), and may reduce contrast. Both low and mid-frequency errors may degrade optical system performance. However, some surface form accuracy imperfections may be omitted from the surface form accuracy specification, as may be the case for power and occasional astigmatism. An optical system may allow individual optics to be focused, de-centered, or tilted to compensate for specific aberrations. Surface accuracy and surface form precision are terms often used to capture both areas. To avoid ambiguity, one may use microns as the unit value in the specifications.

[0146] 12A and 12B are directed to the creation of a disk-shaped corneal strip. FIG. 12A shows a corneal strip 820 consisting of an anterior surface 451, which may be created by incision 45, via step 114 of FIGS. 7 and 9, and a posterior surface 461, which may be created by incision 46, via step 118 of FIGS. 7 and 9. A hinge 1020 may be created via step 202 of FIG. 9, which is the translation of the contact plate to a second position between the creation of incisions 46 and 45. In this figure, the corneal strip, as shown, may appear to be a flat disk as shown when spread out on a flat surface. FIG. 12B shows a cross-sectional view of the same corneal strip 820 of FIG. 12A. In this embodiment, a nominally planar contact plate may be positioned at a first position (or "depth" or "location") to create incision 46 and then translated to a second, more anterior (or "proximal") position to create incision 45. In the configuration of this embodiment, cross-sectional shape 1010 may be nominally rectangular and faces 451 and 461 may be nominally parallel. Alternatively, incision 45 may be created at a position posterior (or "distal") to that of incision 46 by appropriate translation of the contact plate.

[0147] 13 is directed to a plano-convex type corneal strip similar to that of FIG. 12B, according to an embodiment of the present disclosure. Here, corneal strip 820 comprises an anterior surface 451, which may be created by incision 45, and a posterior surface 461, which may be created by incision 46. The contact plate, or elements of the contact plate consisting of multiple translatable elements, may be configured to produce a non-planar type surface for surface 451. The configuration of this embodiment may be utilized to create a plano-convex type corneal strip, as shown.

[0148] 14 is directed to a meniscus shaped corneal strip similar to that of FIG. 13, according to an embodiment of the present disclosure. Here, the corneal strip 820 comprises an anterior surface 451, which may be created by incision 45, and a posterior surface 461, which may be created by incision 46. The contact plate, or elements of the contact plate consisting of multiple translatable elements, may be configured to produce non-planar type surfaces for both surfaces 451 and 461. The configuration of this embodiment may be utilized to create a meniscus type corneal strip, as shown.

[0149] 15 is directed to a hybrid type corneal strip similar to that of FIG. 14, according to an embodiment of the present disclosure. Here, corneal strip 820 comprises an anterior surface 451, which may be created by incision 45, and a posterior surface 461, which may be created by incision 46. The contact plate, or elements of the contact plate consisting of multiple translatable elements, may be configured to produce non-planar type surfaces for both surfaces 451 and 461. The configuration of this embodiment may be utilized to create a meniscus type corneal strip, as shown.

[0150] 16A and 16B are directed to histological images of incisions in a porcine cornea generated in accordance with an embodiment of the present disclosure. FIG. 16A shows image 900, a conventional sagittal section (H&E stained) histological microscope image of a porcine cornea that was incised in a fresh state (≦2 days after collection and stored at ∼2° C.) and subsequently fixed in a 4% paraformaldehyde solution. The incision system was configured with the following: PRF ∼1 MHz, V ∼±250 V, sinusoidal waveform, P rms ~15W;v t, max ~400mm·s -1 ;~2,000mm·s -2 constant acceleration; [ka] 99.99% pure tungsten wire electrodes with L~10 mm; T~290 mN; ~35 μm contact plate (flat) rearward displacement between incisions 45 and 46, and a vacuum gauge pressure of ~-500 mmHg for the suction element 810, as measured by vacuum sensor 854. Electrode assembly translation was accomplished using a M-664.164 piezoelectric motor actuator (PI, Karlsruhe, Germany). The target tissue 2 is corneal stromal tissue. Incision 45 was separated to expose surfaces 451 and 452. Incision 46 was left intact with corneal strip 820 in place. Damage may be visible as darker bands along incisions 45 and 46 and may be in the order of ~3 μm. Figure 16B shows an image 902 similar to that of Figure 16A, but at a higher magnification and with a different spacing between incisions 45 and 46, using a rear contact plate translation of -50 μm. Again, a thin damage zone is evident.

[0151] 17 is directed to a plot 910 displaying an example electrode voltage versus time waveform 912, constituting features according to an embodiment of the present disclosure. The waveform 912 comprises individual cycles 914. Bursts 916 are made up of pulses (cycles 914) and are constrained by a modulation envelope 918. The modulation envelope 918 may be configured to be a combination of relationships described elsewhere herein, including pulsation, duty cycle, and modulation (e.g., titration) relationships. Although shown here at the level of pulses and bursts for clarity, the entire dissection waveform may be similarly configured.

[0152] Figure 18 shows the equivalent sensitivity and t shWe focus on image 960, a 576 pixel by 464 pixel frame, such as might be acquired using a high-speed digital camera, such as an AOSM-VIT4000 (AOS Technologies, Daettwil, Switzerland), when configured to operate at a shutter speed (or "integration time") of .about.250 μs. In this figure, multiple vapor cavities 635 along image element 962 may exhibit a staccato disruption process, similar to that of FIG. 6-10E, i.e., v t, max ~400mm·s -1 ;~2,000mm·s -2 constant acceleration; [ka] 17. For a dissection system configured as: L ∼ 10 mm, ∼ ≥ 99.99% pure tungsten wire electrodes; T ∼ 280 mN, and a vacuum gauge pressure of ∼ -640 mmHg for the suction element 810, as measured using vacuum sensor 854, nominally utilizing the waveform of FIG. t *t sh →~13μm and PRF*t sh → may correspond to approximately one diametric electrode translation for ∼250 cycles of a ∼1 MHz waveform. Vapor cavities 635 may be visible along image element 962 as electrode 702 (located in image element 962, but otherwise not visible in this view) is actuated and translates along axis of motion 12 in direction 121 to create an incision in cornea 843. Vapor cavities 635 may comprise regions from which light is emitted in association with the formation of plasma, the light may have a wavelength that is a function of the plasma temperature and may be in the range of about 400 nm to about 750 nm.

[0153] According to embodiments of the present disclosure, technique dependency of scleral incisions may be reduced by semi-automating flap creation using plasma-induced cutting tools, which limits tissue damage and provides predictable, accurate, and precise incisions in the sclera and / or cornea, including the sclerocorneal limbus. According to embodiments of the present disclosure, pockets in the sclera and / or cornea, including the sclerocorneal limbus, may be created rather than the traditionally used flaps. Further embodiments may provide incisions in other tissues, such as those listed in FIG. 1A. As non-limiting examples, plasma-induced incisions may be created in the capsule to produce a capsulotomy, in the lens to produce lens fragments or to simplify lens fragmentation and / or lens removal, in the retina to produce a pocket or flap, in the TM to improve drainage and / or reduce IOP, and in the iris to produce an iridotomy.

[0154] A flap may be described as an incision that results in a "flap" of tissue that can be lifted and pivoted on a "hinge" to provide access to the tissue beneath. As a non-limiting example, cutting three sides of a square to a 50% depth and cutting a plane at that 50% depth just below the edge of the square in tissue may result in a half thickness flap with the fourth uncut side of the square as its hinge. The flap may be severed by completing the fourth side of an exemplary square incision.

[0155] A pocket may be described as an incision that separates a first depth (or layer) of tissue from a second depth (or layer) of a section of tissue, without necessarily creating a flap. As a further non-limiting example, cutting one side of a square to a 50% depth and cutting a plane at that 50% depth just below the edge of the tissue square may result in a half thickness pocket.

[0156] Semi-automated cutting tools may be used to provide improved incisions over those of conventional sharp-edged instruments. Plasma-induced semi-automated cutting tools may be used to provide improved incisions over those of semi-automated cutting tools configured for use with sharp-edged instruments.

[0157] A semi-automated cutting system with at least one degree of motion can be used to create 5x5mm and 4x4mm flaps instead of creating them manually. For example, a system with both 5mm wide and 4mm wide "blades" can be used to create 5x5mm and 4x4mm flaps, respectively. The electrodes may comprise wires and / or blades.

[0158] FIG. 19A shows a flap 40 in tissue 2 as seen above, and FIG. 19B shows the same flap 40 as seen from cross section AA. Flap 40 is constructed from incisions 42 and 44, which create a base 43 and form three sides of a square (as is the case in the example of FIGS. 19A-19D, but other such shapes are also considered within the scope of this disclosure). The flap may be elevated and hinged about the missing side of the square to expose the tissue underneath. Base 43 may be flat or curved. The flap may be separated by completing the fourth side of the exemplary square incision.

[0159] 19A and 19B, Fig. 19C shows a pocket 41 in tissue 2 as seen above, and Fig. 19D shows the same pocket 41 as seen from cross section AA. However, in this configuration, pocket 41 consists of incision 42, which creates base 43, but lacks incision 44. Again, base 43 may be flat or curved, but this time will depend on the longitudinal shape (or "profile") of the incision to avoid creating incision 44.

[0160] FIG. 20 is directed to a system according to an embodiment of the present disclosure configured to generate a rectangular flap or pocket such as may be useful in canaloplasty for the reduction of IOP in the treatment of glaucoma. Tissue 2 may be incised using an electrode 4, which in this exemplary embodiment is configured in a U-shape of width 6 and length 8, with a bend 10. The electrode 4 may be connected to a power RF driver 18 via a lead 20. A lead 22 may be connected to the patient and generate the electrode 24, which may in turn be part of the return path. The RF driver may produce bipolar pulses. The electrode 4 may be enclosed within a sheath 16, shown here as partially cut away for clarity. A direction of motion 12 may be used to provide lateral coverage to the incision, and a direction of motion 14 may be orthogonal to the direction of motion 12 and perpendicular to a plane described by the width 6 of the U-shape of the electrode 4, which may be used to generate a tissue flap and / or pocket. Alternatively, direction of motion 14 may be employed to create an incision nominally perpendicular to the surface of tissue 2. Width 6 may be selected to be between 1 mm and 10 mm, specifically 4 mm or 5 mm, as described above. Length 8 may be configured to traverse tissue a distance greater than width 6 but less than length 8. For example, a 4 mm x 4 mm flap may be created by configuring width 6 to be 4 mm and length 8 to be greater than 4 mm but to traverse 4 mm of tissue along direction of motion 12.

[0161] FIG. 21 is directed to a system similar to that of FIG. 20 configured to generate a flap, as viewed from the side, with the addition of a probe body 26 containing an electrode 4, a sheath 16, and an actuator 50, also oriented at an angle 30 relative to the surface of the tissue 2. The actuator 50 is operatively coupled to the electrode 4 and can move in motion directions 12 and 14 such that the electrode 4 is translated within the tissue 2 along a motion profile described by moving first in direction 32, then in direction 34, then in direction 36, which is the opposite direction of direction 34, then in direction 38, which is the opposite direction of direction 32. This configuration can then generate a flap 40 (not explicitly shown for purposes of clarity) by generating an incision 42, then an incision 44, and a base 43. As a non-limiting example, the actuator 50, such as a motor or a voice coil, can be powered. Alternatively, the actuator 50 may comprise a series of springs and ratchets or stops and triggers to generate the described motion profile. The element electrodes 4 and / or the sheath 6 and / or the probe body 26 may be configured to be subsystems that engage the actuator 50 and RF driver 18 and are discarded after use. In an alternative embodiment, the flaps may be detached by modifying the motion profile as follows: first in direction 32, then in direction 34, then in direction 38, which is opposite direction 32.

[0162] Alternatively, the system of FIG. 21 may be configured such that the actuator 50 first translates the electrode 4 in a direction nominally along the angle 30 and then retracts the electrode 4 along a second direction nominally opposite to the first direction to generate a pocket rather than a flap.

[0163] Alternatively, the second electrode may also be used to generate a second flap or pocket of a different size and / or shape than the first flap or pocket. For example, a 5mm x 5mm flap may be created first, followed by a 4mm x 4mm flap. The exemplary 4mm x 4mm flap may also be a cut-away flap.

[0164] 22A-22C are directed to details of an electrode configured according to an embodiment of the present disclosure, with electrode 4 comprising regions 300, 302 and bend 10. Nominally, the surface area may be kept constant along electrode 4. As a non-limiting example, electrode 4 may comprise a solid wire between 50 μm and 300 μm in diameter and comprise a material selected from the group consisting of tungsten, nitinol, steel, copper, stainless steel, beryllium-copper alloy, cupro-nickel alloy, and aluminum. Additionally, in alternative embodiments, the electrode may be at least partially coated with another conductive material, such as gold. Region 302 may comprise the same base structure as region 300, with the modification that it is compressed in a direction parallel to the plane of the image and stretched in an orthogonal direction. Such a configuration may maintain the surface area while providing increased strength in the aforementioned orthogonal direction for improved reliability and strength while dissecting tissue by reducing dimension 303 below dimension 301. Bend 10 may be made from either the configuration of region 300, the configuration of region 302, or made to transition between regions 300 and 302. Alternatively, regions 300 and 302 and / or bend 10 may be joined from dissimilar materials. In a further alternative embodiment, electrode 4 may be constructed from a tungsten wire with a diameter of .about.250 .mu.m, which is compressed everywhere except for region 300, which is .about.3 mm long, and dimension 301 is nominally the same as the original diameter of the wire of .about.250 .mu.m, while dimension 303 is configured to be formed to .about.400 .mu.m by said compression, while dimension 302 is compressed to .about.400 .mu.m, while dimension 303 is compressed to .about.400 .mu.m by said compression ...2 is compressed to .about.400 .mu.m by said compression.

[0165] For purposes of clarity, the electrodes 4 have been shown thus far to be U-shaped, but need not be. The RF driver 18 may provide an alternating current to the electrodes 4. Such alternating current may be, by way of non-limiting examples, a sine wave, a square wave, a sawtooth wave, a triangular wave, or combinations thereof. The signal provided by the RF driver 18 may be configured to have a base (or "carrier") frequency between 10 kHz and 10 MHz, and may further be modulated to comprise bursts of pulses at frequencies between 100 Hz and 3 MHz to produce a duty cycle. The duty cycle may be between 0.01% and 100%. In alternative embodiments, the duty cycle may be between 60% and 80%. The peak-to-peak voltage provided by the RF driver 18 may be between 500V and 2,000V. In alternative embodiments, the peak-to-peak voltage provided by the RF driver 18 may be between 400V and 800V. In one embodiment, the RF driver 18 signal is applied to the electrode 4 in the region 300. [ka]

[0036] It may be configured to have a peak-to-peak bipolar voltage of ~800V (with amplitudes of both ~+400V and ~-400V), with a carrier frequency of ~1 MHz and a modulation frequency of ~10 kHz, as may be useful when made of 1 mm diameter tungsten wire.

[0166] FIG. 23 is directed to a system 400 configured according to an embodiment of the present disclosure. In addition to the elements associated with the previous figures, the system 400 further comprises a controller 60, a power supply 70, a user interface 80, and a coupler 52. A connection 62 connects the controller 60 and the RF driver 18 and is at least a unidirectional connection. The connection 62 may also be a bidirectional connection, with the controller 60 being able to sense and / or respond to signals from at least the RF driver 18. Such signals may be safety signals related to sensed voltage or current. In further alternative embodiments, the RF driver 18 may provide feedback to the controller 60 or use such feedback internally or share such feedback as a signal with the controller 60. Such feedback may be, for example, EMF or current feedback and may be useful in determining when the electrode 4 contacts tissue and / or the status of the plasma. Such a status may be, for example, whether the plasma is in a glow discharge regime. Similarly, a connection 65 connects the controller 60 and the actuator 50 and is at least a unidirectional connection. The actuator 50 may consist of at least one electric motor and may further comprise a position encoder. The connection 65 may alternatively be a bidirectional connection, with signals such as position, velocity, acceleration, out-of-bounds error, etc. being shared between the controller 60 and the actuator 50. In further alternative embodiments, the actuator 50 may provide feedback to the controller 60 or use such feedback internally, and may share such feedback as a signal with the controller 60. Such feedback may be, for example, force feedback, which may be useful in determining when the electrode 4 contacts tissue or exerts excessive force on the tissue to be incised. Similarly, the connection 67 connects the controller 60 and the power supply 70, and is at least a unidirectional connection.In further alternative embodiments, the power supply 70 may provide feedback to the controller 60 or may use such feedback internally or may share such feedback as a signal with the controller 60. Such feedback may be, for example, an error signal. Such error signals may be temperature error, input voltage error, output voltage error, input current error, output current error, etc. Similarly, the connection 68 connects the controller 60 and the user interface 80 and is at least a unidirectional connection. In further alternative embodiments, the interface 80 may provide feedback to the controller 60 or may use such feedback internally or may share such feedback as a signal with the controller 60. For example, the user interface 80 may be a graphical user interface or a button that is used to signal the actuator 50 to move the electrode 4 and cut the tissue. This exemplary embodiment of the system 400 also includes a coupler 52, which may couple the electrode 4 to the actuator 50 such that the electrode 4 may be moved as described with respect to the previous figures. The coupler 52 may be constructed from an electrically insulating material and configured to electrically insulate the electrode 4 from at least one other element of the system 400. The coupler 52, and / or the sheath 16 and the electrode 4 may be spliced ​​into a subsystem that may be discarded after use. Although not shown, an alternative embodiment is a configuration for the coupler 52 that may be fabricated to connect both sides of the (exemplary) U-shaped electrode 4 to the actuator 50. The electrode 4 is moved by the actuator 50 at a distance of ∼200 mm·s. -1 can be translated at a rate of

[0167] 24A and 24B are directed to details involving the creation and use of complementary features in tissue 2 that provide improved mechanical stability and better maintain a fixed relationship between elements of tissue 2 that may be at least partially separated from one another by incisions 45 using the systems and methods described herein, including when creating corneal flap or other surgical refractive corrections. Thus, incisions 45 may comprise a refractive correction portion as described elsewhere herein and an additional stability portion. Target tissue 2 may be incised along incisions 45 to create a flap 40 and a bed 44 in cornea 843, which in turn may contain an anterior surface 842 and a posterior surface 844. In this example, incisions 45 may be configured to create protrusions 1110 and depressions 1112, which are nominally complementary features, in flap 40 and on bed 44, respectively. Such complementary features may be configured, at least in part, to interlock and at least in part, to prevent the flap 40 or any other adjacent incision elements from displacing from the cornea 843 during healing, and may also serve, at least in part, to block epithelial cells from entering the wound along the incision edge 1114. As shown, the angle between the corneal surface 842, whose apex is along the edge 1114, and the incision 45 may be a fairly shallow angle, such as may be created when using a conventional microkeratome. In this example, the cornea 843 of the eye EYE contains the target tissue 2, but other anatomical locations and configurations are also considered within the scope of this disclosure. Although shown as such in this figure, the flap 40 need not be completely separated from the target tissue 2, and may include a hinge portion. When completely separated from the cornea 843, the flap 40 may be considered a "cap." Caps may be particularly well suited for use in corneal transplant procedures. Pocket incisions may also be configured to utilize such complementary features for similar purposes. As described elsewhere herein, the incision system may be configured to create protrusions 1110 and recesses 1112 that are nominally complementary features via the surface profile of the contact plate.Alternatively, such features may be created using suction element 810 to deform the target tissue prior to and / or during the creation of the incision.

[0168] 25 is directed to a further embodiment of the present disclosure for creating and using complementary features in tissue 2 similar to those of FIGS. 24A and 24B, modified to include the addition of a cutting element 1120 in incision 45 to provide a steeper angle between the corneal surface 842 and incision 45. The cutting element 1120 may further exclude epithelial wound penetration, improve the mechanical stability of incision 45, and serve, at least in part, to maintain the relative position of the incised target tissue.

[0169] 26 is directed to an embodiment in which the contact element 810 may be further configured to include a refractive correction portion 819 as described elsewhere herein and an additional stability portion 1108. In the case of a corneal incision, the stability portion 1108 may be configured to be outside of the field opening 1150 (shown in subsequent figures) and may be configured to create nominally complementary features, a protrusion 1110 and a depression 1112. The refractive correction portion 819 may be within the field opening 1150. The refractive correction portion 819 may be configured to produce a corneal strip 820, as a non-limiting example. A tensioned electrode 702 may be supported by arms 710 and 712 and create at least an incision 45 containing a refractive portion 819, shown as corneal strip 820, bounded by an incision 47 and extending beyond a field of view aperture 1150 (known as the "optical effective aperture"), and a stability portion, shown as stability portion 1108. The electrode may be translated along axis of motion 12 in direction 34 to location 1121 to create hinge 1020 and incision boundary 1113, and then translated in direction 36 to at least location 1122 to incise refractive portion 819 and at least a portion of stability portion 1108. Translation along direction 36 or power to the electrode may be interrupted at location 1122 to prevent re-cutting a redundant portion of the incision, such as the corneal incision shown. A suction channel 1210 may be utilized to anchor the target tissue, as described elsewhere herein. Regions 1209 and 1211, which may form at least a portion of surface 1200, may be configured to form a nominally flat surface 1200 or to be at different heights.

[0170] 27A-27C are directed to an embodiment of a suction element 810 that may be used to both stabilize tissue 2 against contact plate 804 (as described elsewhere herein, but not shown in this figure) and / or electrode 4 (as described elsewhere herein, but not shown in this figure) by drawing at least a portion of tissue 2 into at least a portion of a channel 1210 (here shown as an annular ring) on ​​contact surface 1200, and to impart complementary features to incision 45. Suction element 810 may be configured to support a nominally open annular ring for channel 1210, as shown, or alternatively, by any other applicable construct to achieve fixation to the eye, such as a single open pocket, or multiple open pockets, or multiple such channels 1210, and combinations thereof. The suction element 810 may be operatively coupled to a vacuum pump 850 (as described elsewhere herein, but not shown in this figure) via a vacuum line 870, here shown to protrude from the proximal surface 1202 and provide negative pressure within the suction element 810 prior to and / or during the creation of the incision, causing elements of the target tissue 2 to be drawn at least partially into the open space of the channel 1210. A second such channel, channel 1212, is included within this exemplary embodiment and may be utilized to evacuate fluid from the target tissue 2, but is not required to practice the present disclosure. The suction line 870 may be configured to provide the same vacuum circuit to channels 1210 and 1212, or to address them individually, as shown in the cross-sectional view of FIG. 27C. This embodiment may be configured to use only the channel 1210 to engage tissue 2 immediately adjacent or near the location of the incision 45 to produce the results shown in Figures 24A-25, where the protrusions 1110 and depressions 1112 are shown as nominally continuous. In the case of a corneal incision, the channel 1210 may engage the corneal surface inside the electrode path, as opposed to outside the electrode path on the sclera and / or limbus, as previously described.Thus, tissue captured by the channel 1210 may be incised by the electrode 4 as part of the incision 45, which may comprise a refraction correction portion and a stability portion. Region 1209 may reside between the central opening of the suction element 810 and the channel 1210. Region 1211 may reside between the channels 1210 and 1212. The width (in this embodiment, radial) of the channel 1210 may be configured to be between 50 μm and 500 μm, such that the width of the resulting correlated complementary features protrusions 1110 and depressions 1112 may be between 30 μm and 500 μm. Similarly, the depth of the channel 1210 may be configured to be between 50 μm and 500 μm, such that the height of the resulting correlated protrusions 1110 and depth of depressions 1112 may be between 30 μm and 450 μm. Regions 1209 and 1211 may be configured to deviate between 30 μm and 200 μm from each other and / or from that of surface 1200. The vacuum pressure used to achieve such a result may be between -100 mmHg and -600 mmHg.

[0171] 28A-28B are directed to a further embodiment of suction element 810 similar to that of FIGS. 27A-27C, but with the addition of channel 1214 not configured to provide suction to tissue 2. Instead, channel 1214 may be located adjacent to or near channel 1210. While shown in this exemplary embodiment as located radially beyond channels 1210 and 1212, channel 1214 may alternatively be located between channels 1210 and 1212. The width and / or depth of channel 1214 may be configured to be between 50 μm and 500 μm, such that when a vacuum gauge pressure between ∼−100 mmHg and ∼−600 mmHg is used to provide suction to at least one of channels 1210 and 1212, the correlated resulting width and / or depth / height of protrusions 1110 and recesses 1112 may be between ∼30 μm and ∼450 μm. Channels 1210 and 1212 and 1214 may be separated (in this example radially) by between 200 μm and 1,000 μm. Regions 1209, 1211, and 1213 may be configured to deviate between 30 μm and 200 μm from each other and / or from that of surface 1200. Although shown as nominally regular annular, channels 1210, 1212, and 1214 need not be regular and may be configured with variable widths and / or depths.

[0172] FIG. 29 is directed to a further embodiment similar to that of FIGS. 27A-28B, but with the modification that channels 1210 and 1214 are not configured as regular annular channels. In this example, channels 1210 and 1212 comprise a plurality of openings 1220 and 1222, respectively. Such a configuration may result in a plurality of corresponding protrusions 1110 and recesses 1112 for channels 1210 and 1212, and a nominally continuous protrusion 1110 and recess 1112 corresponding to channel 1214. Openings 1220 and 1222 may be configured to utilize widths between 50 μm and 500 μm, lengths between 50 μm and 3000 μm, and separations (in this example, radial) between 200 μm and 1000 μm. Additionally, suction line 870 is shown not to protrude beyond proximal surface 1202.

[0173] FIG. 30 illustrates an embodiment in which target tissue 2 may be incised along axis of motion 12 by tensioned electrode 702, supported by arms 710 and 712, and through incisions 45 and 46, which may generate flap 40, containing a refractive portion. Corneal strip 820 is shown bounded by incision 47 and extending beyond field aperture 1150 (known as the "optical effective aperture"), with a stability portion shown as protrusion 1110. Flap 40 may be configured with hinge 1020 and boundary 1114, and incised along axis of motion 12 with directions 34 and 36, as described elsewhere herein. Although not illustrated for clarity, it should be understood that complementary features for the stability portion of the incision may be present in bed 44.

[0174] 31A-31C are directed to alternative embodiments of the present disclosure similar to those of FIG. 30, but further comprising various configurations for the stability portion of the incision. FIG. 31A is directed to a stability portion 1110 that may be configured to be constrained to be outside of the inflection portion of the incision relative to the axis of motion 12 (as may be defined by the boundary 1150 and / or the incision 47). Alternatively, FIG. 31B is directed to a configuration for the stability portion 1110 that may be configured to be located nominally opposite the hinge 1020 such that the hinge 1020 itself inherently provides an amount of stability against displacement of the flap 40. The inherent stability may be a function of the size and / or length of the hinge 1020. Alternatively, FIG. 31C is directed to a configuration for the stability portion 1110 that may be configured to comprise multiple stability portions 1110. Combinations of the above configurations are also considered within the scope of the present disclosure.

[0175] FIG. 32 is directed to an embodiment of the present disclosure configured to perform a pocket incision. The embodiment shown in FIG. 32 may include similar features to the embodiment shown in FIG. 39. In some embodiments, arms 710, 712 include extension portions 7101, 7121, respectively. Extension portions 7102, 7122 may be configured to extend distally beyond a portion or portions of arms 710 and / or 712 supporting electrode 702, including incision width 6, as shown. Extensions 7101 and / or 7121 may further include tips 7104, 7124, respectively. Tips 7104, 7124 may be configured to be the plasma inducing portion of the electrode. Tips 7104 and / or 7124 may further be configured to be needle-like. Such needle-like tips 7104 and / or 7124 may be configured to penetrate tissue as if the needle were not the plasma inducing portion of the electrode. Insulating coatings or layers may be used to better isolate the ablation process to the intended portion or portions of the electrode and / or provide improved lubricity over the native material of the electrode support arm. As non-limiting examples, such coatings may include fluorinated hydrocarbon materials, polytetrafluoroethylene (PTFE), perfluoroalkoxy, flexible silicone elastomers, rigid insulating materials, powdered insulating materials, ceramics, ceramic composites, parylene, silane polymers, epoxies, silicates, and combinations thereof. Such materials may be coatings that have a dielectric strength between 10V / μm and 80V / μm and may be applied over a portion of the electrode assembly that is not part of the active incision and is intended to be masked from some other portion of the electrode assembly to prevent it from contributing to plasma-induced ablation. An exemplary configuration is ElectroBond®, available from Surface Solutions Group, which is between 5 μm and 50 μm thick on the stainless steel hypotubes (often used to fabricate hypodermic needles, therefore also known as "hypodermic tubing") that make up the arms 710 and / or 712. TM or FluoroBondTM may be a coating of, and the radial structure 708 may be affixed into a gap made along a portion of the inner edge (not shown) and the non-exposed portion electrode 702 nominally contained within the hypotube. The inner surface of the hypotube may also be insulated with the coating, or an insulating tube may be inserted in place of a direct coating. Additionally, the radial structure 708 and / or tip 7104 and / or 7124 may be constructed from any of the insulating materials previously mentioned and affixed to the hypotube using an adhesive. Alternatively, the radial structure 708 and / or tip 7104 and / or 7124 may be constructed from the same or similar conductive material as the hypotube, such as stainless steel, and affixed to the hypotube via welding or brazing, and portions of this assembly may be coated for electrical insulation and / or lubricity using any of the coating materials previously mentioned. In an alternative embodiment, the arms 710, 712, including the extension portions 7101, 7121 and the tips 7104, 7124, may be made from a single piece, such as a molded piece, which may further include an internal lumen within which at least a portion of the electrode 702 may be at least partially positioned.

[0176] As non-limiting examples, the tip 7104 and / or 7124 and / or portions of the arms 710 and / or 712 may be constructed from tubing (such as hypotubes) fabricated from stainless steel, niobium, titanium, nickel, Inconel, or combinations thereof. The tip 7104 and / or 7124. The metal tubing may be further modified to include a dielectric oxide surface layer for electrical insulation. The tip 7104, 7124 may further include a distal bevel and / or lancet. The bevel type may be selected from the list consisting of, but not limited to, long, short, true short, standard, back cut, intradermal, multi-bevel, A-bevel, B-bevel, C-bevel, Bias, Chiba, Crawford, Courand, diamond tip, Franseen, Huber, Mengini, Quincke, Trocar, and combinations thereof. In alternative embodiments, the tip 7104 may be formed into a "pencil point", such as when the tubing is crimped to produce a conical end and proximal opening for the radial structure 708, as shown in this embodiment, with a tip type, such as may be selected from the list consisting of, but not limited to, Gertie-Marx, Sprotte, Whitacre, Polymedic, reverse-bevel, and combinations thereof. The trailing end of the bevel may further include anti-coring features, such as surface roughening, to prevent undesired extraction. The extension 7102 (or equivalently, "prong", "tine", or "protrusion") may comprise a distal portion of the electrode support arm that is shaped to extend distally beyond the electrode.

[0177] 33A is directed to an embodiment of the present disclosure similar to the side view of FIG. 32, showing further detail in which arm 710 may be generated using hypotube 1300 and includes slit 7106, at least a single radial structure 708, extension 7102, tip 7104, and inner lumen 1302. Radial structure 708 may be inserted into opening 7106 and affixed therein. In this embodiment, radial structure 708 may further include surfaces 7082, 7084 that merge to form track 7086 and route electrode 702 (not shown for clarity). In some embodiments, the radial structure 708 may be considered a "spindle." The hypotube 1300 may be configured to have an outer diameter between 230 μm and 15,000 μm with an inner diameter between 50 μm and 1,400 μm, be constructed from stainless steel, and may be coated, at least in part, using a ≧10 μm thick layer of FluoroBond, as a non-limiting example. Alternatively, a type 304H32RW hypotube having a nominal outer diameter of 230 μm and a nominal inner diameter of 127 μm may be used to construct the arm 710. While the arm 710 is shown for convenience, it should be noted that the present embodiment is not limited to a single arm, and may comprise multiple arms as described herein.

[0178] In some embodiments, the radial structure 708 is defined with a curved surface, such as the curved surface of the track 7086. In some embodiments, the radial structure 708 comprises a curved surface of a guide, such as the track 7086.

[0179] The stiffness of an at least partially hollow electrode support arm 710 or 712 may be affected by its wall thickness. For example, the maximum deflection of an arm 710 of length .about.8 mm, including a hypotube with an outer diameter 1300 of .about.1.0 mm, is [ka] (where q is the uniformly distributed load per unit length (assumed to be .05 N / mm), L is the electrode arm length, E is the elastic modulus (e.g., .about.193 GPa for 304 and 316L stainless steel and Inconel, .about.110 Gpa for Ti-6AI-4V, and .about.84 Gpa for niobium), and I is the moment of inertia, which varies with geometry) may be as given in the table below. [Table 2] A deflection ≦10 μm across a 6.5 mm long incision may be acceptable when generating corneal strips for visual field correction such as may be provided by the exemplary electrode support arm given in the table above with a wall thickness ≧0.1 mm. Furthermore, such a relatively thick wall may provide for simpler fabrication when joining radius 708 to arm 710, especially when the radius will reside at least partially within slot 7016.

[0180] The electrode 702 has a radius r e , may be under tension as described elsewhere herein, may be configured to reduce additional stress on the electrode 702 as the track 7086 is directed away from or out of the arm 710, and may be configured to be smooth without burrs or inclusions or dents or scrapes. Such a track 7086 may have a track radius r t (or equivalently, a "bending radius" or "radius of curvature"). Such a track 7086 may be configured to be nominally circular. Such a track radius may be a minimum radius if the curvature is not constant. The curvature ratio r of the track radius to the electrode radius t / r emay be configured to be between ∼5 and ∼500, or alternatively, between ∼10 and ∼50. For example, the track curvature radius may be between ∼38 μm and ∼750 μm when using ∼>98% pure tungsten ∼15 μm diameter wire electrodes and a curvature ratio between ∼5 and ∼100.

[0181] While track 7086 can be configured in many ways, in some embodiments, surfaces 7082 and 7084 comprise curved surfaces to guide the electrode wire onto a radius of track 7086 at the intersection of surfaces 7082 and 7086. In some embodiments, surfaces 7082, 7084 comprise a radius of a toric surface formed on track 7086. Alternatively, surfaces 7082, 7084 comprise beveled surfaces to guide the electrode wire onto a central portion of track 7086. In some embodiments, the curved central surface of track 7086 comprises, for example, a toric surface.

[0182] 32, in some embodiments, the elongated electrode 702 comprises a wire, each of the multiple arms 710, 712 comprises a tube, and the track is positioned within the tube to align the wire with the elongated axis of the tube between the track and a mounting portion, such as mounting portion 702 or mounting portion 706. In some embodiments, the wire is aligned, for example, generally coaxially with the elongated axis of the tube.

[0183] FIG. 33B is directed to an embodiment of the present disclosure similar to the side view of FIG. 33A and shows further details regarding the radial structure 708 and slot 7106 in a side view. The slot 7106 may comprise a width 7107 and a length 7109 as shown. The radial structure 708 may be configured to be affixed in or near the slot 7106. The radial structure 708 may be thicker than the wall thickness of the arm 710 and configured for placement within the slot 7106, and therefore at least partially residing within the inner lumen 1302 of the arm 710. The track comprising the radial structure 708 can be configured to at least partially reside within the slot 7106, for example, to reduce protrusion beyond the outer surface of the tube of the arm 710. The width 7107 may be configured to be relatively small relative to the corresponding width of the arm 710, which in this embodiment is the outer diameter, including the rounded hypotube. In such a configuration, the width 7107 may be configured to be between 5% and 50% of the corresponding width of the arm 710, or alternatively, between 15% and 25% of the corresponding length of the arm 710. Alternatively, the curved surface of the radial structure 708 may be configured to reside nominally behind the slot 7106 and reside entirely within the inner lumen 1302 of the arm 710. Alternatively, the radial structure 708 may be configured with surfaces 7087, 7089 that may comprise a surface curvature to nominally match that of the arm 710, against which the radial structure 708 will be used to prevent the radial structure 708 from protruding beyond the outer surface of the arm 710. Alternatively, the track that comprises the radial structure 708 may be set back from the outer surface of the arm 710 to prevent it from protruding beyond the outer surface of the arm 710. Length 7109 may be configured to be between ∼50% and ∼500% of the corresponding width of either radial structure 708 or track 7086, or alternatively, between ∼125% and ∼250% of the corresponding length of either radial structure 708 or track 7086, when the radial structure 708 is configured to reside at least partially within slot 7106.The length 7109 may be configured to be between 20% and 200% of the corresponding width of either the radial structure 708 or the track 7086, or alternatively, between 50% and 100% of the corresponding length of either the radial structure 708 or the track 7086, when the radial structure 708 is configured to reside nominally completely within the inner lumen 1302 of the arm 710. The radial structure 708 may be constructed, at least in part, using an electrically insulating material. Such an electrically insulating material may be selected from the group consisting of, but not limited to, ceramic, glass, crystal, polymer, and combinations thereof. In some embodiments, the electrically insulating material comprises an electrically insulating deposition material, such as parylene, as described herein. The radial structure 708 may be attached to the arm 710 using fusion, welding, laser welding, brazing, semi-fusion, and / or adhesive forces. The radial structure 708 may comprise sections 7083 and 7085. Sections 7083, 7085 may further be configured to produce track 7086 at their junction with surfaces 7082, 7084 and / or surfaces 7087, 7086, respectively, as shown in this embodiment. Electrode assembly 5 comprising .about.12.5 μm diameter pure tungsten wire as electrode 702 and radial structure 708 may be configured with arm 710 machined using type 20HV hypotube having a nominal outer diameter of .about.902 μm and a nominal inner diameter of .about.495 μm, with spindle-type radial structure 708 with track 7086 with a track radius of .about.200 μm, with slot 7106 having a width of .about.200 μm and a length of .about.500 μm, machined from alumina ceramic and affixed to arm 710 using epoxy, bonding at least a portion of sections 7083 and / or 7085 to arm 710.

[0184] 33C-33E are directed to an embodiment of the present disclosure, similar to the side view of FIG. 33A, showing further details regarding an exemplary construction for the track 7086 in a cross section through its center. In some embodiments, the angular extent of the radial structure relates to the amount of angular deflection between the arms. In some embodiments, for example, with fixed arms, the radial structure of the track engages the wire electrode along an arc length of about 90 degrees, and the size and shape of the track 7086 can be configured as described herein to allow the track to be placed within the lumen and guide the wire electrode, as appropriate. Alternatively, the arms may comprise arms with variable angular offsets relative to one another, and the arc length of the radial structure at the center of the track 7086 may be increased as appropriate. In some embodiments, the curved wire that engages the surface of the track comprises an arc length of 135 degrees or less, which can allow the size of the track to be reduced. In some embodiments, the curved wire that engages the surface of the track comprises a length of, for example, 100 degrees or less.

[0185] FIG. 33C depicts a track 7086 similar to that of FIG. 33A and B, where region 70863 may be formed such that surface 7083 (or 7085) extends to track 7086. This is shown in this embodiment as a sharp corner, which may be acceptable in some embodiments, notwithstanding the desire to maintain an otherwise smooth track 7086, as this may not guide electrode 702 with region 70863. Region 708061 may include a location of proximal contact between electrode 702 and track 7086 and / or radial structure 708. FIG. 33D depicts a further alternative embodiment of track 7086, of similar configuration to that of FIG. 33C, where at least a portion of region 70863 may be removed, as it is nominally not required to guide electrode 702. The region 70863 may be configured with a smooth transition rather than a corner, since at least a portion of the region 70863 may serve to guide the electrode 702 and may otherwise impart undue stress to the electrode 702. The configuration shown in the figure may provide for smaller parts and / or greater curvature to be used than might otherwise be possible, thereby further reducing stress on the induced electrode 702. For example, FIG. 33E depicts a further alternative embodiment of a track 7086 similar to that of FIG. 33D, where at least a portion of the region proximal to the region 70861 may further be configured by removing material that is nominally not required to guide the electrode 702. The region 70861 may be configured with a smooth transition rather than a corner, since at least a portion of the region 70861 may serve to guide the electrode 702 and may otherwise impart undue stress to the electrode 702. The configuration of the present figure may permit smaller parts and / or greater curvature to be used than might otherwise be possible, thereby further reducing the stress induced on electrode 702.

[0186] 33F-33K are directed to an embodiment of the present disclosure similar to the side view of FIG. 33A and show further details regarding example constructions for the tips 7104 (or 7124) of the prongs 7102.

[0187] FIG. 33F depicts an embodiment of the present disclosure similar to that of FIG. 33A, where tip 7104 is configured to be a "pencil tip" or "cone tip."

[0188] Figure 33G depicts an embodiment of the present disclosure similar to that of Figure 33F, where tip 7104 is configured to be a "trocar" with surface 7104X. Such surface 7104X may be fabricated by grinding a solid rod to produce a faceted tip.

[0189] Figure 33H depicts an embodiment of the present disclosure similar to that of Figure 33G, where tip 7104 is configured to be a "bevel" with surface 7104X. Such surface 7104X may be fabricated by grinding a hypotube, as may be done to fabricate needles as recited elsewhere herein.

[0190] 33I depicts an embodiment similar to that of FIG. 33F but with the further modification of configuring slot 7106 to reside at least partially within tip 7104. At least a portion of radial structure 708 may be further configured to reside within or near tip 7104, within a distal portion of slot 7106, reducing the length of prong 7102.

[0191] 33J depicts an embodiment similar to that of FIG. 33G but with the further modification of configuring slot 7106 to reside at least partially within tip 7104. At least a portion of radial structure 708 may be further configured to reside within or near tip 7104, within a distal portion of slot 7106, reducing the length of prong 7102.

[0192] Figure 33K depicts an embodiment similar to that of Figure 33H, but with the further modification of configuring slot 7106 to reside at least partially within tip 7104. At least a portion of radial structure 708 may be further configured to reside within or near tip 7104, within a distal portion of slot 7106, reducing the length of prong 7102. Tip 7102 may be configured to have a length between -250 μm and -2500 μm, with longer lengths being utilized with thicker arms for stability.

[0193] The use of materials within or around the cavity of the electrode support arm may reduce fluid infiltration and / or act as electrical insulators and / or act as lubricants. By way of non-limiting examples, such materials may be selected from one or more of hydrophobic materials, oleophilic materials, waxes, oils, gels, jellies, petroleum derivatives, paraffins, carnauba wax, castor wax, oleogels, organogels, monoglycerides, methylcellulose, or lanolin, and combinations thereof. Such materials may preferably be non-toxic and / or biocompatible. Such materials may further have a dielectric strength between .about.3V / .mu.m and .about.200V / .mu.m.

[0194] 34A-34E are directed to embodiments similar to those of FIGS. 32 and 33A, which may include one or more features of the embodiments shown in FIGS. 32-33K. In FIG. 34A, arms 710, 712 are translated along a direction of motion 12 such that a pocket incision of a width centered on electrode incision width 6 will be made in the cornea 843 of the eye using electrode 702. Electrode 702 may be located proximal to extensions 7102, 7122 as shown, and may further include tips 7104 and 7124. In some embodiments, arms 710 and 712 remain substantially fixed relative to one another during translational motion 12.

[0195] 34B shows the electrode assembly moving further along direction 12, creating the initial portion of what will become incision 42, open portion 4210, and closed portion 4220 (not labeled in this view to coincide with arms 710 and 712). Open portion 4210 is shown as curved, as may be the case when cutting into a nominally spherical structure such as the cornea. In some embodiments, open portion 4210 comprises an opening to a pocket that is formed in tissue.

[0196] 34C shows the electrode assembly moving still further along direction 12, creating a length of incision 42, the electrode can be moved in the opposite direction and / or turned off, manually retracted and removed from the tissue. As described elsewhere herein, the electrode may be retracted by the motion control system while energized to compartmentalize the tissue using contact elements (not shown for purposes of clarity), such as when creating a corneal leaflet.

[0197] FIG. 34D shows the electrode assembly being retracted in a direction opposite that of direction 12 , creating the entire incision 42 , consisting of the open section 4210 , the closed section 4220 , and the distal section 4230 .

[0198] 34E is directed to an embodiment in which contact elements (not shown for purposes of clarity) as described herein may be used to generate a corneal slice 820 that is nominally located within the lateral boundaries of the incision 42. The corneal slice 820 may be removed through the open section 4210 of the incision 42 to modify the surface of the cornea 843, and may be configured to extend beyond the intended effective aperture such that optical distortion due to edge effects of the corneal slice 820 and / or the incision 42 is reduced. Additionally, the tissue from which the corneal slice 820 is being removed may potentially be less likely to dislocate or slide than a flap incision would, potentially providing improved refractive outcomes compared to, for example, a flap incision.

[0199] FIG. 35 is directed to an embodiment of the present disclosure similar to that of FIGS. 34A-34E and 40A-40E, but with a modification in which the electrode incision width 6 is increased so that more open sections 4210 can be located, where the electrode incision width 6 is ≧ the tissue range (e.g., compressed corneal diameter). Specifically, the "superior corner" of the incision is open in this example due to the shape of the cornea. This "multiple aperture incision" may still be considered a pocket incision since it does not include a hinge section as a flap does.

[0200] FIG. 36 is directed to an embodiment similar to that of FIG. 32, but with a modification in which at least one of the arms 710, 712 supporting the electrode 702 is configured to move such that the incision width 6 of the electrode 702 can be varied to generate a pocket incision of variable width. For example, at least one of the arms 710, 712 may be pivoted (or equivalently "rotated" or "turned" or "swiveled", etc.) about a pivot point 7210, 7212, respectively, during incision along the axis of motion 12 to vary the width 6. As a non-limiting example, coordinating the movement of the arms 710 and / or 712 to vary the width 6 may be accomplished using at least a single actuator, which may be selected from the group comprising one or more of a motor, a rotary motor, a squiggle motor, a linear motor, a solenoid, a rotary solenoid, a linear solenoid, a voice coil, a spring, a moving coil, a piezoelectric actuator, a pneumatic actuator, a hydraulic actuator, or a fluid actuator, and combinations thereof. Alternatively, the width 6 may be varied using a passive device, which may be selected from the group comprising one or more of a mechanical linkage, a cam and follower arrangement, a gear, a set of gears, or a similar passive mechanical means, or a combination thereof. Furthermore, the tension element 700 may be selected to maintain a nominally fixed tension on the electrode 712 and accommodate any changes to the length of the electrode, which corresponds to the variable width 6. A coil spring coaxial with a bobbin for holding the electrode 712 may be very suitable for this purpose. Alternatively, the tension may be varied with the width 6, and a compound spring may be very suitable for this purpose. Although not shown in this embodiment, linearly and / or laterally translating the arms 710 and / or 712 to vary the width 6 is also considered within the scope of this disclosure and is discussed elsewhere herein.

[0201] 37 is directed to an embodiment of the present disclosure similar to that of FIGS. 34A-34E and 35, made using the embodiment of FIG. 36 and varying the width of the incision 42 along the direction of movement 12. Although shown to increase linearly between the open portion 4210 and a location halfway along the direction 12 of the incision 42, and then decrease between the closed portion 4230 and a location halfway along the direction 12 of the incision 42, the shape (or equivalently, "curve" or "trace" or "form" or "geometry" or "contour" or "profile", etc.) may be determined according to the therapeutic intent and anatomical conditions. For example, portion 4220 may be rounded, as appropriate for corneal flake extraction as shown in FIG. 38.

[0202] A controller, such as system controller 60, may vary the incision parameters, in which the exposed electrode length 6 is varied during the incision. Such variable incision parameters may be selected from the group comprising, by way of non-limiting examples, one or more of frequency, polarity, bias, voltage, current, waveform, duty cycle, pulse duration, burst duration, envelope function, speed, direction, velocity, acceleration, jerk, jerk-to-jerk, jerk-to-jerk, or jerk-to-jerk-to-jerk, and combinations thereof.

[0203] FIG. 39 is directed to an embodiment of the present disclosure configured to create a pocket incision and may include one or more features of the embodiments shown in FIGS. 4 and 6. In some embodiments, the track with radial structure 708 is located near the distal end of the arms 710, 712 for incising tissue with an electrode near the distal end of the arm. In some embodiments, the track with radial structure 708 is located sufficiently close to the end of the arms 710, 712 to allow tissue to at least partially enter the track and engage a portion of the electrode supported on the track for incision with plasma as described herein. In some embodiments, the track with radial structure 708 is located on the distal end of the arms 710, 712 and the wire 702 is covered by a tube on each arm between the radial structure 708 and the attachments 704, 706. In some embodiments, the arms each include a wedge-shaped end to urge the tissue outwardly and away from the electrode, which may facilitate advancement of the arms and electrode when dissecting the pocket.

[0204] In some embodiments, the incision width 6 is configured to create a pocket incision in the target tissue 2, in which the electrode cutting width is less than approximately the tissue presentation width 7, and the electrode is configured not to engage tissue beyond the incision width 6, for example, by bending at the radial structure 708 and extending back into the canal. The opening to the canal may include an electrically insulating material, such as an electrically insulating hydrophobic material, to reduce infiltration of materials, such as tissue, bodily fluids, saline, etc. Also, the opening to the lumen of the arm may be dimensioned to pass a wire electrode and reduce passage of materials, for example, by having a diameter of no more than 150% of the wire diameter, no more than 250% of the wire diameter, or no more than 500% of the wire diameter. In some embodiments, the diameter of the opening is less than the diameter of the lumen.

[0205] The tissue presented width 7 may be considered as the width of the tissue as seen by the electrodes along the translation direction. For example, the tissue 2 may be the cornea 843, and a pocket may be created in the anterior aspect of the cornea 843 by using a contact plate as described herein to flatten or otherwise compress said anterior corneal surface, resulting in a lateral dimension for the incision 42 of between 3mm and 11mm, or alternatively between 6mm and 8mm, or alternatively, 7mm, all of which may be at least approximately equal in extent to the incision width 6 and less than the tissue presented width 7. That is, for cutting a pocket, the tissue presented width 7 may be .gtoreq. incision width 6 for creating an incision with a border that is at least partially a partially rounded rectangle, similar to that shown in FIGS. 40A-40E (e.g., when configured with a straight uncut portion). On the other hand, for cutting a flap, the incision width 6 may be .gtoreq. tissue presented width 7 for creating an incision 47 such as that shown in FIG. 10F. Alternatively, a two-aperture pocket incision may be created using a pocket incision configuration allowing the electrode to traverse the entire distance through the cornea along the translation direction, resulting in an incision that is shaped, at least in part, as a rounded rectangle, similar to that shown in Figs. 41A-41C. It should be understood that the final shape of such an incision will depend, at least in part, on the natural and / or given shape of the tissue being incised. An insulating coating or layer may be used to better isolate the ablation process to the intended portion or portions of the electrode and / or to provide improved electrical insulation and / or lubricity over the natural material of the electrode support arms 710, 712 and radial structure 708. As non-limiting examples, such coatings may comprise one or more of fluorinated hydrocarbon materials, polytetrafluoroethylene (PTFE), perfluoroalkoxy, flexible silicone elastomers, rigid insulating materials, powdered insulating materials, ceramics, ceramic composites, parylene, silane polymers, epoxies, or silicates, and combinations thereof.Such a coating may be applied on a portion of the electrode assembly that is not intended to be part of the active cutting and is masked from some other portion of the electrode assembly to allow it to contribute to plasma-induced ablation. Some of these coatings, particularly fluoropolymers, may decompose and release unhealthy by-products when heated to >260° C. An exemplary configuration is ElectroBond, available from Surface Solutions Group, which is between 5 μm and 50 μm thick. TM or FluoroBond TM The coating may be applied as appropriate.

[0206] Figures 40A-40E are directed to embodiments related to that of Figure 39. In Figure 40A, arms 710, 712 are translated along direction of motion 12 such that a pocket incision with a width centered around electrode incision width 6 will be made in the cornea 843 of the eye using electrode 702.

[0207] 40B shows the electrode assembly moving further along direction 12, creating the initial portion of what will become incision 42, open portion 4210, and closed portion 4220 (not labeled in this view to coincide with arms 710 and 712). Open portion 4210 is shown as curved, as may be the case when cutting into a nominally spherical structure such as the cornea.

[0208] 40C shows the electrode assembly moving still further along direction 12, creating a length of incision 42, the electrode may be moved in the opposite direction and / or de-energized, manually retracted and removed from the tissue. As described elsewhere herein, the electrode may be retracted by the motion control system while energized to compartmentalize the tissue using contact elements (not shown for purposes of clarity), such as when creating a corneal leaflet.

[0209] FIG. 40D shows the electrode assembly being retracted in a direction opposite that of direction 12 , creating the entire incision 42 , consisting of the open section 4210 , the closed section 4220 , and the distal section 4230 .

[0210] FIG. 40E is directed to an embodiment in which contact elements (not shown for purposes of clarity) may be used to generate a corneal strip 820 that is nominally located within the lateral boundaries of the incision 42. For shaped tissue extraction such as this embodiment of a corneal strip, the incision width 6 should exceed the intended extent of the tissue to be extracted. In particular, for the cornea, a distance ranging from 100 μm to 1 mm intervals between the incision edge of the strip and the extraction edge of the pocket may be used as a perimeter to prevent interference between the incision used to form the pocket and the extraction along the boundaries of the strip. Alternatively, a perimeter between 300 μm and 800 μm intervals between the incision edge and the extraction edge may be used. Alternatively, a perimeter ranging from 100 μm to 1 mm intervals between the outer arm edge and the outer extraction edge may be used. Alternatively, a perimeter between 300 μm and 800 μm intervals between the outer arm edge and the outer extraction edge may be used. The corneal slice 820 may be removed through the open section 4210 of the incision 42 to modify the surface of the cornea 843, and may be configured to extend beyond the intended effective aperture such that optical distortion due to edge effects of the corneal slice 820 and / or the incision 42 is reduced. Additionally, the tissue from which the corneal slice 820 is removed may potentially be less likely to dislocate or slide than a flap incision would, thereby providing improved refractive outcomes over that of a flap incision according to some embodiments.

[0211] 41A-41C are directed to an embodiment similar to that of FIGS. 40C-40E, where the electrode 702 continues in direction 12 and instead of a closed portion 4230, a second open portion 4210 may be created, which may result in a pocket incision shaped as a rounded rectangle as shown, or similar, depending on the natural and / or given shape of the tissue.

[0212] FIG. 42 is directed to an embodiment of the present disclosure configured to vary the exposed electrode length 6 of the electrodes 702 by varying the electrode support arm spacing 11, which may be nominally along the direction of motion 13, which may be nominally perpendicular to the directions of motion 12, 14. The embodiment shown in FIG. 42 may be similar to those of FIGS. 6, 36, and 39 and may include one or more features of the embodiments shown in FIGS. 6, 36, and 39. The electrode arm spacing 11 may be considered as the distance that the electrodes extend between at least a portion of the electrode arms 710, 712. In some embodiments, the exposed electrode distance constitutes the distance between the radial structures 708 of the track, and the exposed distance is varied by moving one or more of the electrodes relative to the other electrodes to vary the distance between the radial structures 708. At least one of the electrode support arms 710, 712 may be mounted to the electrode spacing adjustment member 9 via attachments 704, 706. An electrode spacing adjustment member 9 may be connected to the electrode subassembly 4. The movement of at least one of the electrode support arms 710, 712 may be controlled via the electrode spacing adjustment member 9 using an actuator 550. The actuator 550 provides an axis of motion (or equivalently, a direction of motion, e.g., "translation" along the axis of motion 13) and may be coupled to a position encoder 551 via connection 553, and both the position encoder 551 and the actuator 550 may be connected to an actuator driver 557 via connections 556, 559, respectively. To adjust the spacing of the arms, reference is made to translation, but spacing can also be adjusted by rotating one or more of the arms with the actuator, and by a combination of rotation and translation as described herein.

[0213] As non-limiting examples, the connection 555 may comprise one or more of the following: a mechanical coupler, an electrical coupler, a magnetic coupler, or an optical coupler. It should be noted that to practice some embodiments of the present disclosure, such as in the creation of a corneal pocket utilizing a single incision, only a single axis of motion may be relied upon, but more than one axis may be used. The axes of motion 13, 12, which are the axes of motion for the actuator 550 and the electrode mechanism 5, respectively, may be configured to be orthogonal or at least non-colinear, e.g., transverse to one another. The actuator 550 may further be connected via a connection 552 to a system controller 60 to coordinate its motion with other aspects of the system. Such coordination between the actuator 500 and, for example, the actuator 504, may provide incisions of variable width in tissue, such as those shown in FIGS. 43A-43F. Additional actuators may also be used as described herein, and their movements coordinated with a processor, such as the system controller 60. Although the electrode arms 710, 712 are shown as curved, that need not be considered within the scope of this disclosure and may be, for example, generally straight. Actuators and / or passive mechanical devices as described elsewhere herein, such as with respect to FIG. 36, may be used for translation.

[0214] Figures 43A-43F are directed to embodiments related to those of Figures 40A-40E, 41A-41C, and 42. In Figure 43A, at least a portion of the electrode assembly 5 is oriented along a direction of movement 12 while at least one of the arms 710, 712 is translated along a direction of movement 13 such that a variable electrode incision width 6 will create an incision in the cornea 843 of the eye using the electrode 702.

[0215] 43B shows the electrode assembly moving further along direction 12, creating the initial portion of what will become the incision 42, an open portion 4210, and a closed portion 4220. The open portion 4210 is shown as curved, as may be the case when cutting into a nominally spherical structure such as the cornea.

[0216] 43C shows the electrode assembly moving still further along direction 12, creating a length of incision 42, the electrode can be moved in the opposite direction and / or turned off, manually retracted and removed from the tissue. As described elsewhere herein, the electrode may be retracted by the motion control system while energized to compartmentalize the tissue using contact elements (not shown for purposes of clarity), such as when creating a corneal leaflet.

[0217] Fig. 43D shows the electrode assembly retracted in a direction opposite to that of the initial direction 12, creating the entire incision 42, consisting of the open section 4210, the closed section 4220, and the distal section 4230. Although not shown, an excision portion, such as a corneal flap, may be created within the pocket created by the incision 42 as in Figs. 40E and 41C.

[0218] Figure 43E is directed to an embodiment of the present disclosure in which electrode 702 may continue in direction 12 and create a second open portion 4210, which may result in a two-opening pocket incision similar to that of Figure 41B. Although not shown, an excision portion, such as a corneal flap, may be created within the pocket created by incision 42 as in Figures 40E and 41C.

[0219] FIG. 44 is directed to an embodiment of the present disclosure similar to those of FIGS. 4, 6, and 42 in which the electrode support arms 710, 712 are configured to partially overlap (or "cross") at or about an overlap region 19, whereby the exposed electrode length 6 can be changed (or "adjusted" or "varied") by translating at least one of the electrode support arms 710, 712 in the directions of motion 15, 16, respectively. The electrode arm spacing 11 of FIG. 42 may be replaced by at least a function of the variable angle 13A to determine the exposed electrode length 6. Such overlap may cause differences in electrode location along the direction of motion 14 between the arms 710, 712 due to the thickness of at least one of the arms 710, 712, which may be adjusted, for example, by tilting the electrode assembly to accommodate.

[0220] In an alternative embodiment, overlap region 19 may further comprise a pivot location 21. Electrode support arms 710, 712 may be articulated about pivot location 21 according to variable angle 13A to vary exposed electrode length 6, and the overall movement of electrode assembly 5 may be coordinated along direction of movement 12 to compensate for movement along direction of movement 12 as variable angle 13A is increased, as to the left in this figure.

[0221] In some embodiments, the actuator is configured to translate an electrode assembly comprising an elongated electrode 702, a plurality of arms 710, 712, and a plurality of actuators for translating an exposed portion of the elongated electrode in a first direction 12 to cut tissue with the electrode, and the plurality of actuators are configured to translate the plurality of arms in a second direction 13 transverse to the second direction to adjust the separation distance between the plurality of arms and the length of the exposed electrode. The angle 13A may also be adjusted using the actuators as described herein.

[0222] In some embodiments, a processor, such as a controller as described herein, is operably coupled to a number of actuators, which coordinate translation in the first direction 12 and translation in the second direction 13 to adjust the width of the incision. The processor can also be configured to adjust the angle, for example, to adjust the pivot location 21.

[0223] 45A-45F are directed to an embodiment similar to that of FIGS. 43A-43F and 44. In FIG. 45A, at least a portion of the electrode assembly 5 is oriented along the motion direction 12, while at least one of the arms 710, 712 and the pivot location 21 are translated by varying the adjustable angle 13A such that the variable electrode incision width 6 will create an incision in the cornea 843 of the eye using the electrode 702. There may be no translation along the motion directions 15, 16 directly associated with the arms 710, 712, but in this configuration the motion directions 15, 16 may change with the change in the adjustable angle 13A. In some embodiments, the movement is provided substantially along the motion directions 15, 16 by the combined translational movement 12 and pivoting about the mounts 704, 706 to change the angle 13A. Alternatively, or in combination, the separation distance between mounting portions 704, 706 is adjusted as the electrode assembly is translated in movement direction 12 to define movement directions 15, 16, for example to correspond to the lateral boundaries of the incision.

[0224] In some embodiments, the pivot location 21 corresponds to a physical structure, such as a pin, bearing, protrusion, recess, hole, or rivet, to define a location of the pivot location 21 on the arms 710, 712. Alternatively, or in combination, the pivot location 721 can be provided by coordinated translation of the arms 710, 712 relative to the mountings 704, 706, and by pivoting about the mountings 704, 706 to define the pivot location 721. In some embodiments, a processor, such as the controller 60, is configured to translate the electrode assembly in the direction 12, translate the mountings 704, 706 transversely to the direction 12, e.g., generally perpendicular to the direction 12, and pivot the arms, e.g., about the mountings 704, 706, to define the pivot location. In some embodiments, the processor is configured to coordinate the translation of the electrode assembly 12 and the pivoting and translation of the arm to move a pivot location on the arm to correspond to an opening to the incision, e.g., the open portion 4210, which can, for example, reduce the size of the opening. Such a configuration can be considered to have a "remote center location" that is nominally within or near the open portion 4210.

[0225] 45B shows the electrode assembly moving further along direction 12, creating the initial portion of what will become the incision 42, an open portion 4210, and a closed portion 4220. The open portion 4210 is shown as curved, as may be the case when cutting into a nominally spherical structure such as the cornea. The exposed electrode length 6 may be varied in coordination with the movement along the movement direction 12 by varying the adjustable angle 13A, as shown.

[0226] 45C shows the electrode assembly moving still further along direction 12, creating a length of incision 42; the electrode can be moved in the opposite direction or turned off, manually retracted and removed from the tissue. As described elsewhere herein, the electrode may be retracted by the motion control system while energized to compartmentalize the tissue using contact elements (not shown for purposes of clarity), such as when creating a corneal leaflet.

[0227] Fig. 45D shows the electrode assembly retracted in a direction opposite to that of the initial direction 12, creating the entire incision 42, consisting of the open section 4210, the closed section 4220, and the distal section 4230. Although not shown, an excision portion, such as a corneal flap, may be created within the pocket created by the incision 42 as in Figs. 40E and 41C.

[0228] 45E and 45F are directed to an embodiment of the present disclosure similar to that of FIGs. 45C and 45D, in which electrode 702 may continue in direction 12 to create a second open portion 4210, which may result in a two-opening pocket incision similar to that of FIG. 41B. Although not shown, an excision portion, such as a corneal flap, may be created within the pocket created by incision 42 as in FIGs. 40E and 41C.

[0229] Figures 46A-46E are directed to an embodiment similar to that of Figures 44 and 45A-45F. In Figure 46A, at least a portion of the electrode assembly 5 is oriented along a direction of movement 12 while the arm 710 is translated by varying the adjustable angle 13A and / or translated along a direction of movement 15 such that a variable electrode incision width 6 will create an incision in the cornea 843 of the eye using the electrode 702. The directions of movement 15, 16 may change with the change in the adjustable angle 13A as shown in this embodiment.

[0230] 46B shows the electrode support arms 710, 712 translating in direction 12 to create an open section 4210 of what will become the incision 42. The arm 712 may cease translation after creating the open portion / section 4201, while the arm 710 may be moved along a direction of motion 15, which may vary with variations in the adjustable angle 13A, to at least partially shape the incision along direction 12 and create a closed portion 4220. The open portion 4210 is shown as curved, as may be the case when cutting into a nominally spherical structure such as the cornea. Independent actuators and / or passive mechanical devices as described elsewhere herein may be used to translate the arm 710 and change the adjustable angle 13A. The translation of arm 710 may be stopped at an intermediate location and arm 712 may be moved / translated along a direction of movement 16, which may also vary with variation in adjustable angle 13A, to at least partially shape the incision along direction 12 and generate a second closure portion 4220.

[0231] 46C shows such a second closure portion 4220 created by translating the arm 712 along the direction of motion 16 to create a second closure portion 4220. This configuration may be considered an intermediate toward a larger incision 42.

[0232] FIG. 46D shows the electrode assembly moving further along direction 12 to create a length of incision 42 by varying arms 710, 712 along motion directions 15, 16, respectively, while also varying adjustable angle 13A and translating at least a portion of the electrode assembly along direction 12 to create a second open portion 4210, which may result in a two-opening pocket incision similar to that of FIG. 45E, although configurations such as that of FIG. 45C may be created as well. Alternatively, angle 13A may be held constant (and have no associated actuators or passive mechanical devices to impart adjustment or motion profiles) and arms 710, 712 may be translated along motion directions 15, 16, respectively, in coordination with the translation along direction 12. Such translation of arms 710, 712 may occur simultaneously or sequentially in coordination with the translation of at least a portion of electrode assembly 5 along direction 12. The electrodes can be moved in the opposite direction or turned off and manually retracted and removed from the tissue. As described elsewhere herein, the electrodes may be retracted by the motion control system while energized to compartmentalize tissue using contact elements (not shown for purposes of clarity), such as when creating a corneal leaflet.

[0233] Fig. 46E shows the electrode assembly retracted in a direction opposite to that of the initial direction 12, creating an entire incision 42 consisting of an open section 4210 and a closed section 4220. Although not shown, an excision portion, such as a corneal flap, may be created within the pocket created by the incision 42 as in Figs. 40E and 41C.

[0234] As used herein, the words "nominally," "substantially," "approximately," and "about" refer to variations in nature that may vary by an amount such as 15%, unless otherwise indicated.

[0235] As used herein, the terms "flex," "deform," "vibrate," "stretch," and "bend" may be used interchangeably.

[0236] As used herein in reference to tissue interactions, the terms "disrupt," "disintegrate," and "ablate" may be used interchangeably.

[0237] The symbol "~" is used herein as equivalent to "about." For example, a statement such as "~100 ms" is equivalent to a statement such as "about 100 ms" and "~100 ms" is equivalent to a statement such as "~100 ms." t =~5mm s -1 " etc. are written as "v t is about 5 mm s -1 This is comparable to the description "is."

[0238] symbol [ka] is used herein to indicate that the value that follows is a diameter. For example, [ka] is comparable to the statement "diameter of 10 μm." [ka] etc. is comparable to a statement of "diameter of approximately 12 μm."

[0239] The symbol "∝" is used herein to indicate proportionality. For example, "∝r -2 " etc. are written as "r -2 This is comparable to the statement "proportional to."

[0240] Dot notation is used herein to represent compound units for clarity and brevity. For example, the notation k = ~40 N m -1 is equivalent to saying "k=~40N / meter".

[0241] As used herein, "mN" refers to "millinewtons," which is 10 -3 It's Newton.

[0242] As described herein, the computing devices and systems described and / or illustrated herein broadly represent any type or form of computing device or system capable of executing computer-readable instructions such as those contained within the modules described herein. In their most basic configurations, these computing devices may each include at least one memory device and at least one physical processor.

[0243] The term "memory" or "memory device" as used herein generally refers to any type or form of volatile or non-volatile storage device or medium capable of storing data and / or computer-readable instructions. In one embodiment, a memory device may store, load, and / or maintain one or more of the modules described herein. Examples of memory devices include, but are not limited to, random access memory (RAM), read-only memory (ROM), flash memory, hard disk drive (HDD), solid state drive (SSD), optical disk drive, cache, any variation or combination of one or more of the same, or any other suitable storage memory.

[0244] Additionally, the term "processor" or "physical processor" as used herein generally refers to any type or form of hardware-implemented processing unit capable of interpreting and / or executing computer-readable instructions. In one embodiment, the physical processor may access and / or modify one or more modules stored in the memory device described above. Examples of physical processors include, but are not limited to, a microprocessor, a microcontroller, a central processing unit (CPU), a field programmable gate array (FPGA) implementing a soft-core processor, an application specific integrated circuit (ASIC), a portion of one or more of the same, a variation or combination of one or more of the same, or any other suitable physical processor. The processor may comprise a distributed processor system, e.g., a parallel processor invocation, or a remote processor such as a server, and combinations thereof.

[0245] Although illustrated as separate elements, the method steps described and / or illustrated herein may represent parts of a single application. Additionally, in some embodiments, one or more of these steps may represent or correspond to one or more software applications or programs that, when executed by a computing device, may cause the computing device to perform one or more tasks, such as method steps.

[0246] In addition, one or more of the devices described herein may transform data, physical devices, and / or representations of physical devices from one form to another. Additionally or alternatively, one or more of the modules listed herein may transform a processor, volatile memory, non-volatile memory, and / or any other portion of a physical computing device from one form of computing device to another form of computing device by executing on the computing device, storing data on the computing device, and / or otherwise interacting with the computing device.

[0247] The term "computer-readable medium" as used herein generally refers to any form of device, carrier, or medium capable of storing or carrying computer-readable instructions. Examples of computer-readable media include, but are not limited to, transmission-type media such as carrier waves, and non-transitory-type media such as magnetic storage media (e.g., hard disk drives, tape drives, and floppy disks), optical storage media (e.g., compact discs (CDs), digital video discs (DVDs), and BLU-RAY discs), electronic storage media (e.g., solid-state drives and flash media), and other distributed systems.

[0248] Those skilled in the art will recognize that any process or method disclosed herein can be modified in many ways. The process parameters and sequences of steps described and / or illustrated herein are given as examples only and can be varied as desired. For example, although the steps illustrated and / or described herein are shown or discussed in a particular order, these steps do not necessarily have to be performed in the order illustrated or discussed.

[0249] The various exemplary methods described and / or illustrated herein may also omit one or more of the steps described or illustrated herein, or may comprise additional steps in addition to those disclosed. Furthermore, the steps of any method as disclosed herein can be combined with any one or more steps of any other method as disclosed herein.

[0250] A processor as described herein may be configured to perform one or more steps of any of the methods disclosed herein. Alternatively, or in combination, a processor may be configured to combine one or more steps of one or more methods as disclosed herein.

[0251] Unless otherwise stated, the terms "connected to" and "coupled to" (and their derivatives) as used in the specification and claims are intended to be interpreted as allowing for both direct and indirect (i.e., via other elements or components) connections.

[0252] Unless otherwise noted, the terms "operably connected to" and "operably coupled to" (and derivatives thereof) as used in the specification and claims are intended to be interpreted as allowing for both direct and indirect (i.e., via other elements or components) connections to perform functions.

[0253] Additionally, the terms "a" and "an," as used in the specification and claims, are intended to mean "at least one of." Finally, for ease of use, the terms "including" and "having" (and their derivatives) as used in the specification and claims are intended to be synonymous with and have the same meaning as the word "comprising."

[0254] A processor as disclosed herein may be configured with instructions to perform any one or more steps of any method as disclosed herein.

[0255] It should be understood that the terms "first," "second," "third," etc. may be used herein to describe various layers, elements, components, regions, or sections without referring to any particular order or sequence of events. These terms are merely used to distinguish one layer, element, component, region, or section from another layer, element, component, region, or section. A first layer, element, component, region, or section as described herein could be referred to as a second layer, element, component, region, or section without departing from the teachings of the present disclosure.

[0256] As used herein, the term "or" is used inclusively to refer to items both as alternatives and in combination.

[0257] As used herein, letters such as numbers refer to similar elements.

[0258] This disclosure includes the following numbered appendices:

[0259] Appendix 1. A system for incising tissue with plasma, the system comprising: an elongated electrode configured to flex, generate plasma, and incise tissue; an electrical energy source operably coupled to the elongated electrode and configured to provide electrical energy to the electrode and generate plasma; a tensioning element operably coupled to the elongated electrode, the tensioning element configured to provide tension to the elongated electrode to enable the elongated electrode to flex and generate plasma in response to the elongated electrode engaging tissue; and a plurality of arms operably coupled to the electrode and the tensioning element, each of the plurality of arms comprising a tip distal to the elongated electrode for penetrating tissue.

[0260] Appendix 2. The system of Appendix 1, wherein each of the plurality of elongate arms comprises an opening into the lumen and a track located within the lumen and routing the elongate electrode from the lumen through the opening.

[0261] Addendum 3. The system of Addendum 2, wherein each of the multiple arms includes an extension extending between the track and the tip, positioning the tip distal to the elongated electrode.

[0262] Addendum 4. The system of Addendum 2, wherein each of the multiple arms comprises a tube, a lumen and track located within the tube, and an opening formed in the tube.

[0263] Clause 5. The system of clause 2, wherein the track has a curved surface.

[0264] Clause 6. The system of clause 5, wherein the curved surface comprises a radius.

[0265] Addendum 7. The system of Addendum 5, wherein the track comprises a first surface and a second surface that merge to form the track and route the electrode through the opening.

[0266] Clause 8. The system of clause 2, wherein the opening has a width within a range of about 5% to about 50% of a corresponding cross-sectional width of the arm.

[0267] Clause 9. The system of clause 2, wherein the opening is sized to receive the track.

[0268] Addendum 10. The system of Addendum 2, wherein the track is affixed to the arm.

[0269] Clause 11. The system of clause 2, wherein the opening comprises a slit.

[0270] Clause 12. The system of clause 9, wherein the slit has a length and a width, the length being greater than the width, and the length being within the range of 50% to 500% of the radius of the track, optionally within the range of 125% to 250% of the radius of the track.

[0271] Clause 13. The system of clause 12, wherein the width is within the range of 5% to 50% of the cross-sectional width of the arm, optionally within the range of 15% to 25% of the cross-sectional width of the arm.

[0272] Clause 14. The system of clause 2, wherein the track is configured to engage the elongated electrode along an arc length of 135 degrees or less, optionally 100 degrees or less.

[0273] Clause 15. The system of clause 14, wherein the track has curved ends.

[0274] Addendum 16. The system of Addendum 2, wherein the track is sized and shaped to be placed within the lumen of each of the multiple arms.

[0275] Addendum 17. The system of Addendum 2, wherein the track is configured to allow the elongated electrode to slide when tensioned between the multiple arms.

[0276] Addendum 18. The system of Addendum 2, wherein the track comprises an electrically insulating material.

[0277] Clause 19. The system of clause 2, wherein the track has a track radius and the electrode has an electrode radius across a cross section of the electrode, and wherein a ratio of the track radius to the electrode radius is in the range of about 5 to about 500, optionally about 5 to 100, further optionally about 10 to about 50.

[0278] Clause 20. The system of clause 19, wherein the track radius is in the range of about 0.038 mm to about 1 mm, optionally in the range of about 0.04 mm to about 0.75 mm.

[0279] Addendum 21. The system of Addendum 2, wherein the elongate electrode comprises a wire, each of the multiple arms comprises a tube, and the track is positioned within the tube to align the wire with an elongate axis of the tube between the track and the attachment portion.

[0280] Clause 22. The system of clause 21, wherein the wire is aligned approximately coaxially with the elongation axis of the tube.

[0281] Addendum 23. The system of Addendum 2, wherein each of the plurality of arms has an inner cross-sectional diameter sized to receive a track.

[0282] Clause 24. The system of clause 23, wherein the track has a radius less than or equal to the inner cross-sectional diameter.

[0283] Addendum 25. The system of Addendum 1, wherein each tip is configured to incise tissue.

[0284] Addendum 26. The system of Addendum 1, wherein each tip includes an electrically insulating material to isolate the tip from electrical energy applied to the elongated electrode.

[0285] Addendum 27. The system of Addendum 1, wherein the distance between the first arm and the second arm remains fixed when a tip of each of the multiple arms penetrates tissue.

[0286] Addendum 28. The system of Addendum 1, further comprising an actuator for adjusting an exposed length of the extension electrode between the multiple arms.

[0287] Clause 29. The system of clause 28, wherein the actuator is configured to adjust a separation distance between the first track and the second track to adjust the exposure length.

[0288] Addendum 30. The system of Addendum 28, wherein the actuator is configured to effect one or more of a translation or rotation of at least one of the arms to adjust the exposure length.

[0289] Addendum 31. The system of Addendum 30, wherein the actuator is configured to rotate at least one arm about a pivot point to adjust the separation distance, and optionally rotate the arm about the mounting portion.

[0290] Addendum 32. The system of Addendum 30, wherein the actuator is configured to translate at least one arm, adjust the separation distance, and optionally translate the mounting portion of the at least one arm.

[0291] Addendum 33. The system of Addendum 30, wherein the actuator is configured to rotate and translate at least one arm to adjust the separation distance.

[0292] Clause 34. The system of clause 30, further comprising a processor operably coupled to the actuator to adjust an exposed length of the elongated electrode to vary the width of the incision.

[0293] Addendum 35. The system of Addendum 30, wherein the actuator comprises a plurality of actuators configured to rotate and translate the plurality of arms to adjust the separation distance.

[0294] Addendum 36. The system of Addendum 35, further comprising an actuator configured to translate an electrode assembly comprising an elongated electrode, a plurality of arms, and a plurality of actuators to translate an exposed portion of the elongated electrode in a first direction and cut tissue with the electrode, the plurality of actuators configured to translate the plurality of arms in a second direction transverse to the first direction to adjust a separation distance between the plurality of arms and a length of the exposed electrode.

[0295] Clause 37. The system of clause 36, further comprising a processor operatively coupled to the plurality of actuators and the actuators to coordinate translation in a first direction and translation in a second direction to adjust the width of the incision.

[0296] Addendum 38. The system of Addendum 1, wherein the arms of the multiple arms cross each other.

[0297] Addendum 39. The system of Addendum 38, wherein the arms cross each other at a pivot location.

[0298] Clause 40. The system of clause 39, wherein the pivot angle is adjustable, varying the pivot angle and corresponding incision width.

[0299] Addendum 41. The system of Addendum 38, further comprising a pivot structure for pivoting the arm at a location, the pivot structure comprising one or more of a pin, a bearing, a protrusion, a recess, a hole, or a rivet.

[0300] Clause 42. The system of clause 39, further comprising a processor operatively coupled to the actuator to cause the arms to cross at the pivot location.

[0301] Addendum 43. The system of Addendum 1, wherein a track is located on a distal end of each of the multiple arms, the track having a radius configured to direct an elongated electrode into a lumen of each of the multiple arms, the lumen of each of the multiple arms extending to an opening, the opening having a diameter of 150% or less than a diameter of the wire, 250% or less than a diameter of the wire, or 500% or less than a diameter of the wire.

[0302] Addendum 44. The system of Addendum 43, wherein the diameter of the opening is smaller than the diameter of the lumen.

[0303] Addendum 45. The system of Addendum 1, wherein the tip and extension electrodes of each of the multiple arms are configured to pierce tissue and create a pocket incision.

[0304] Addendum 46. The system of Addendum 1, wherein a tip of each of the multiple arms is configured to incise tissue, and optionally, each tip forms a portion of a blade.

[0305] Addendum 47. The system of Addendum 1, wherein each tip includes a conductive material for cutting tissue using plasma.

[0306] Addendum 48. The system of Addendum 1, wherein a tip is located on a distal end of each of the multiple arms.

[0307] Addendum 49. The system of Addendum 1, wherein each of the plurality of arms is at least partially hollow, and optionally, an unexposed portion of the electrode extends along the hollow portion of each of the plurality of arms.

[0308] Addendum 50. The system of Addendum 1, wherein an incision of variable width is generated by adjusting an active length of the elongated electrode, optionally the active length constituting an exposed length of the tensioned electrode.

[0309] Clause 51. The system of clause 50, wherein the active length of the elongate electrode is adjusted by moving the multiple arms along the length of the incision in a direction different from the direction of movement of the electrode.

[0310] Addendum 52. The system of Addendum 1, further comprising an actuator that adjusts the separation distance between the multiple arms and adjusts the length of the elongated electrodes tensioned between the multiple arms to adjust the width of the incision.

[0311] Addendum 53. The system of Addendum 52, wherein the actuator is configured to translate one or more of the plurality of electrodes to adjust the separation distance.

[0312] Addendum 54. The system of Addendum 52, wherein the actuator is configured to rotate one or more of the arms to adjust the separation distance.

[0313] Addendum 55. The system of Addendum 52, wherein the actuator comprises one or more of a mechanical linkage, a cam and follower arrangement, a gear, or a set of gears, and optionally, the actuator comprises a passive actuator configured to adjust the separation distance in response to translation of the electrodes.

[0314] Addendum 56. The system of Addendum 52, wherein the actuator comprises one or more of a motor, a rotary motor, a squiggle motor, a linear motor, a solenoid, a rotary solenoid, a linear solenoid, a voice coil, a spring, a moving coil, a piezoelectric actuator, a pneumatic actuator, a hydraulic actuator, or a fluid actuator, and optionally, the actuator comprises an active actuator.

[0315] Addendum 57. The system of Addendum 52, wherein the actuator is configured to adjust the separation distance while the electrodes are translated to create the curved incision.

[0316] Clause 58. The system of clause 1, further comprising a processor operably coupled to the plurality of arms to move the plurality of arms and incise tissue using the elongated electrodes.

[0317] Clause 59. The system of clause 58, wherein the processor is configured to generate a pocket incision by repeating the sequence of distal and proximal translation of the elongated electrode more than once.

[0318] Addendum 60. The system of Addendum 59, wherein the processor is configured to adjust an initial contact location between the electrode and the tissue from a first location for the first incision to a second location for the second incision.

[0319] Addendum 61. The system of Addendum 60, wherein the positional relationship between the first incision and the second incision comprises one or more of a perpendicular position, an orthogonal position, an opposing position, an opposite position to one another, an angularly deviated position, a position in plane with one another, a position out of plane with one another, a position adjacent to one another, a position where the first incision is lower than the second incision, or a position where the first incision is elevated relative to the second incision.

[0320] Clause 62. The system of clause 59, wherein the elongated electrode is energized exclusively in only one of the distal translation or the proximal translation.

[0321] Addendum 63. The system of Addendum 59, wherein a different extension electrode is used for each repetition of the sequence.

[0322] Addendum 64. The system of Addendum 58, wherein the pocket incision comprises at least two substantially parallel curves.

[0323] Addendum 65. The system of Addendum 64, wherein the at least two substantially parallel curves are joined by at least two open incisions.

[0324] Addendum 66. The system of Addendum 64, wherein the at least two substantially parallel curves form substantially concentric circular arcs.

[0325] Addendum 67. The system of Addendum 1, wherein at least one of the multiple arms is configured to move independently of another arm.

[0326] Addendum 68. The system of Addendum 67, wherein the multiple arms include a first arm and a second arm configured to overlap each other at a location corresponding to an external opening into the incision.

[0327] Addendum 69. The system of Addendum 68, wherein the location along the first arm and the second arm corresponding to the opening to the incision changes when the electrodes are translated and the location of overlap between the first arm and the second arm is adjusted in response to the translated position of the electrodes.

[0328] Addendum 70. The system of Addendum 69, wherein the location is adjusted using one or more of an actuator or a processor in response to a translational position of the electrode.

[0329] Addendum 71. The system of Addendum 70, wherein one or more of the plurality of arms are configured to pivot and define a path to intersect the location of the overlap with an outer opening of the incision.

[0330] Addendum 72. The system of Addendum 71, wherein the path comprises a curve.

[0331] Addendum 73. The system of Addendum 68, wherein the location of the overlap defines an angle between the first arm and the second arm.

[0332] Clause 74. The system of clause 73, wherein the first arm and the second arm are configured to translate together while the arms overlap at an angle to maintain an exposed length of the extension electrode between the first arm and the second arm.

[0333] Clause 75. The system of clause 73, wherein the first arm and the second arm are configured to translate toward or away from each other to maintain an angle and adjust an exposed length of the electrode.

[0334] Addendum 76. The system of Addendum 68, wherein the location of overlap is located between the extension electrode and a pivot location of at least one of the multiple arms.

[0335] Addendum 77. The system of Addendum 68, wherein the first arm and the second arm are configured to rotate and translate together to adjust the location of the overlap.

[0336] Addendum 78. The system of Addendum 77, wherein the first arm is configured to pivot about a first axis, the second arm is configured to pivot about a second axis, and the actuator is configured to adjust the distance between the first axis and the second axis.

[0337] Addendum 79. The system of Addendum 1, wherein the electrode is not supported between the two arms.

[0338] Addendum 80. The system of Addendum 1, wherein the electrode is configured to vibrate transversely to the electrode's axis of elongation.

[0339] Addendum 81. The system of Addendum 1, further comprising a support structure operably coupled to the plurality of arms and tension element, the support structure configured to advance the plurality of arms and tension element to advance the elongated electrode into tissue and incise the tissue.

[0340] Clause 82. The system of clause 81, wherein the cutout portion of the elongated electrode is suspended between multiple arms using tension from a tension element, and a gap extends between the multiple arms.

[0341] Clause 83. The system of clause 82, wherein a gap extends between the incision portion of the elongated electrode, the plurality of arms, and the support structure.

[0342] Clause 84. The system of clause 82, wherein the gap is sized to receive the incised tissue along the incision made using the elongated electrode.

[0343] Clause 85. The system of clause 81, wherein the support structure is operably coupled to one or more actuators to move the elongated electrodes in one or more directions.

[0344] Clause 86. The system of clause 85, wherein the one or more actuators are configured to move the electrodes with variable speed.

[0345] Addendum 87. The system of Addendum 1, wherein the tension element is selected from the group consisting of a spring, a coil spring, a leaf spring, a torsion spring, a mesh, a hinge, and a living hinge.

[0346] Addendum 88. The system of Addendum 1, wherein the elongated electrode constitutes a first portion of an elongated filament and the tension element constitutes a second portion of the elongated filament shaped to tension the elongated electrode.

[0347] Addendum 89. The system of Addendum 1, further comprising an electrode assembly comprising a support structure operably coupled to the plurality of arms and tension element, the electrode assembly configured to advance the electrode into tissue and incise the tissue.

[0348] Addendum 90. The system of Addendum 1, wherein the electrodes are configured to sequentially contact multiple locations of the tissue to generate incisions.

[0349] Clause 91. The system of Clause 90, wherein the plurality of locations comprises a plurality of non-contiguous locations.

[0350] Addendum 92. The system of Addendum 91, wherein the electrode is configured to vaporize tissue in contact with the electrode at each of a plurality of discrete locations.

[0351] Addendum 93. The system of Addendum 1, wherein the electrode is configured to generate multiple flashes of light energy at multiple locations while the electrode cuts the tissue.

[0352] Addendum 94. The system of Addendum 93, wherein the multiple flashes of light energy comprise visible light energy having a wavelength in the range of about 400 nm to about 750 nm.

[0353] Addendum 95. The system of Addendum 93, wherein each of the multiple flashes of light energy has a maximum traversal distance of about 1 mm or less.

[0354] Clause 96. The system of clause 93, wherein the multiple flashes are generated within a time interval of about 250 μs or less, optionally about 25 μs or less.

[0355] Addendum 97. The system of Addendum 93, wherein the multiple flashes are generated with an electrode travel distance of about 100 μm or less, optionally about 10 μm or less.

[0356] Addendum 98. The system of Addendum 93, wherein the multiple flashes of light are dispersed in multiple non-overlapping regions.

[0357] Clause 99. The system of clause 98, wherein the multiple non-overlapping regions are located along the elongated electrode.

[0358] Addendum 100. The system of Addendum 93, wherein the multiple flashes of light are generated at a first rate involving a first speed of the electrodes and at a second rate involving a second speed of the electrodes, the first rate exceeding the second rate when the first speed is less than the second speed, and the first rate being less than the second rate when the first speed is greater than the second speed.

[0359] Addendum 101. The system of Addendum 100, wherein the multiple flashes of light are generated at a substantially constant rate within about 25%, and one or more of the pulse rate or burst rate of the waveform to the elongated electrode is varied in response to the variable speed of the electrode to maintain a substantially constant rate.

[0360] Addendum 102. The system of Addendum 1, wherein the elongated electrode comprises a filament, the filament comprising one or more of a wire or a thread.

[0361] Addendum 103. The system of Addendum 1, wherein the elongated electrode comprises a wire.

[0362] Addendum 104. The system of Addendum 103, wherein the wire diameter is within the range of 5 μm to 200 μm, optionally about 5 μm to about 100 μm, optionally about 5 μm to about 50 μm, optionally about 5 μm to about 25 μm, or optionally about 5 μm to about 20 μm.

[0363] Addendum 105. The system of Addendum 1, wherein the elongated electrode has a cross-sectional distance of about 25 μm or less.

[0364] Addendum 106. The system of Addendum 1, wherein the elongated electrode operably coupled to the tension element has a mechanical resonant frequency in the range of about 1 kHz to about 100 kHz, optionally in the range of about 2 kHz to about 50 kHz.

[0365] Addendum 107. The system of Addendum 1, wherein the tension element is configured to tension the elongated electrode with a force in the range of about 20 mN to about 2 N, optionally in the range of about 50 mN to about 1 N, and further optionally in the range of about 100 mN to about 500 mN.

[0366] Appendix 108. The extension electrode is approximately 0.2 μg mm -1 to approximately 3 μg mm -1 2. The system of claim 1, comprising a mass per unit length in the range of

[0367] Addendum 109. The system of Addendum 1, wherein the elongated electrode comprises a material selected from the group consisting of tungsten, nitinol, steel, copper, brass, titanium, stainless steel, beryllium-copper alloy, cupro-nickel alloy, palladium, platinum, platinum-iridium, silver, and aluminum.

[0368] Addendum 110. The system of Addendum 1, wherein the elongate electrode has an axis along an elongate direction of the electrode, and the electrode is configured to incise tissue using movement lateral to the axis.

[0369] Appendix 111. The extension electrode is about 1 m s -12. The system of claim 1, configured to cut tissue transversely to the direction of electrode extension at a speed greater than or equal to 1000 rpm.

[0370] Appendix 112. The extension electrode is approximately 0.5 cm s -1 from about 10 m s -1 Within the range of approximately 1 cm s -1 From about 5 m s -1 2. The system of claim 1, configured to cut tissue transversely to a direction of electrode extension at a speed within a range of.

[0371] Appendix 113. The electrode is approximately 5 mm2·s -1 to approximately 50,000 mm2·s -1 , optionally within the range of about 500 mm2·s -1 to approximately 25,000 mm2·s -1 2. The system of claim 1, configured to incise an area of ​​tissue at a rate within a range of.

[0372] Addendum 114. The system of Addendum 1, wherein the electrical energy source is configured to deliver a waveform, the waveform comprising one or more of a pulsatile waveform, a sinusoidal waveform, a square waveform, a sawtooth waveform, a triangular waveform, a fixed frequency waveform, a variable frequency waveform, or a gated waveform.

[0373] Clause 115. The system of clause 114, wherein the waveform comprises a sine wave waveform, the sine wave waveform having a frequency in the range of about 0.5 MHz to about 2 MHz.

[0374] Addendum 116. The system of Addendum 114, wherein the waveform comprises a combination of a sine wave waveform and a gated waveform, the sine wave waveform having a frequency in the range of about 0.5 MHz to about 2 MHz, and the gated waveform having a gating frequency in the range of about 20 kHz to about 80 kHz and a duty cycle in the range of about 35% to about 100%.

[0375] Addendum 117. The system of Addendum 1, further comprising a controller operably coupled to the source of electrical energy.

[0376] Addendum 118. The system of Addendum 117, wherein the controller is configured to control parameters of the electrical energy source by modulating the waveform using parameters selected from the group consisting of voltage, current, carrier frequency, modulation frequency, duty cycle, power set point, power limit, energy per pulse set point, energy per pulse limit, and modulation envelope.

[0377] Addendum 119. The system of Addendum 118, wherein the waveform comprises a pulsatile voltage waveform comprising pulses and a substantially constant frequency within the range of about 10 kHz to about 10 MHz, optionally within the range of about 0.5 MHz to about 2 MHz.

[0378] Addendum 120. The system of Addendum 119, wherein the waveform provides energy per pulse in the range of about 0.5 μJ to about 50 μJ, optionally in the range of about 1 μJ to about 10 μJ.

[0379] Clause 121. The system of Clause 120, wherein the controller is configured to modulate the substantially constant frequency waveform to produce the burst.

[0380] Clause 122. The system of clause 121, wherein the frequency of the burst is in the range of about 100 Hz to about 3 MHz, optionally in the range of about 1 kHz to about 100 kHz.

[0381] Addendum 123. The system of Addendum 122, wherein the waveform from the electrical energy source is configured to provide an average power in the range of about 1 W to about 25 W.

[0382] Addendum 124. The system of Addendum 81, further comprising a translation element operably coupled to the support structure and configured to orient the support structure along an axis of motion transverse to the extension axis of the electrode.

[0383] Addendum 125. The system of Addendum 124, wherein the translation element is selected from the group consisting of a translation stage, a linear stage, a rotary stage, a rail, a rod, a cylindrical sleeve, a screw, a roller screw, a traveling nut, a rack, a pinion, a belt, a chain, a linear motion bearing, a rotary motion bearing, a cam, a flexure, and a dovetail.

[0384] Addendum 126. The system of Addendum 125, comprising an actuator operably coupled to the translation element to move the support structure along the axis of motion.

[0385] Addendum 127. The system of Addendum 126, wherein the translation element is manually actuated.

[0386] Addendum 128. The system of Addendum 126, wherein the actuator is selected from the group consisting of a motor, a rotary motor, a squiggle motor, a linear motor, a solenoid, a rotary solenoid, a linear solenoid, a voice coil, a spring, a moving coil, a piezoelectric actuator, a pneumatic actuator, a hydraulic actuator, and a fluid actuator.

[0387] Addendum 129. The system of Addendum 81, wherein a portion of the support structure comprises a material selected from the group consisting of tungsten, nitinol, steel, copper, brass, titanium, stainless steel, beryllium-copper alloy, cupronickel alloy, palladium, platinum, platinum-iridium, silver, aluminum, polyimide, PTFE, polyethylene, polypropylene, polycarbonate, poly(methyl methacrylate), acrylonitrile butadiene styrene, polyamide, polylactic acid, polyoxymethylene, polyether ether ketone, polyvinyl chloride, polylactic acid, glass, and ceramic.

[0388] Addendum 130. The system of Addendum 124, wherein the translation element comprises a first translation element having a first axis of motion and a second translation element having a second axis of motion different from the first axis of motion.

[0389] Clause 131. The system of clause 130, wherein each of the first and second translation elements is selected from the group consisting of a translation stage, a linear stage, a rotary stage, a rail, a rod, a cylindrical sleeve, a screw, a roller screw, a traveling nut, a rack, a pinion, a belt, a chain, a linear motion bearing, a rotary motion bearing, a cam, a flexure, and a dovetail.

[0390] Clause 132. The system of clause 131, further comprising a contact plate operably coupled to the second translation element and configured to engage a portion of the tissue and shape the tissue prior to cutting the tissue with the electrode.

[0391] Addendum 133. The system of Addendum 1, further comprising a contact plate operably coupled to the elongated electrode, the contact plate configured to engage a portion of the cornea and shape the cornea prior to incising the cornea with the electrode.

[0392] Addendum 134. The system of Addendum 133, wherein the contact plate comprises a first contact plate having a first surface profile and a second contact plate having a second surface profile, a difference between the first surface profile and the second surface profile corresponding to a refractive correction of the eye to correct a refractive error of the eye.

[0393] Addendum 135. The system of Addendum 133, wherein the contact plate comprises a freeform optical surface shaped to correct wavefront aberrations of the eye.

[0394] Addendum 136. The system of Addendum 133, wherein the contact plate comprises a plurality of independently adjustable actuators to shape the cornea.

[0395] Addendum 137. The system of Addendum 136, wherein the contact plate comprises a plurality of plates operably coupled to independently adjustable actuators to shape the cornea.

[0396] Addendum 138. The system of Addendum 137, wherein each of the plurality of plates is configured to be driven to a first position and a second position at each of a plurality of locations, a difference between the first position and the second position corresponding to a geometric profile of tissue to be ablated from the cornea to improve refractive error of the eye.

[0397] Addendum 139. The system of Addendum 138, wherein the multiple locations comprise multiple two-dimensional locations and the shape profile comprises a three-dimensional tissue ablation profile.

[0398] Addendum 140. The system of Addendum 136, wherein the plurality of actuators comprises at least 10 actuators, optionally, the plurality of actuators comprises at least 16 actuators, optionally, the plurality of actuators comprises at least 42 actuators, optionally, the plurality of actuators comprises at least 100 actuators.

[0399] Addendum 141. The system of Addendum 136, wherein the contact plate comprises a deformable membrane operably coupled to a plurality of independently adjustable actuators.

[0400] Addendum 142. The system of Addendum 136, wherein the contact plate comprises a first configuration for making a first incision with an electrode along a first incision profile and a second configuration for making a second incision with an electrode along a second incision profile, a difference between the first incision profile and the second incision profile corresponding to a shape of a corneal piece of tissue to be removed from the cornea to treat refractive error of the eye.

[0401] Addendum 143. The system of Addendum 133, wherein the contact plate is configured to correct one or more of the spherical power, cylindrical aberration, coma aberration, spherical aberration, or sagittal aberration of the eye.

[0402] Addendum 144. The system of Addendum 133, further comprising a suction element that engages tissue and holds tissue in contact with the second translation element in a substantially fixed position while the first translation element moves the electrode and cuts the tissue.

[0403] Addendum 145. The system of Addendum 133, further comprising a sterile barrier for placement on the contact plate to maintain sterile conditions of the eye.

[0404] Addendum 146. The system of Addendum 145, wherein the sterile barrier comprises a thin conformal barrier that conforms to the shape of the contact plate, with the sterile barrier between the eye and the contact plate.

[0405] Addendum 147. The system of Addendum 145, wherein the sterile barrier comprises a peel-and-adhesive sterile barrier.

[0406] Addendum 148. The system of Addendum 133, wherein the length of the elongated electrode is in the range of about 6 mm to about 12 mm, the tissue comprises corneal tissue, the electrode comprises a wire having a diameter in the range of about 5 μm to about 20 μm, and the tension element is configured to provide a tension in the range of about 100 mN to about 500 mN to the electrode.

[0407] Addendum 149. The system of Addendum 1, further comprising a processor operably coupled to the elongate electrode, the processor configured with instructions to advance the electrode distally and retract the electrode proximally.

[0408] Addendum 150. The system of Addendum 149, wherein the elongated electrode is sized for insertion into the tissue, and the processor is configured with instructions for dissecting the tissue with the electrode and defining a volume of dissected tissue, the volume having a geometric profile.

[0409] Addendum 151. The system of Addendum 150, wherein the processor is configured with instructions for moving the electrode with a first movement to define a first surface on a first side of the tissue volume and with a second movement to define a second surface on a second side of the tissue volume.

[0410] Addendum 152. The system of Addendum 150, wherein the processor is configured with instructions to advance the electrode distally to define a first surface on a first side of the tissue volume and retract the electrode proximally to define a second surface on a second side of the tissue volume.

[0411] Addendum 153. The system of Addendum 152, wherein a gap extends between the elongated electrode and the support structure, the gap being sized to receive tissue, and the tissue extending into the gap is incised when the electrode is retracted proximally.

[0412] Addendum 154. The system of Addendum 150, wherein the contact plate comprises a first configuration for defining a first surface on a first side of the tissue volume and a second configuration for defining a second surface on a second side of the tissue volume.

[0413] Addendum 155. The system of Addendum 150, wherein the first contact plate has a first geometric profile for defining a first surface on a first side of the tissue volume and a second geometric profile for defining a second surface on a second side of the tissue volume.

[0414] Clause 156. The system of clause 150, wherein the shape profile comprises a thickness profile.

[0415] Addendum 157. A system for treating refractive error of an eye, the system comprising: an elongated electrode for incising corneal tissue; a plurality of arms operably coupled to the electrode and a tensioning element, each of the plurality of arms having a tip distal to the elongated electrode for penetrating tissue; an electrical energy source operably coupled to the elongated electrode and configured to provide electrical energy to the electrode; a contact plate configured to engage a portion of the cornea and shape the cornea prior to incising the cornea with the electrode; and a support structure operably coupled to the elongated electrode and the plate, the support structure configured to move the electrode relative to the plate and incise corneal tissue with the electrode.

[0416] Clause 158. The system of clause 157, further comprising a translation element operably coupled to the support structure and the elongate electrode, the translation element using translation of the electrode to incise the corneal tissue.

[0417] Addendum 159. The system of Addendum 157, wherein the contact plate comprises a first contact plate having a first surface profile and a second contact plate having a second surface profile, a difference between the first surface profile and the second surface profile corresponding to a refractive correction of the eye to correct a refractive error of the eye.

[0418] Addendum 160. The system of Addendum 157, wherein the contact plate comprises a freeform optical surface shaped to correct wavefront aberrations of the eye.

[0419] Addendum 161. The system of Addendum 157, wherein the contact plate comprises a plurality of independently adjustable actuators to shape the cornea.

[0420] Addendum 162. The system of Addendum 161, wherein the contact plate comprises a plurality of plates operably coupled to independently adjustable actuators to shape the cornea.

[0421] Addendum 163. The system of Addendum 162, wherein each of the plurality of plates is configured to be driven to a first position and a second position at each of a plurality of locations, a difference between the first position and the second position corresponding to a geometric profile of tissue to be ablated from the cornea to improve refractive error of the eye.

[0422] Addendum 164. The system of Addendum 163, wherein the multiple locations comprise multiple two-dimensional locations and the shape profile comprises a three-dimensional tissue ablation profile.

[0423] Addendum 165. The system of Addendum 161, wherein the plurality of actuators comprises at least 10 actuators, optionally, the plurality of actuators comprises at least 16 actuators, optionally, the plurality of actuators comprises at least 42 actuators, optionally, the plurality of actuators comprises at least 100 actuators.

[0424] Addendum 166. The system of Addendum 161, wherein the contact plate comprises a deformable membrane operably coupled to a plurality of independently adjustable actuators.

[0425] Addendum 167. The system of Addendum 161, wherein the contact plate comprises a first configuration for making a first incision with an electrode along a first incision profile and a second configuration for making a second incision with an electrode along a second incision profile, a difference between the first incision profile and the second incision profile corresponding to a shape of a corneal flap of tissue to be removed from the cornea to treat refractive error of the eye.

[0426] Addendum 168. The system of Addendum 157, wherein the contact plate is configured to correct one or more of the spherical power, cylindrical aberration, coma aberration, spherical aberration, or sagittal aberration of the eye.

[0427] Addendum 169. The system of Addendum 157, further comprising a suction element that engages tissue and holds tissue in contact with the second translation element in a substantially fixed position while the first translation element moves the electrode and cuts the tissue.

[0428] Item 170. The system of item 157, further comprising a sterile barrier for placement on the contact plate to maintain sterile conditions of the eye.

[0429] Addendum 171. The system of Addendum 170, wherein the sterile barrier comprises a thin conformal barrier that conforms to the shape of the contact plate, with the sterile barrier between the eye and the contact plate.

[0430] Item 172. The system of item 170, wherein the sterile barrier comprises a peel-and-adhesive sterile barrier.

[0431] Addendum 173. The system of Addendum 157, wherein the length of the elongated electrode is in the range of 6 mm to 12 mm, the electrode comprises a wire having a diameter in the range of 5 μm to 20 μm, and the tension element is configured to provide a tension in the range of 100 mN to 500 mN to the electrode.

[0432] Clause 174. The system of clause 157, further comprising a processor operably coupled to the elongate electrode, the processor configured with instructions to advance the electrode distally and retract the electrode proximally.

[0433] Addendum 175. The system of Addendum 174, wherein the elongated electrode is sized for insertion into a cornea of ​​an eye to treat refractive error of the eye, and the processor is configured with instructions to incise the cornea using the electrode and define a corneal slice of corneal tissue within the pocket, the corneal slice having a geometric profile corresponding to the treatment of the refractive error.

[0434] Addendum 176. The system of Addendum 175, wherein the processor is configured with instructions to move the electrode with a first movement to define a first surface on a first side of the corneal piece and to move the electrode with a second movement to define a second surface on a second side of the corneal piece.

[0435] Addendum 177. The system of Addendum 175, wherein the processor is configured with instructions to advance the electrode distally to define a first surface on a first side of the corneal strip and retract the electrode proximally to define a second surface on a second side of the corneal strip.

[0436] Addendum 178. The system of Addendum 177, wherein a gap extends between the elongated electrode and the support structure, the gap is sized to receive tissue, and the tissue extending into the gap is incised when the electrode is retracted proximally.

[0437] Addendum 179. The system of Addendum 175, wherein the contact plate has a first configuration for defining a first surface on a first side of the corneal piece and a second configuration for defining a second surface on a second side of the corneal piece.

[0438] Addendum 180. The system of Addendum 175, wherein the first contact plate has a first shape profile for defining a first surface on a first side of the corneal piece and a second shape profile for defining a second surface on a second side of the corneal piece.

[0439] Addendum 181. The system of Addendum 175, wherein the shape profile comprises a thickness profile.

[0440] CLAIM 182. A method for cutting tissue using plasma, comprising: penetrating tissue with distal tips located on a plurality of arms, an elongated electrode supported between the plurality of arms; and cutting tissue with the elongated electrode, the elongated electrode configured to flex, generate plasma, and cut tissue; an electrical energy source is operably coupled to the elongated electrode and provides electrical energy to the electrode to generate plasma; and a tensioning element is operably coupled to the elongated electrode and provides tension to the elongated electrode, enabling the elongated electrode to flex and generate plasma in response to the elongated electrode engaging the tissue.

[0441] Addendum 183. A method for treating refractive error of an eye, the method including penetrating corneal tissue with a distal tip located on a first arm and a second arm, wherein an elongated electrode is supported between the first arm and the second arm; incising the corneal tissue with the elongated electrode by providing electrical energy to the electrode; and engaging a portion of the cornea with a contact plate and shaping the cornea prior to incising the cornea with the electrode, wherein a support structure moves the electrode relative to the plate and incises the corneal tissue with the electrode.

[0442] Addendum 184. A method for treating refractive error of an eye, the method including penetrating a cornea of ​​the eye with a distal tip located on a plurality of arms, an elongated electrode supported between the plurality of arms, incising the cornea with the electrode to define a corneal fragment of corneal tissue in a pocket, and removing the corneal fragment, the corneal fragment having a geometric profile corresponding to the treatment of the refractive error.

[0443] Clause 185. The system or method of any one of the preceding clauses, further comprising a processor operably coupled to the elongated electrode for moving the elongated electrode and incising tissue.

[0444] The embodiments of the present disclosure are shown and described herein and are provided only as examples. Those skilled in the art will recognize numerous adaptations, changes, modifications, and substitutions without departing from the scope of the present disclosure. Several alternatives and combinations of the embodiments disclosed herein may be utilized without departing from the scope of the present disclosure and the invention disclosed herein. Therefore, the scope of the invention of the present disclosure shall be defined only by the scope of the appended claims and their equivalents.

Claims

1. 1. A system for cutting tissue using plasma, comprising: an elongated electrode configured to flex, generate the plasma, and cut the tissue; an electrical energy source operably coupled to the elongated electrode and configured to provide electrical energy to the electrode to generate the plasma; and a tension element operably coupled to the elongated electrode, the tension element configured to provide tension to the elongated electrode, allowing the elongated electrode to flex and generate the plasma in response to the elongated electrode engaging the tissue; a plurality of arms operably coupled to the electrode and the tension element, each of the plurality of arms including a tip distal to the elongated electrode for penetrating tissue; A system comprising:

2. The system of claim 1 , wherein each of the plurality of elongated arms comprises an opening into a lumen and a track located within the lumen that routes the elongated electrode from the lumen through the opening.

3. The system of claim 2 , wherein each of the plurality of arms comprises an extension extending between the track and the tip, the extension positioning the tip distal to the elongated electrode.

4. The system of claim 2 , wherein each of the plurality of arms comprises a tube, the lumen and the track located within the tube, and the opening formed within the tube.

5. The system of claim 2 , wherein the track comprises a curved surface.

6. The system of claim 5 , wherein the curved surface comprises a radius.

7. The system of claim 5 , wherein the track comprises a first surface and a second surface that merge to form the track and route the electrode through the opening.

8. The system of claim 2 , wherein the opening comprises a width in the range of about 5% to about 50% of a corresponding cross-sectional width of the arm.

9. The system of claim 2 , wherein the opening is sized to receive the track.

10. The system of claim 2 , wherein the track is affixed to the arm.

11. The system of claim 2 , wherein the opening comprises a slit.

12. The system described in claim 9, wherein the slit has a length and a width, the length being greater than the width, and the length being within the range of 50% to 500% of the radius of the track, optionally within the range of 125% to 250% of the radius of the track.

13. 13. The system of claim 12, wherein the width is in the range of 5% to 50% of the cross-sectional width of the arm, optionally in the range of 15% to 25% of the cross-sectional width of the arm.

14. The system of claim 2 , wherein the track is configured to engage the elongated electrode along an arc length of 135 degrees or less, optionally 100 degrees or less.

15. The system of claim 14 , wherein the track comprises a curved end.

16. The system of claim 2 , wherein the track is sized and shaped to be placed within a lumen of each of the plurality of arms.

17. The system of claim 2 , wherein the track is configured to allow the elongated electrode to slide when tensioned between the plurality of arms.

18. The system of claim 2 , wherein the track comprises an electrically insulating material.

19. 3. The system of claim 2, wherein the track comprises a track radius and the electrode comprises an electrode radius across a cross section of the electrode, the ratio of the track radius to the electrode radius being in the range of about 5 to about 500, optionally in the range of about 5 to about 100, further optionally in the range of about 10 to about 50.

20. 20. The system of claim 19, wherein the track radius is in the range of about 0.038 mm to about 1 mm, optionally in the range of about 0.04 mm to about 0.75 mm.

Images